  | GREGOIRE, C., Louis, E., BRIQUET, A., LECHANTEUR, C., BAUDOUX, E., GIET, O., Beguin, Y., & BARON, F. (2017). The role of mesenchymal stromal cells in the treatment of ulcerative colitis and Crohn’s disease. In The Biology and Therapeutic Application of Mesenchymal Cells (pp. 730-753). Hoboken, United States: John Wiley & Sons, Inc.  Peer reviewed |
 | GREGOIRE, C., DETRY, O., Jouret, F., BRIQUET, A., LECHANTEUR, C., BAUDOUX, E., Beguin, Y., & GIET, O. (2017). The use of mesenchymal stromal cells in solid organ transplantation. In The Biology and Therapeutic Application of Mesenchymal Cells (pp. 825-835). Hoboken, United States: John Willey & Sons, Inc. Peer reviewed |
 | Beguin, Y., & Vanstraelen, G. (2008). Prediction of response to recombinant human erythropoietin in the anemia of cancer. In M. R. Nowrousian, Recombinant human erythropoietin (rhEPO) in clinical oncology (2nd Ed.). Berlin - Heidelberg, Germany: Springer-Verlag. |
 | Vanstraelen, G., & Beguin, Y. (2008). rhEPO in hematopoietic stem cell transplantation. In M. R. Nowrousian, Recombinant human erythropoietin (rhEPO) in clinical oncology (2nd Ed.) (pp. 583-614). Berlin - Heidelberg, Germany: Springer-Verla. |
 | Beguin, Y., & Estatiev, R. (2008). Iron deficiency. In C. Gasche, Anemia in inflammatory bowel disease (pp. 42-47). Uni-Med Verlag. |
 | Beguin, Y. (2008). Erythropoiesis. In C. Gasche, Anemia in inflammatory bowel disease (pp. 38-42). Uni-Med Verlag. |
 | Beguin, Y., Dujardin, C., Piron, M., & Vanstraelen, G. (2006). Treatment of anaemia with erythropoietin. In C. Brugnara & C. Beaumont, ESH Scientific Updates. Disorders of Iron Homeostasis, Erythrocytes and erythropoiesis (pp. 180-209). Elsevier Science. |
 | Beguin, Y. (2005). Erythropoietic agents and iron. In M. Aapro, C. Bokemeyer, ... H. Ludwig, ESO Scientific Updates, Vol. 6 (2nd ed). Anaemia in cancer (pp. 199-220). Elsevier Science. |
 | Beguin, Y. (2005). Endogenous erythropoietin in the anemia of chronic disorders. In W. Weiss, V. R. Gordeuk, ... C. Hershko, Anemia of chronic disease (pp. 145-200). New York, United States - New York: Marcel Dekker. |
  | Jerusalem, G., Hustinx, R., Beguin, Y., & Fillet, G. (2005). Whole-Body Positron Emission Tomography using 18F-Fluorodeoxyglucose for Staging Response Assessment in Hodgkin's Disease. In B. C. Heinz (Ed.), Trends in Hodgkin's Disease Research (pp. 169-188). New York, United States: Nova Science Publishers. |
 | Beguin, Y. (2002). Predictive factors for response of anemia to recombinant human erythropoietin. In M. R. Nowrousian, Recombinant human erythropoietin (rhEPO) in clinical oncology (pp. 263-286). Berlin - Heidelberg, Germany: Springer-Verlag. |
 | Beguin, Y. (2001). Prediction of response to rHuEpo. In C. Bokemeyer & H. Ludwig, ESO Scientific Upadtes, Vol. 6 Anaemia in cancer (pp. 153-165). Elsevier Science. |
 | Clement, J., De Bock, R., & Beguin, Y. (1994). Defective Epo production contributes to anemia persistent after ARF in nephropathia epidemica (NE). In Papadimitriou & Alexopoulos, Proceedings of the 3rd International Satellite Symposium on Acute Renal Failure (pp. 467-473). Thessaloniki, Greece: University Studio Press. |
 | Baudoux, E., Janssens, M., Beguin, Y., Sondag, D., Fillet, G., & Lamy, M. (1993). Erythropoietin in surgery. In Proceedings of the 4th Regional Congress of the International Society of Blood Transfusion (pp. 213-217). |
 | Fillet, G., & Beguin, Y. (1992). Iron availability for erythropoiesis. In C. Drewienkiewicz, The potential use of erythropoietin to diminish the need for homologous blood in surgery (pp. 43-49). Medical Action Communication. |
 | Beguin, Y., Huebers, H., Finch, C. A., Weber, G., & Roelandts, I. (1988). The regulation of liver iron metabolism. In P. Bratter & P. Schramel, Trace element analytical chemistry in medicine and biology, Vol. 5 (pp. 542-547). Walter de Gruyter. |
 | Beguin, Y., Weber, G., Delbrouck, J.-M., Robaye, G., Roelandts, I., Bury, J., & Fillet, G. (1987). Dosage du zinc sérique chez des patients atteints de leucémie aiguë. In A. Favier, J. Arnaud, ... H. Faure, Le zinc en médecine et biologie (pp. 224-226). Paris, France: Editions Médicales Internationales. |
 | Beguin, Y., Detroz, B., Defraigne, J.-O., Bury, J., Boniver, J., Fillet, G., & Lejeune, G. (1985). Solitary plasmacytoma of the thyroid with serum monoclonal IgG. In J. Radl, W. Hijmans, ... B. Van Camp, Monoclonal gammopathies. Clinical significance and basic mechanisms (pp. 251-253). Eurage. |
 | Beguin, Y., Delbrouck, J.-M., Roelandts, I., & Weber, G. (1984). Serum trace elements in hemoproliferative diseases. In P. Bratter & P. Schramel, Trace element analytical chemistry in medicine and biology, Vol. 3 (pp. 383-389). Walter de Gruyter. |
 | Bayoudh, F., Giot, J.-B., Descy, J., Fontaine, C., Hayette, M.-P., Baron, F., WILLEMS, E., Beguin, Y., FRIPPIAT, F., & Servais, S. (March 2024). Oral minocycline as systemic therapy for uncomplicated venous access device-related bloodstream infection with coagulase-negative staphylococci after allogeneic hematopoietic cell transplantation. Current Research in Translational Medicine, 72 (1), 103422. doi:10.1016/j.retram.2023.103422 Peer Reviewed verified by ORBi |
 | Lombardo, G., HAFRAOUI, K., Beguin, Y., & VERTENOEIL, G. (February 2024). Comment j’explore … une polyglobulie. Revue Médicale de Liège, 79 (2), 110 - 115. Editorial Reviewed verified by ORBi |
 | Conrad, A., Beguin, Y., Guenounou, S., Le Bourgeois, A., Ménard, A.-L., Rialland, F., Layal, S., Mamez, A.-C., Yakoub-Agha, I., & El Cheikh, J. (2024). Mise à jour du calendrier vaccinal après allogreffe de cellules souches hématopoïétiques : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC). Bulletin du Cancer, 111 (25), 40-S49. doi:10.1016/j.bulcan.2023.05.007 Peer Reviewed verified by ORBi |
 | Ortí, G., Gras, L., Koster, L., Kulagin, A., Byrne, J., Apperley, J. F., Halaburda, K., Blau, I. W., Clark, A., Kröger, N., Griskevicius, L., Carlson, K., Collin, M., Bloor, A., Raiola, A. M., Blaise, D., Aljurf, M., López-Corral, L., Sakellari, I., ... Yakoub-Agha, I. (2024). Graft-versus-Host Disease Prophylaxis with Post- Transplantation Cyclophosphamide in Chronic Myeloid Leukemia Patients Undergoing Allogeneic Hematopoietic Cell Transplantation from an Unrelated or Mismatched Related Donor: A Comparative Study from the Chronic Malignancies Working Party of the EBMT (CMWP-EBMT). Transplantation and Cellular Therapy, 30, 93.e1 - 93.e12. doi:10.1016/j.jtct.2023.09.019 Peer Reviewed verified by ORBi |
 | Lacan, C., Lambert, J., Forcade, E., Robin, M., Chevallier, P., Loron, S., Bulabois, C.-É., Orvain, C., Ceballos, P., Daguindau, E., Charbonnier, A., Chalandon, Y., Bernard, M., Simand, C., Rubio, M.-T., Turlure, P., Maertens, J., Huynh, A., Loschi, M., ... Nguyen, S. (2024). Bone marrow graft versus peripheral blood graft in haploidentical hematopoietic stem cells transplantation: a retrospective analysis in1344 patients of SFGM-TC registry. Journal of Hematology and Oncology, 17, 2. doi:10.1186/s13045-023-01515-4 Peer Reviewed verified by ORBi |
 | Robin, M., Gras, L., Koster, L., Gagelmann, N., van Gorkom, G., Ederr, M., Itälä-Remes, M., Zuckerman, T., Beguin, Y., Schaap, N., Drozd-Sokolowska, J., Raj, K., Hayden, P. J., de Wreede, L. C., Battipaglia, G., Polverelli, N., Czerw, T., Hernandez Boluda, J. C., Kröger, N., ... McLornan, D. P. (2024). Early liver complications after allogeneic haematopoietic stem cell transplantation in patients with myelofibrosis: A study on behalf of the Chronic Malignancies Working Party of the EBMT. British Journal of Haematology, 204, 715 - 718. doi:10.1111/bjh.19214 Peer Reviewed verified by ORBi |
 | Voisot, A., Triffaux, F., Roland, I., Meex, C., Detrembleur, N., Baron, F., WILLEMS, E., WALTREGNY, D., Beguin, Y., & Servais, S. (22 September 2023). Endovesical instillation of Cidofovir in the treatment of BK polyomavirus hemorrhagic cystitis after allogeneic hematopoietic cell transplantation. Current Research in Translational Medicine, 71 (1), 103366. doi:10.1016/j.retram.2022.103366 Peer Reviewed verified by ORBi |
 | COVID-19 Host Genetics Initiative, Rahmouni, S., Georges, M., Moutschen, M., Darcis, G., & Beguin, Y. (September 2023). A second update on mapping the human genetic architecture of COVID-19. Nature, 621 (7977), 7 - E26. doi:10.1038/s41586-023-06355-3 Peer Reviewed verified by ORBi |
 | Ritacco, C., Köse, M. C., Courtois, J., Canti, L., Beguin, C., DUBOIS, S., Vandenhove, B., Servais, S., Caers, J., Beguin, Y., Ehx, G.* , & Baron, F.*. (17 March 2023). Post-transplant cyclophosphamide prevents xenogeneic graft-versus-host disease while depleting proliferating regulatory T cells. iScience, 26 (3), 106085. doi:10.1016/j.isci.2023.106085 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Erpicum, P., Pinto Coelho, T., BONVOISIN, C., Bouquegneau, A., GROSCH, S., Navez, M., Vandermeulen, M., Beguin, Y., Detry, O., Jouret, F., & WEEKERS, L. (February 2023). Reprise retardée de fonction du greffon après transplantation rénale : un challenge clinique toujours d’actualité. Revue Médicale de Liège, 78 (2), 107 - 113. Editorial Reviewed verified by ORBi |
 | Rey, G., Daguenet, E., Bonjean, P., Devillier, R., Fegueux, N., Forcade, E., Srour, M., Chevallier, P., Robin, M., Suarez, F., Micol, J.-B., Labussière-Wallet, H., Bilger, K., Daguindau, E., Bay, J.-O., Fayard, A., Bulabois, C.-E., Nguyen-Quoc, S., Genthon, A., ... Tavernier, E. (2023). Allogeneic hematopoietic stem cell transplantation for adults with therapy-related acute myeloid leukaemia: a retrospective multicentre study on behalf of the SFGM-TC. Bone Marrow Transplantation, 58, 1331 - 1338. doi:10.1038/s41409-023-02082-5 Peer Reviewed verified by ORBi |
 | Schmitz, L., Pirotte, M., Lebeau, A., Ernst, M., Fillet, M., DEVEY, A., SCHMITT, J., Cobraiville, G., BINSFELD, M., Gofflot, S., Beguin, Y.* , & Vertenoeil, G.*. (2023). Alterations of erythropoiesis in Covid-19 patients: prevalence of positive Coombs tests and iron metabolism. Therapeutic Advances in Hematology, 14, 20406207231199837. doi:10.1177/20406207231199837 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Saccardi, R., Putter, H., Eikema, D., Busto, M., McGrath, E., Middelkoop, B., Adams, G., Atlija, M., Ayuk, A., Baldomero, H., Beguin, Y., del la Camara, R., Cedillo, A., Sureda, A., Chabannon, C., Corbacioglu, S., Dolstra, H., Duarte, R., Dulery, R., ... Snowden, J. (2023). Benchmarking of survival outcomes following Haematopoietic Stem Cell Transplantation (HSCT): an update of the ongoing project of the European Society for Blood and Marrow Transplantation (EBMT) and Joint Accreditation Committee of ISCT and EBMT (JACIE). Bone Marrow Transplantation, 58, 659-666. doi:10.1038/s41409-023-01924-6 Peer Reviewed verified by ORBi |
 | Lejeune, M., Köse, M. C., Jassin, M., Gou, M.-J., Herbet, A., Duray, E., Cobraiville, G., FOGUENNE, J., Boquet, D., Gothot, A., Beguin, Y., Fillet, M., & Caers, J. (2023). Integrative Analysis of Proteomics and Transcriptomics Reveals Endothelin Receptor B as Novel Single Target and Identifies New Combinatorial Targets for Multiple Myeloma. HemaSphere, 22, 901. doi:10.1097/HS9.0000000000000901 Peer Reviewed verified by ORBi |
 | Servais, S., Baron, F., LECHANTEUR, C., Seidel, L., BAUDOUX, E., BRIQUET, A., Selleslag, D., Maertens, J., Poire, X., Schroyens, W., Graux, C., De Becker, A., Zachee, P., Ory, A., Herman, J., Kerre, T., & Beguin, Y. (2023). Multipotent mesenchymal stromal cells as treatment for poor graft function after allogeneic hematopoietic cell transplantation: A multicenter prospective analysis. Frontiers in Immunology, 14. doi:10.3389/fimmu.2023.1106464 Peer Reviewed verified by ORBi |
 | Reenaers, C., GILLARD, R., Coimbra, C., GILLARD, R., Meunier, P., LECHANTEUR, C., BAUDOUX, E., BOUTAFFALA, L., Beguin, Y., & Louis, E. (2023). Clinical and MRI evolution after local injection of bone marrow-derived mesenchymal stem cells in perianal fistulae in Crohn’s disease: results from a prospective monocentric study. Journal of Crohn's and Colitis, 17, 728-737. doi:10.1093/ecco-jcc/jjac192 Peer Reviewed verified by ORBi |
 | Tournilhac, O., van Gelder, M., Eikema, D., van Biezen, A., Dreger, P., Bornhäuser, M., Vucinic, V., Scheid, C., Cornelissen, J., Schroeder, T., Jindra, P., Sengeloev, H., Nguyen, S., Stelljes, M., Blau, I., Mayer, J., Paneesha, S., Chevalier, C., Forcade, E., ... Yakoub-Agha, I. (2023). The European landscape on allogeneic haematopoeietic cell transplantation in Chronic Lymphocytic Leukaemia between 2009-2019: a perspective from the Chronic Malignancies Working Party of the EBMT. Bone Marrow Transplantation, 58, 621-624. doi:10.1038/s41409-023-01955-z Peer Reviewed verified by ORBi |
 | Kaphan, E., Bettega, F., Forcade, E., Labussière-Wallet, H., Fegueux, N., Robin, M., Peffault De Latour, R., Huynh, A., Lapierre, L., Berceanu, A., Marcais, A., Debureaux, P.-E., Vanlangendonck, N., Bulabois, C.-E., Magro, L., Daniel, A., Galtier, J., Lioure, B., Chevallier, P., ... Thiebaut-Bertrand, A. (2023). Late relapse after hematopoietic stem cell transplantation for acute leukemia: a retrospective study by SFGM-TC. Transplantation and Cellular Therapy, 362, 1 - e12. doi:10.1016/j.jtct.2023.02.020 Peer Reviewed verified by ORBi |
 | Chauvet, P., Paviglianiti, A., Labopin, M., Labussière, H., Boissel, N., Robin, M., Maillard, N., Ouachée-Chardin, M., Forcade, E., Poiré, X., Chantepie, S., Huynh, A., Bulabois, C., Leclerc, M., Maury, S., Chevallier, P., Cluzeau, T., Mear, J., Cornillon, J., ... Brissot, E. (2023). Combining blinatumomab and donor lymphocyte infusion in B-ALL patients relapsing after allogeneic hematopoietic cell transplantation: A study of the SFGM-TC. Bone Marrow Transplantation, 58, 72-79. doi:10.1038/s41409-022-01846-9 Peer Reviewed verified by ORBi |
 | Srour, M., Alsuliman, T., Labreuche, J., Bulabois, C., Chevalier, P., Daguindau, E., Forcade, E., François, S., Guillerm, G., Coiteux, V., Turlure, P., Beguin, Y., Yakoub-Agha, I., & Magro, L. (2023). Nilotinib efficacy and safety as salvage treatment following imatinib intolerance and/or inefficacy in steroid refractory chronic graft-versus-host-disease: A prospective, multicenter, phase II study on behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC). Bone Marrow Transplantation, 58, 401-406. doi:10.1038/s41409-022-01898-x Peer Reviewed verified by ORBi |
 | El Moussaoui, M., Desmecht, S., Lambert, N., Maes, N., Braghini, J., MARECHAL, N., Quintana, C., BRIQUET, K., Gofflot, S., Toussaint, F., Hayette, M.-P., Vermeersch, P., Lutteri, L., GREGOIRE, C., Beguin, Y., Rahmouni, S., Moutschen, M., Desmecht, D., & Darcis, G. (2023). Cluster Analysis Identifies Distinct Patterns of T-Cell and Humoral Immune Responses Evolution Following a Third Dose of SARS-CoV-2 Vaccine in People Living with HIV. Viruses, 15, 1435. doi:10.3390/v15071435 Peer Reviewed verified by ORBi |
 | Michel, C., Robin, M., Morisset, S., Blaise, D., Maertens, J., Chevalier, P., Castilla-Llorente, C., Forcade, E., Ceballos, P., Yakoug-Agha, I., Poire, X., Carre, M., Bay, J.-O., Beguin, Y., Loschi, M., Huynh, A., Guillerm, G., François, S., Mear, J.-B., ... D'Aveni, M. (2023). Outcome after allogeneic stem cell transplantation with haploidentical versus HLA-matched donors in patients with higher-risk MDS. Bone Marrow Transplantation, 58, 534 - 543. doi:10.1038/s41409-023-01931-7 Peer Reviewed verified by ORBi |
 | El Moussaoui, M., Desmecht, S., Tashkeev, A., Lambert, N., Maes, N., Braghini, J., MARECHAL, N., Quintana, C., BRIQUET, K., Gofflot, S., TOUSSAINT, F., Hayette, M.-P., Vermeersch, P., Lutteri, L., Grégoire, C., Beguin, Y., Rahmouni, S., Moutschen, M., Desmecht, D., & Darcis, G. (05 September 2022). Reduced T-cell response following a third dose of SARS-CoV-2 vaccine in infection-naïve people living with HIV. Journal of Infection, 85, 751-755. doi:10.1016/j.jinf.2022.09.006 Peer Reviewed verified by ORBi |
 | De Voeght, A., WILLEMS, E., Servais, S., Seidel, L., Pirotte, M., Massion, P., Layios, N., Pereira, M., Misset, B., CANIVET, J.-L., Beguin, Y., & Baron, F. (31 August 2022). Overall Survival Rate in Allogeneic Stem Cell Transplanted Patients Requiring Intensive Care Can Be Predicted by the Prognostic Index for Critically Ill Allogeneic Transplantation Patients (PICAT) and the Sequential Organ Failure Assessment (SOFA) Scores. Cancers, 14 (17), 4266. doi:10.3390/cancers14174266 Peer Reviewed verified by ORBi |
 | Pathak, G. A., Karjalainen, J., Stevens, C., Neale, B. M., Daly, M., Ganna, A., Andrews, S. J., Kanai, M., Cordioli, M., Polimanti, R., Harerimana, N., Pirinen, M., Liao, R. G., Chwialkowska, K., Trankiem, A., Balaconis, M. K., Nguyen, H., Solomonson, M., Veerapen, K., ... Baillie, J. K. (03 August 2022). A first update on mapping the human genetic architecture of COVID-19. Nature, 608, 1-E10. doi:10.1038/s41586-022-04826-7 Peer Reviewed verified by ORBi |
 | GREGOIRE, C.* , LAYIOS, N.* , LAMBERMONT, B., LECHANTEUR, C., BRIQUET, A., Bettonville, V., BAUDOUX, E., THYS, M., Dardenne, N., Misset, B.* , & BEGUIN, Y.*. (04 July 2022). Bone Marrow-Derived Mesenchymal Stromal Cell Therapy in Severe COVID-19: Preliminary Results of a Phase I/II Clinical Trial. Frontiers in Immunology, 13, 932360. doi:10.3389/fimmu.2022.932360 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Nabergoj, M., Mauff, K., Beelen, D., Ganser, A., Kröger, N., Stölzel, F., Finke, J., Passweg, J., Cornelissen, J., Schub, N., Veelken, J. H., Beguin, Y., Wilson, K., Zuckerman, T., Hunault-Berger, M., Lioure, B., Porras, R. P., Turlure, P., Kerre, T., ... Yakoub-Agha, I. (July 2022). Allogeneic hematopoietic cell transplantation in patients with therapy-related myeloid neoplasm after breast cancer: a study of the Chronic Malignancies Working Party of the EBMT. Bone Marrow Transplantation, 57, 1072 - 1078. doi:10.1038/s41409-022-01686-7 Peer Reviewed verified by ORBi |
 | El Moussaoui, M., Maes, N., Hong, S. L., Lambert, N., Gofflot, S., DELLOT, P., Belhadj, Y., Huynen, P., Hayette, M.-P., Meex, C., Bontems, S., Defêche, J., Godderis, L., Molenberghs, G., Meuris, C., Artesi, M., Durkin, K., Rahmouni, S., GREGOIRE, C., ... DARCIS, G. (14 June 2022). Evaluation of Screening Program and Phylogenetic Analysis of SARS-CoV-2 Infections among Hospital Healthcare Workers in Liège, Belgium. Viruses, 14 (6), 1302. doi:10.3390/v14061302 Peer Reviewed verified by ORBi |
 | GREGOIRE, C.* , HUYNEN, P.* , Gofflot, S., Seidel, L., Maes, N., VRANKEN, L., DELCOUR, S., MOUTSCHEN, M., HAYETTE, M.-P., KOLH, P., MELIN, P., & BEGUIN, Y. (13 June 2022). Predictive factors for the presence and long-term persistence of SARS-CoV-2 antibodies in healthcare and university workers. Scientific Reports, 12, 9790. doi:10.1038/s41598-022-13450-4 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | SERVAIS, S., BEGUIN, Y., & BARON, F. (27 May 2022). Current Status and Perspectives of Allogeneic Hematopoietic Stem Cell Transplantation in Elderly Patients with Acute Myeloid Leukemia. Stem Cells Translational Medicine, 11 (5), 461-477. doi:10.1093/stcltm/szac015 Peer Reviewed verified by ORBi |
 | BARZIN, A., Geurten, C., WILLEMS, E., Baron, F., Beguin, Y., & Servais, S. (May 2022). Maladie du greffon contre l’hôte aiguë et chronique après allogreffe de cellules souches hématopoïétiques. Revue Médicale de Liège, 77 (5-6), 345 - 353. Editorial Reviewed verified by ORBi |
 | Canti, L., Ariën, K. K., Desombere, I., Humblet-Baron, S., Pannus, P., Heyndrickx, L., HENRY, A., SERVAIS, S., WILLEMS, E., Ehx, G., Goriely, S., SEIDEL, L., Michiels, J., Willems, B., Goossens, M. E., Beguin, Y., Marchant, A., & Baron, F. (11 April 2022). Antibody response against SARS-CoV-2 Delta and Omicron variants after third-dose BNT162b2 vaccination in allo-HCT recipients. Cancer Cell, 40 (4), 335-337. doi:10.1016/j.ccell.2022.02.005 Peer Reviewed verified by ORBi |
 | GREGOIRE, C., SERVAIS, S., WILLEMS, E., BAUDOUX, E., LECHANTEUR, C., BRIQUET, A., Bettonville, V., DETRY, O., ERPICUM, P., JOURET, F., LOUIS, E., BARON, F., & BEGUIN, Y. (April 2022). Immunothérapie cellulaire au CHU de Liège : avancées, défis et perspectives. Revue Médicale de Liège, 77 (4), 206-211. Editorial Reviewed verified by ORBi |
 | HUYNEN, P.* , GREGOIRE, C.* , GOFFLOT, S., SEIDEL, L., MAES, N., VRANKEN, L., DELCOUR, S., MOUTSCHEN, M., HAYETTE, M.-P., KOLH, P., MELIN, P., & BEGUIN, Y. (25 March 2022). Long-term longitudinal evaluation of the prevalence of SARS-CoV-2 antibodies in healthcare and university workers. Scientific Reports, 12 (1), 5156. doi:10.1038/s41598-022-09215-8 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | BARON, F., Canti, L., Ariën, K. K., Kemlin, D., Desombere, I., Gerbaux, M., Pannus, P., BEGUIN, Y., Marchant, A., & Humblet-Baron, S. (2022). Insights From Early Clinical Trials Assessing Response to mRNA SARS-CoV-2 Vaccination in Immunocompromised Patients. Frontiers in Immunology, 13, 827242. doi:10.3389/fimmu.2022.827242 Peer Reviewed verified by ORBi |
 | Teyssier, A.-C., Michel, G., Jubert, C., Rialland, F., Visentin, S., Ouachée, M., Bilger, K., Gandemer, V., Beguin, Y., Marie-Cardine, A., Chalandon, Y., Ansari, M., Baumstarck, K., Loundou, A., Dalle, J.-H., & Sirvent, A. (2022). Unrelated Cord Blood Transplantation in Children, Adolescents, and Young Adults with Acute Leukemia or Myelodysplastic Syndrome: A Retrospective Comparative Study from the French Society for Bone Marrow Transplantation and Cellular Therapy Between Real-World Data and Previously Reported Results of a Randomized Clinical Trial. Transplantation and Cellular Therapy, 28, 780.e1 - 780.e7. doi:10.1016/j.jtct.2022.08.019 Peer Reviewed verified by ORBi |
 | Onida, F., Sbianchi, G., Radujkovic, A., Sockel, K., Kröger, N., Sierra, J., Socié, G., Cornelissen, J., Poiré, X., Raida, L., Bourhis, J.-H., Finke, J., Passweg, J., Salmenniemi, U., Schouten, H. C., BEGUIN, Y., Martin, S., Deconinck, E., Ganser, A., ... Yakoub-Agha, I. (2022). Prognostic value of a new clinically-based classification system in patients with CMML undergoing allogeneic HCT: a retrospective analysis of the EBMT-CMWP. Bone Marrow Transplantation, 57, 896-902. doi:10.1038/s41409-021-01555-9 Peer Reviewed verified by ORBi |
 | Poiré, X., Graux, C., ORY, A., Herman, J., Baron, F., Schoemans, H., Lewalle, P., De Becker, A., Deeren, D., Berneman, Z., Kerre, T., Zachée, P., Selleslag, D., & Beguin, Y. (2022). Sequential administration of 5-azacytidine (AZA) and donor lymphocyte infusion (DLI) for patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) in relapse after allogeneic stem cell transplantation (SCT): a prospective study from the Belgian Hematology Society (BHS). Bone Marrow Transplantation, 57, 116-118. doi:10.1038/s41409-021-01464-x Peer Reviewed verified by ORBi |
 | BAYOUDH, F., JASPERS, A., Azerad, M.-A., SOMJA, J., Marechal, H., & Beguin, Y. (2022). A rare case of massive myocardial infiltration by a disseminated extra-nodal NK/T-cell lymphoma. EJHaem, 3, 547-548. Peer Reviewed verified by ORBi |
 | VANDERMEULEN, M., Mohamed-Wais, M., ERPICUM, P., DELBOUILLE, M.-H., LECHANTEUR, C., BRIQUET, A., MAGGIPINTO, G., Jouret, F., Beguin, Y., & Detry, O. (2022). Infusion of allogeneic mesenchymal stromal cells after liver transplantation: Five-year follow-up. Liver Transplantation, 28, 636-646. doi:10.1002/lt.26323 Peer reviewed |
 | Pochon, C., Detrait, M., Dalle, J.-H., Michel, G., Dhédin, N., Chalandon, Y., Brissot, E., Forcade, E., Sirvent, A., Izzadifar-Legrand, F., Michallet, M., Renard, C., Yakoub-Agha, I., Gonzales, F., Bay, J.-O., Kanold, J., Cornillon, J., Bulabois, C. E., Angoso, M., ... Rubio, M.-T. (2022). Improved outcome in children compared to adolescents and young adults after allogeneic hematopoietic stem cell transplant for acute myeloid leukemia: a retrospective study from the Francophone Society of Bone Marrow Transplantation and Cell Therapy (SFGM-TC). Journal of Cancer Research and Clinical Oncology, 148, 2083-2097. doi:10.1007/s00432-021-03761-w Peer Reviewed verified by ORBi |
 | Albert, M. H., Sirait, T., Eikema, D.-J., Bakunina, K., Wehr, C., Suarez, F., Fox, M. L., Mahlaoui, N., Gennery, A. R., Lankester, A. C., Beier, R., Bernardo, M. E., Bigley, V., Lindemans, C. A., Burns, S. O., Carpenter, B., Dybko, J., Güngör, T., Hauck, F., ... Vinh, D. C. (2022). Hematopoietic stem cell transplantation for adolescents and adults with inborn errors of immunity: an EBMT IEWP study. Blood, 140, 1635 - 1649. doi:10.1182/blood.2022015506 Peer Reviewed verified by ORBi |
 | Averbuch, D., De Greef, J., Duréault, A., Wendel, L., Tridello, G., Lebeaux, D., Mikulska, M., Gil, L., Knelange, N., Zuckerman, T., Daguindau, E., Robin, C., Xhaard, A., Aljurf, M., Beguin, Y., Le Bourgeois, A., Botella-Garcia, C., Khanna, N., Van Praet, J., ... Styczynski, J. (2022). Nocardia infections in hematopoietic cell transplant recipients: a multicenter international retrospective study of the Infectious Diseases Working Party (IDWP) of the European Society for Blood and Marrow Transplantation (EBMT). Clinical Infectious Diseases, 75, 88-97. doi:10.1093/cid/ciab866 Peer Reviewed verified by ORBi |
 | VIEUJEAN, S., LOLY, J.-P., BOUTAFFALA, L., MEUNIER, P., REENAERS, C., BRIQUET, A., LECHANTEUR, C., BAUDOUX, E., BEGUIN, Y., & LOUIS, E. (2022). Mesenchymal Stem Cell Injection in Crohn's Disease Strictures: a phase I-II clinical study. Journal of Crohn's and Colitis, 16, 506-510. doi:10.1093/ecco-jcc/jjab154 Peer Reviewed verified by ORBi |
 | Narinx, J., Houbiers, M., Seidel, L., & Beguin, Y. (2022). Adherence to Sars-CoV2 vaccination in hematological patients. Frontiers in Immunology, 13, 994311. doi:10.3389/fimmu.2022.994311 Peer Reviewed verified by ORBi |
 | Le Calvez, B., Tessoullin, B., Renaud, L., Botella-Garcia, C., Srour, M., Le Gouill, S., Guillerm, G., Gressin, R., Nguyen Quoc, S., Furst, S., Chauchet, A., Sibon, D., Lewalle, P., Poiré, X., Maillard, N., Villate, A., Loschi, M., Paillassa, J., Beguin, Y., ... Le Bourgeois, A. (2022). Outcomes after allogeneic hematopoietic stem cell transplantation for adults with primary mediastinal B cell lymphoma: a SFGM-TC and LYSA study. Acta Oncologica, 61, 1332 - 1338. doi:10.1080/0284186X.2022.2130709 Peer Reviewed verified by ORBi |
 | Courtois, J., Ritacco, C., DUBOIS, S., Canti, L., Vandenhove, B., SEIDEL, L., Daulne, C., CAERS, J., SERVAIS, S., Beguin, Y., Ehx, G., & BARON, F. (2021). Itacitinib prevents xenogeneic GVHD in humanized mice. Bone Marrow Transplantation, 56, 2672-2681. doi:10.1038/s41409-021-01363-1 Peer Reviewed verified by ORBi |
 | Narinx, J., SERVAIS, S., BARON, F., BEGUIN, Y., & WILLEMS, E. (2021). Allogreffes de cellules souches hématopoïétiques : principes généraux et progrès récents. Revue Médicale de Liège, 76, 464-469. Peer reviewed |
 | Vrancken, L., Lejeune, M., PIROTTE, M., Duray, E., Köse, M. C., BEGUIN, Y., & CAERS, J. (2021). Le myélome multiple : un tour d’horizon des nouveautés dans sa biologie et son traitement. Revue Médicale de Liège, 76, 482-488. Peer reviewed |
 | LECHANTEUR, C., BRIQUET, A., Bettonville, V., BAUDOUX, E., & BEGUIN, Y. (2021). MSC Manufacturing for Academic Clinical Trials: From a Clinical-Grade to a Full GMP-Compliant Process. Cells, 10, 1320. doi:10.3390/cells10061320 Peer Reviewed verified by ORBi |
 | Janssens, A., Selleslag, D., Depaus, J., BEGUIN, Y., & Lambert, C. (2021). Primary immune thrombocytopenia in adults: Belgian recommendations for diagnosis and treatment anno 2021 made by the Belgian Hematology Society. Belgian Journal of Hematology, 12, 112-127. Peer Reviewed verified by ORBi |
 | MAQUET, C., BEGUIN, Y., DE PRIJCK, B., WILLEMS, E., SERVAIS, S., & BONNET, C. (2021). Le lymphome diffus à grandes cellules B : nouveau traitement révolutionnaire par des cellules immunitaires génétiquement modifiées appelées «CAR T cells». Revue Médicale de Liège, 76, 476-481. Peer reviewed |
 | Kröger, N., Sbianchi, G., Sirait, T., Wolschke, C., Beelen, D., Passweg, J., Robin, M., Vrhovac, R., Helbig, G., Sockel, K., Conneally, E., Rubio, M. T., Beguin, Y., Finke, J., Bernasconi, P., Morozova, E., Clausen, J., von dem Borne, P., Schaap, N., ... Yakoub-Agha, I. (2021). Impact of prior JAK-inhibitor therapy with ruxolitinib on outcome after allogeneic hematopoietic stem cell transplantation for myelofibrosis: a study of the CMWP of EBMT. Leukemia, 35, 3551-3580. doi:10.1038/s41375-021-01276-4 Peer Reviewed verified by ORBi |
 | Janssens, A., Selleslag, D., Depaus, J., BEGUIN, Y., & Lambert, C. (2021). Primary immune thrombocytopenia in adults. Belgian recommendations for diagnosis and treatment anno 2021 made by the Belgian Hematology Society. Acta Clinica Belgica, 26, 1-14. doi:10.1080/17843286.2021.1876310 Peer Reviewed verified by ORBi |
 | Bay, J. O., Beguin, Y., CARPENTIER, A., Dard, C., Guillaume, T., Labussiere-Wallet, H., Lacassagne, M. N., Sauze, S., Yakoub-Agha, I., & Chalandon, Y. (2021). Comment faire face à un évènement inattendu pouvant modifier l’activité normale de thérapie cellulaire? Recommandations de la Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC). Bulletin du Cancer, 108, 20-S25. doi:10.1016/j.bulcan.2021.05.002 Peer Reviewed verified by ORBi |
 | Lejeune, M., Duray, E., Peipp, M., Clémenceau, B., Baron, F., Beguin, Y., & Caers, J. (2021). Balancing the CD38 Expression on Effector and Target Cells in Daratumumab-Mediated NK Cell ADCC against Multiple Myeloma. Cancers, 13 (12), 3072. doi:10.3390/cancers13123072 Peer Reviewed verified by ORBi |
 | Niemi, M., Gazon, H., JUSZCZAK, D., FADEUR, M., CAMBY, S., MEURIS, C., THYS, M., JACQUES, J., HENKET, M., BEGUIN, Y., Rahmouni, S., Lebrun, M., MOUTSCHEN, M., Misset, B., DARCIS, G., GUIOT, J., AZARZAR, S., DELLOT, P., GOFFLOT, S., ... HUYNEN, P. (Other coll.). (2021). Mapping the human genetic architecture of COVID-19. Nature, 600, 472-477. doi:10.1038/s41586-021-03767-x Peer Reviewed verified by ORBi |
 | SCHEEN, A., BEGUIN, Y., & JERUSALEM, G. (2021). L’oncologie, à un tournant de son histoire. Revue Médicale de Liège, 76, 297-299. Peer reviewed |
 | BEGUIN, Y. (2021). L’Institut de Cancérologie Arsène Burny (ICAB) et son nouveau bâtiment du Centre Intégré d’Oncologie (CIO) au CHU de Liège. Revue Médicale de Liège, 76, 300-306. Peer reviewed |
 | Miano, M., Eikema, D.-J., de la Fuente, J., Bosman, P., Ghavamzadeh, A., Smiers, F., Sengeløv, H., Yesilipek, A., Formankova, R., Bader, P., Díaz Pérez, M. Á., Bertrand, Y., Niemeyer, C., Diallo, S., Ansari, M., Bykova, T. A., Faraci, M., Bonanomi, S., Gozdzik, J., ... Dufour, C. (2021). Stem Cell Transplantation for Diamond-Blackfan Anemia. A Retrospective Study on Behalf of the Severe Aplastic Anemia Working Party of the European Blood and Marrow Transplantation Group (EBMT). Transplantation and Cellular Therapy, 27 (3), 274.e1-274.e5. doi:10.1016/j.jtct.2020.12.024 Peer Reviewed verified by ORBi |
 | Xhaard, A., Xhaard, C., d'Aveni, M., Salvator, H., Chabi-Charvillat, M.-L., Coman, T., BEGUIN, Y., Chalandon, Y., Poiré, X., Loschi, M., Paillard, C., Bruno, B., Ceballos, P., Dalle, J.-H., Bilger, K., Bay, J.-O., Robin, M., N'Guyen-Quoc, S., & Rubio, M.-T. (2021). Risk factors for a severe form of COVID-19 after allogeneic haematopoietic stem cell transplantation : a SFGM-TC multicentre cohort study. British Journal of Haematology, 192, 121-e135. doi:10.1111/bjh.17260 Peer Reviewed verified by ORBi |
 | Duray, E., Lejeune, M., Baron, F., Beguin, Y., Devoogdt, N., Krasniqi, A., Lauwers, Y., Zhao, Y. J., D'Huyvetter, M., Dumoulin, M., & Caers, J. (2021). A non-internalised CD38-binding radiolabelled single-domain antibody fragment to monitor and treat multiple myeloma. Journal of hematology & oncology, 14 (1), 183. doi:10.1186/s13045-021-01171-6 Peer reviewed |
 | Ritacco, C.* , Ehx, G.* , GREGOIRE, C., Daulne, C., WILLEMS, E., SERVAIS, S., BEGUIN, Y., & Baron, F. (2021). High proportion of terminally-differentiated regulatory T cells after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation, 56, 1828-1841. doi:10.1038/s41409-021-01221-0 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Canti, L.* , Humblet-Baron, S.* , Desombere, I., Neumann, J., Pannus, P., Heyndrickx, L., Henry, A., SERVAIS, S., WILLEMS, E., Ehx, G., Goriely, S., Seidel, L., Michiels, J., Willems, B., Liston, A., Ariën, K. K., Beguin, Y., Goossens, M. E., Marchant, A., & Baron, F. (2021). Predictors of neutralizing antibody response to BNT162b2 vaccination in allogeneic hematopoietic stem cell transplant recipients. Journal of hematology & oncology, 14 (1), 174. doi:10.1186/s13045-021-01190-3 Peer reviewed* These authors have contributed equally to this work. |
 | PIROTTE, M., Fillet, M., SEIDEL, L., JASPERS, A., Baron, F., & Beguin, Y. (2021). Erythroferrone and hepcidin as mediators between erythropoiesis and iron metabolism during allogeneic hematopoietic stem cell transplant. American Journal of Hematology, 96 (10), 1275-1286. doi:10.1002/ajh.26300 Peer Reviewed verified by ORBi |
 | DE VOEGHT, A., JASPERS, A., BEGUIN, Y., Baron, F., & DE PRIJCK, B. (2021). Principes généraux de la prise en charges des leucémies aiguës de l’adulte en 2021 en Belgique. Revue Médicale de Liège, 76, 470-475. Peer reviewed |
 | Ehx, G.* , Ritacco, C.* , HANNON, M., DUBOIS, S., Delens, L., WILLEMS, E., SERVAIS, S., Drion, P., BEGUIN, Y., & Baron, F. (2021). Comprehensive analysis of the immunomodulatory effects of rapamycin on human T cells in graft-versus-host disease prophylaxis. American Journal of Transplantation, 21, 2662-2674. doi:10.1111/ajt.16505 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Vandenhove, B., Canti, L., Schoemans, H., Beguin, Y., Baron, F., Graux, C., Kerre, T., & SERVAIS, S. (21 October 2020). How to Make an Immune System and a Foreign Host Quickly Cohabit in Peace? The Challenge of Acute Graft-Versus-Host Disease Prevention After Allogeneic Hematopoietic Cell Transplantation. Frontiers in Immunology, 11, 583564. doi:10.3389/fimmu.2020.583564 Peer Reviewed verified by ORBi |
 | Lejeune, M., Köse, M. C., Duray, E., Einsele, H., Beguin, Y., & Caers, J. (07 May 2020). Bispecific, T-Cell-Recruiting Antibodies in B-Cell Malignancies. Frontiers in Immunology, 11 (762), 1-20. doi:10.3389/fimmu.2020.00762 Peer Reviewed verified by ORBi |
 | VANDERMEULEN, M., ERPICUM, P., WEEKERS, L., BRIQUET, A., LECHANTEUR, C., Detry, O., Beguin, Y., & Jouret, F. (May 2020). Mesenchymal Stromal Cells in Solid Organ Transplantation. Transplantation, 104 (5), 923-936. doi:10.1097/TP.0000000000003077 Peer Reviewed verified by ORBi |
 | Roex, G., Feys, T., BEGUIN, Y., Kerre, T., Poiré, X., Lewalle, P., Vandenberghe, P., Bron, D., & Anguille, S. (2020). Chimeric Antigen Receptor-T-Cell Therapy for B-Cell Hematological Malignancies : An Update of the Pivotal Clinical Trial Center. Pharmaceutics, 12, 194. doi:10.3390/pharmaceutics12020194 Peer Reviewed verified by ORBi |
 | Snowden, J. A., Saccardi, R., Orchard, K., Ljungman, P., Duarte, R. F., Labopin, M., McGrath, E., Brook, N., Ruiz de Elvira, C., Gordon, D., Poirel, H. A., Ayuk, F., Beguin, Y., Bonifazi, F., Gratwohl, A., Milpied, N., Moore, J., Passweg, J., Rizzo, J. D., ... Putter, H. (2020). Benchmarking of Survival Outcomes following Haematopoietic Stem Cell Transplantation: A review of existing processes and the introduction of an international system from the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE). Bone Marrow Transplantation, 55, 681-694. doi:10.1038/s41409-019-0718-7 Peer Reviewed verified by ORBi |
 | Lejeune, M., Köse, M. C., Duray, E., Beguin, Y., & CAERS, J. (2020). Les anticorps bispécifiques ciblant les lymphocytes T dans le myélome multiple. OncoHemato : Revue Multidisciplinaire d'Oncologie et Hématologie, 14 (6), 30-34. Peer reviewed |
 | Vandenhove, B.* , Canti, L.* , Schoemans, H., BEGUIN, Y., BARON, F., WILLEMS, E., Graux, C., Kerre, T.* , & SERVAIS, S.*. (2020). Acute graft-versus-host disease: diagnosis, pathophysiology and prevention. Belgian Journal of Hematology, 11 (4), 159-173. Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Mamez, A.-C., Dupont, A., Blaise, D., Chavallier, P., Forcade, E., Ceballos, P., Mohty, M., Suarez, F., BEGUIN, Y., Peffault de Latour, R., Rubio, M.-T., Tournilhac, O., & Nguyen, S. (2020). Allogeneic stem cell transplantation for peripheral T cell lymphomas: a retrospective study in 285 patients from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC). Journal of Hematology and Oncology, 13, 56. doi:10.1186/s13045-020-00892-4 Peer Reviewed verified by ORBi |
 | HAUZEUR, J.-P., LECHANTEUR, C., BAUDOUX, E., De Maertelaer, V., Pather, S., Katz, R., Malaise, M., Ino, J., & Beguin, Y. (2020). Did Osteoblastic Cell Therapy Improve the Prognosis of Prefracture Osteonecrosis of the Femoral Head? A Randomized, Controlled Trial. Clinical Orthopaedics and Related Research, 478, 1307-1315. Peer Reviewed verified by ORBi |
 | Dubois, V., Amokrane, K., Beguin, Y., Bruno, B., Chevallier, P., Delbos, F., Devillier, R., Giannoli, C., Guidicelli, G., Harif, M., Loiseau, P., Rouzaire, P.-O., Varlet, P., Yakoub-Agha, I., & Nguyen, S. (2020). Greffe de cellules souches hématopoïétiques haplo-identiques avec cyclophosphamide en post-greffe : comment choisir le meilleur donneur en 2019 ? Recommandations de la Société francophone de greffe de mœlle et de thérapie cellulaire (SFGM-TC). Bulletin du Cancer, 107 (Suppl. 1), 72-84. doi:10.1016/j.bulcan.2019.07.011 Peer Reviewed verified by ORBi |
 | Dhédin, N., Paillard, C., Dalle, J.-H., Ouachée, M., Buchbinder, N., Brissot, E., BEGUIN, Y., Masouridi-Levrat, S., Yakoub-Agha, I., Bernit, E., & Pondarre, C. (2020). Allogreffe de cellules souches hématopoïétiques dans la drépanocytose de l'enfant et de l'adulte : indications et modalités. Bulletin du Cancer, 107, 925-933. doi:10.1016/j.bulcan.2020.06.003 Peer Reviewed verified by ORBi |
 | Azerad, M.-A., BAYOUDH, F., Weber, T., Minon, J.-M., Ketelsleggers, O., HOYOUX, M., Ren, X., Kaye, O., De Marneffe, N., Fraipont, V., Masset, C., Bouillon, A.-S., JASPERS, A., Tebache, M., D'Hoen, G., Habibi, A., Efira, A., Thachil, J., Deckmyn, H., & BEGUIN, Y. (2020). Sickle cell disease and COVID-19: Atypical presentations and favorable outcomes. EJHaem, 1 (jha 2.74), 338-341. doi:10.1002/jha2.74 Peer Reviewed verified by ORBi |
 | Engel, N., Rovo, A., Badoglio, M., Labopin, M., Basak, G. W., BEGUIN, Y., Guyotat, D., Ljungman, P., Nagler, A., Schattenberg, A., Schroeder, T., Schroyens, W., Tischer, J., Socie, G., Kolb, H.-J., Tichelli, A., Salooja, N., & Duarte, R. F. (2019). European experience and risk factor analysis of donor cell-derived leukaemias/MDS following haematopoietic cell transplantation. Leukemia, 33, 508-517. doi:10.1038/s41375-018-0218-6 Peer Reviewed verified by ORBi |
 | Delens, L., Ehx, G., SOMJA, J., Vrancken, L., Belle, L., SEIDEL, L., Grégoire, C., Fransolet, G., Ritacco, C., Hannon, M., DUBOIS, S., Beguin, Y., Baron, F., & Servais, S. (2019). In Vitro Th17-Polarized Human CD4(+) T Cells Exacerbate Xenogeneic Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation, 25, 204-215. doi:10.1016/j.bbmt.2018.10.007 Peer Reviewed verified by ORBi |
 | JASPERS, A., & Beguin, Y. (2019). Erythropoiesis and iron metabolism after hematopoietic stem cell transplantation. Belgian Journal of Hematology, 10, 89-95. Peer Reviewed verified by ORBi |
 | WITHOFS, N., Beguin, Y., COUSIN, F., Tancredi, T., SIMONI, P., Alvarez-Miezentseva, V., DE PRIJCK, B., HAFRAOUI, K., Bonnet, C., Baron, F., Hustinx, R., & Caers, J. (2019). Dual-tracer PET/CT scan after injection of combined [ 18 F]NaF and [ 18 F]FDG outperforms MRI in the detection of myeloma lesions. Hematological Oncology, 37, 193-201. doi:10.1002/hon.2600 Peer Reviewed verified by ORBi |
 | Fitzgerald, S. P., Grote Beverborg, N., Beguin, Y., Artunc, F., Falhammar, H., & Bean, N. G. (2019). Population data provide evidence against the presence of a set point for hemoglobin levels or tissue oxygen delivery. Physiological Reports, 7 (12), 14153. doi:10.14814/phy2.14153 Peer Reviewed verified by ORBi |
 | Zephir, H., Puyade, M., Gueguen, A., Michel, L., Terriou, L., Dive, D., Laureys, G., Mathey, G., Labauge, P., Marjanovic, Z., Pugnet, G., Badoglio, M., Lansiaux, P., Ibrahim, Y.-A., Beguin, Y., & Farge, D. (2019). Indications de l'autogreffe dans la sclérose en plaques : recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC) en lien avec la Société francophone de la sclérose en plaques. Bulletin du Cancer, 106 (Suppl. 1), 92-101. doi:10.1016/j.bulcan.2018.11.002 Peer Reviewed verified by ORBi |
 | Nagler, A., Labopin, M., Dholaria, B., Niittyvuopio, R., Maertens, J., Poiré, X., Cornelissen, J., Reményi, P., Bourhis, J. H., Beguin, Y., Malladi, R., Kerre, T., Schroyens, W., Savani, B. N., & Mohty, M. (2019). Impact of antithymocyte globulin on outcomes of allogeneic hematopoietic cell transplantation with TBI. Blood Advances, 3 (13), 1950-1960. doi:10.1182/bloodadvances.2019000030 Peer Reviewed verified by ORBi |
 | Grégoire, C., Ritacco, C., Hannon, M., SEIDEL, L., Delens, L., Belle, L., DUBOIS, S., Veriter, S., LECHANTEUR, C., BRIQUET, A., Servais, S., Ehx, G., Beguin, Y., & Baron, F. (2019). Comparison of Mesenchymal Stromal Cells From Different Origins for the Treatment of Graft-vs.-Host-Disease in a Humanized Mouse Model. Frontiers in Immunology, 10, 619. doi:10.3389/fimmu.2019.00619 Peer Reviewed verified by ORBi |
 | Jaimes-Albornoz, D., Mannone, L., Nguyen-Quoc, S., Chalandon, Y., Chevallier, P., Mohty, M., Meunier, M., Robin, M., Ledoux, M.-P., Guillerm, G., Bay, J.-O., Poiré, X., Maillard, N., Leclerc, M., Daguindau, E., Beguin, Y., Rubio, M. T., & Gyan, E. (2019). Allogeneic Stem Cell Transplantation in Therapy-Related Myelodysplasia after Autologous Transplantation for Lymphoma: A Retrospective Study of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy. Biology of Blood and Marrow Transplantation, 25, 2366-2374. doi:10.1016/j.bbmt.2019.07.013 Peer Reviewed verified by ORBi |
 | Feyx, T., Roex, G., Beguin, Y., Kerre, T., Poiré, X., Lewalle, P., Vandenberghe, P., Bron, D., & Anguille, S. (2019). Chimeric antigen receptor T-cells: a new therapeutic option for relapsed/refractory B-cell malignancies and beyond. Belgian Journal of Hematology, 10, 301-310. Peer Reviewed verified by ORBi |
 | Caulier, A., Drumez, E., Gauthier, J., Robin, M., Blaise, D., Beguin, Y., Michallet, M., Chevallier, P., Bay, J.-O., Vigouroux, S., Desbrosses, Y., Cornillon, J., Nguyen, S., Dauriac, C., de Latour, R. P., Lioure, B., Rohrlich, P.-S., Carré, M., Bourhis, J.-H., ... Yakoub-Agha, I. (2019). Scoring System Based on Post-Transplant Complications in Patients after Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome: A Study from the SFGM-TC. Current Research in Translational Medicine, 67, 8-15. doi:10.1016/j.retram.2018.08.003 Peer Reviewed verified by ORBi |
 | Fayard, A., Daguenet, E., Blaise, D., Chevallier, P., Labussière, H., Berceanu, A., Yakoub-Agha, I., Socié, G., Charbonnier, A., Suarez, F., Huynh, A., Mercier, M., Bulabois, C.-E., Lioure, B., Chantepie, S., Beguin, Y., Bourhis, J.-H., Malfuson, J.-V., Clément, L., ... Cornillon, J. (2019). Evaluation of infectious complications after haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide following reduced-intensity and myeloablative conditioning: a study on behalf of the Francophone Society of Stem Cell Transplantation and Cellular Therapy (SFGM-TC). Bone Marrow Transplantation, 54, 1586-1594. doi:10.1038/s41409-019-0475-7 Peer Reviewed verified by ORBi |
 | Antoine-Poirel, H., Vanspauwen, M., Macq, G., De Geyndt, A., Maertens, J., WILLEMS, E., Selleslag, D., Poiré, X., Theunissen, K., Graux, C., Kerre, T., Zachée, P., Meuleman, N., De Becker, A., Verlinden, A., Van Obbergh, F., Schuermans, C., De Wilde, V., JASPERS, A., ... Beguin, Y. (2019). Providing both autologous and allogeneic hematopoietic stem cell transplants (HSCT) may have a stronger impact on the outcome of autologous HSCT in adult patients than activity levels or implementation of JACIE at Belgian transplant centres. Bone Marrow Transplantation, 54, 1434-1442. doi:10.1038/s41409-019-0458-8 Peer Reviewed verified by ORBi |
 | Cremers, E., de Witte, T., de Wreede, L., Eikema, D.-J., Koster, L., van Biezen, A., Finke, J., Socié, G., Beelen, D., Maertens, J., Nagler, A., Kobbe, G., Ziagkos, D., Itälä-Remes, M., Gedde-Dahl, T., Sierra, J., Niederwieser, D., Ljungman, P., Beguin, Y., ... Kröger, N. (2019). A prospective non-interventional study on the impact of transfusion burden and related iron toxicity on outcome in myelodysplastic syndromes undergoing allogeneic hematopoietic cell transplantation *. Leukemia and Lymphoma, 60, 2404-2414. doi:10.1080/10428194.2019.1594215 Peer Reviewed verified by ORBi |
 | ERPICUM, P., WEEKERS, L., DETRY, O., BONVOISIN, C., DELBOUILLE, M.-H., GREGOIRE, C., BAUDOUX, E., BRIQUET, A., LECHANTEUR, C., MAGGIPINTO, G., SOMJA, J., Pottel, H., Baron, F., Jouret, F., & BEGUIN, Y. (2019). Infusion of third-party mesenchymal stromal cells after kidney transplantation: a phase I-II, open-label, clinical study. Kidney International, 95, 693-707. doi:10.1016/j.kint.2018.08.046 Peer Reviewed verified by ORBi |
 | Muller, J., Duray, E., Lejeune, M., DUBOIS, S., Plougonven, E., Léonard, A., Storti, P., Giuliani, N., Cohen-Solal, M., Hempel, U., Thijssen, V., BEGUIN, Y., Heusschen, R., & CAERS, J. (2019). Loss of stromal galectin-1 enhances multiple myeloma development: Emphasis on a role in osteoclasts. Cancers, 11 (2), 261. doi:10.3390/cancers11020261 Peer Reviewed verified by ORBi |
 | GREGOIRE, C., BRIQUET, A., PIRENNE, C., LECHANTEUR, C., LOUIS, E.* , & BEGUIN, Y.*. (November 2018). Allogeneic mesenchymal stromal cells for refractory luminal Crohn's disease: A phase I-II study. Digestive and Liver Disease, 50 (11), 1251-1255. doi:10.1016/j.dld.2018.08.015 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Farhat, K., Bodart, G., Charlet-Renard, J. D. C., Desmet, C., Moutschen, M., Beguin, Y., Baron, F., Melin, P., Quatresooz, P., Parent, A.-S., Desmecht, D., Sirard, J.-C., Salvatori, R., Martens, H., & Geenen, V. (02 October 2018). Growth hormone (GH) deficient mice with GHRH ablation are severely deficient in vaccine and immune responses against Streptococcus pneumoniae. Frontiers in Immunology, 9, 2175. doi:10.3389/fimmu.2018.02175 Peer Reviewed verified by ORBi |
 | Heusschen, R., Muller, J., Duray, E., WITHOFS, N., Bolomsky, A., Baron, F., Beguin, Y., Menu, E., Ludwig, H., & Caers, J. (2018). Molecular mechanisms, current management and next generation therapy in myeloma bone disease. Leukemia and Lymphoma, 59, 14-28. doi:10.1080/10428194.2017.1323272 Peer Reviewed verified by ORBi |
 | Trento, C., Bernardo, M. E., Nagler, A., Kuçi, S., Bornhäuser, M., Köhl, U., Strunk, D., Galleu, A., Sanchez-Guijo, F., Gaipa, G., Introna, M., Bukauskas, A., Le Blanc, K., Apperley, J., Roelofs, H., Van Campenhout, A., Beguin, Y., Kuball, J., Lazzari, L., ... Dazzi, F. (2018). Manufacturing Mesenchymal Stromal Cells for the Treatment of Graft-versus-Host Disease: A Survey among Centers Affiliated with the European Society for Blood and Marrow Transplantation. Biology of Blood and Marrow Transplantation, 24, 2365-2370. doi:10.1016/j.bbmt.2018.07.015 Peer Reviewed verified by ORBi |
 | Paviglianiti, A., Tozatto Maio, K., Rocha, V., Gehlkopf, E., Milpied, N., Esquirol, A., Chevallier, P., Blaise, D., Gac, A.-C., Leblond, V., Cahn, J. Y., Abecasis, M., Zuckerman, T., Schouten, H., Gurman, G., Rubio, M. T., Beguin, Y., Corral, L. L., Nagler, A., ... Ruggeri, A. (2018). Outcomes of Advanced Hodgkin Lymphoma after Umbilical Cord Blood Transplantation: A Eurocord and EBMT Lymphoma and Cellular Therapy & Immunobiology Working Party Study. Biology of Blood and Marrow Transplantation, 24, 2265-2270. doi:10.1016/j.bbmt.2018.07.019 Peer Reviewed verified by ORBi |
 | HAUZEUR, J.-P., De Maertelaer, V., BAUDOUX, E., MALAISE, M., Beguin, Y., & Gangji, V. (2018). Inefficacy of autologous bone marrow concentrate in stage three osteonecrosis: a randomized controlled double-blind trial. International Orthopaedics, 42, 1429-1435. doi:10.1007/s00264-017-3650-8 Peer Reviewed verified by ORBi |
 | Muller, J., Bolomsky, A., Dubois, S., Duray, E., Stangelberger, K., Plougonven, E., Lejeune, M., Léonard, A., Marty, C., Hempel, U., Baron, F., BEGUIN, Y., Cohen-Solal, M., Ludwig, H., Heusschen, R., & CAERS, J. (2018). Maternal embryonic leucine zipper kinase inhibitor OTSSP167 has preclinical activity on multiple myeloma bone disease. Haematologica, 103, 1359-1368. doi:10.3324/haematol.2017.185397 Peer Reviewed verified by ORBi |
 | Van de Velde, A., Willekens, B., Vanopdenbosch, L., Deryck, O., Selleslag, D., D'Haeseleer, M., De Becker, A., Dubois, B., Dierickx, D., Perrotta, G., De Wilde, V., van Pesch, V., Straetmans, N., Dive, D., Beguin, Y., Van Wijmeersch, B., Theunissen, K., Kerre, T., & Laureys, G. (2018). A Belgian consensus protocol for autologous haematopoietic stem cell transplantation in multiple sclerosis. Belgian Journal of Hematology, 9, 167-174. Peer Reviewed verified by ORBi |
 | Akhtar, S., Montoto, S., Boumendil, A., Finel, H., Masszi, T., Jindra, P., Nemet, D., Fuhrmann, S., Beguin, Y., Castagna, L., Ferrara, F., Capria, S., Malladi, R., Moraleda, J. M., Bloor, A., Ghesquières, H., Meissner, J., Sureda, A., & Dreger, P. (2018). High dose chemotherapy and autologous stem cell transplantation in nodular lymphocyte-predominant Hodgkin lymphoma: A retrospective study by the European society for blood and marrow transplantation-lymphoma working party. American Journal of Hematology, 93 (1), 40-46. doi:10.1002/ajh.24927 Peer Reviewed verified by ORBi |
 | Ehx, G., SOMJA, J., Warnatz, H.-J., Ritacco, C., HANNON, M., Delens, L., Fransolet, G., DELVENNE, P., Muller, J., BEGUIN, Y., Lehrach, H., Belle, L., Humblet-Baron, S., & BARON, F. (2018). Xenogeneic graft-versus-host disease in humanized NSG and NSG-HLA-A2/HHD mice. Frontiers in Immunology, 9, 1943. doi:10.3389/fimmu.2018.01943 Peer Reviewed verified by ORBi |
 | Decroocq, J., Itzykson, R., Vigouroux, S., Michallet, M., Yakoub-Agha, I., Huynh, A., Beckerich, F., Suarez, F., Chevallier, P., Nguyen-Quoc, S., Ledoux, M.-P., Clement, L., Hicheri, Y., Guillerm, G., Cornillon, J., Contentin, N., Carre, M., Maillard, N., Mercier, M., ... Dhedin, N. (2018). Similar outcome of allogeneic stem cell transplantation after myeloablative and sequential conditioning regimen in patients with refractory or relapsed acute myeloid leukemia: A study from the Societe Francophone de Greffe de Moelle et de Therapie Cellulaire. American Journal of Hematology, 93 (3), 416-423. doi:10.1002/ajh.25004 Peer Reviewed verified by ORBi |
 | Lewalle, P., & Beguin, Y. (2018). Extracorporeal photochemotherapy for graft versus host disease : Where we are now and where are we going ! Belgian Journal of Hematology, 9, 254-265. Peer Reviewed verified by ORBi |
 | McLornan, D. P., Szydlo, R., Robin, M., van Biezen, A., Koster, L., Blok, H. J. P., Van Lint, M. T., Finke, J., Vitek, A., Carlson, K., Griskevicius, L., Holler, E., Itala-Remes, M., Schaap, M., Socie, G., Bay, J.-O., BEGUIN, Y., Bruno, B., Cornelissen, J. J., ... Kroger, N. (2018). Outcome of patients with Myelofibrosis relapsing after allogeneic stem cell transplant: a retrospective study by the Chronic Malignancies Working Party of EBMT. British Journal of Haematology, 182, 418-422. doi:10.1111/bjh.15407 Peer Reviewed verified by ORBi |
 | Laureys, G., Willekens, B., Vanopdenbosch, L., Deryck, O., Selleslag, D., D'Haeseleer, M., De Becker, A., Dubois, B., Dierickx, D., Perrotta, G., De Wilde, V., van Pesch, V., Straetmans, N., Dive, D., Beguin, Y., Van Wijmeersch, B., Theunissen, K., Kerre, T., & Van de Velde, A. (2018). A Belgian consensus protocol for autologous hematopoietic stem cell transplantation in multiple sclerosis. Acta Neurologica Belgica, 118 (2), 161-168. doi:10.1007/s13760-018-0905-0 Peer Reviewed verified by ORBi |
 | Gauthier, J., Poiré, X., Gac, A.-C., Leclerc, M., Guillaume, T., Chalandon, Y., Nguyen, S., Forcade, E., Régny, C., Bay, J.-O., Bazarbachi, A., Rohrlich, P.-S., Huynh, A., Farhi, J., Marchand, T., Malfuson, J.-V., Pilorge, S., Labussière-Wallet, H., Renard, C., ... Yakoub-Agha, I. (2018). Better outcome with haploidentical over HLA-matched related donors in patients with Hodgkin's lymphoma undergoing allogeneic haematopoietic cell transplantation - A study by the Francophone Society of Bone Marrow Transplantation and Cellular Therapy. Bone Marrow Transplantation, 53 (4), 400-409. doi:10.1038/s41409-017-0018-z Peer Reviewed verified by ORBi |
 | Vrancken, L., Muller, J., Lejeune, M., Grégoire, C., Delens, L., Jaspers, A., Servais, S., DE PRIJCK, B., Baron, F., Caers, J., & Beguin, Y. (2018). Nouveautes dans la prise en charge du myelome. Revue Médicale Suisse, 14 (615), 1438-1442. Peer Reviewed verified by ORBi |
 | Devos, T., BEGUIN, Y., Noens, L., Van Eygen, K., Zachée, P., Mineur, P., Knoops, L., Doyen, C., Theunissen, K., Benghiat, F. S., Reusens, M., & Pluymers, W. (2018). Disease and treatment characteristics of polycythaemia vera patients in Belgium : results from a scientific survey. European Journal of Haematology, 100, 361-366. doi:10.1111/ejh.13022 Peer Reviewed verified by ORBi |
 | Pirotte, M.* , Forte, F.* , Lutteri, L., WILLEMS, E., DURAN, U., Belle, L., Baron, F., BEGUIN, Y., Maquet, P., BODART, O.* , & Servais, S.*. (2018). Neuronal surface antibody-mediated encephalopathy as manifestation of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Journal of Neuroimmunology, 323, 115-118. doi:10.1016/j.jneuroim.2018.08.003 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Caers, J., Garderet, L., Kortum, K. M., O'Dwyer, M. E., van de Donk, N. W. C. J., Binder, M., Dold, S. M., Gay, F., Corre, J., Beguin, Y., Ludwig, H., Larocca, A., Driessen, C., Dimopoulos, M. A., Boccadoro, M., Gramatzki, M., Zweegman, S., Einsele, H., Cavo, M., ... Engelhardt, M. (2018). European Myeloma Network recommendations on tools for the diagnosis and monitoring of multiple myeloma: what to use and when. Haematologica, 103, 1172-1184. doi:10.3324/haematol.2018.189159 Peer Reviewed verified by ORBi |
 | Servais, S., Baron, F., LECHANTEUR, C., SEIDEL, L., Selleslag, D., Maertens, J., BAUDOUX, E., Zachee, P., Van Gelder, M., Noens, L., Kerre, T., Lewalle, P., Schroyens, W., ORY, A., & Beguin, Y. (2018). Infusion of bone marrow derived multipotent mesenchymal stromal cells for the treatment of steroid-refractory acute graftversus- host disease: A multicenter prospective study. Oncotarget, 9 (29), 20590-20604. doi:10.18632/oncotarget.25020 Peer Reviewed verified by ORBi |
 | Aapro, M. S., Beguin, Y., Bokemeyer, C., Dicato, M., Gascon, P., Glaspy, J. A., Hofmann, A., Link, H., Littlewod, T., Ludwig, H., Osterborg, A., Pronzato, P., Santini, V., Schrijvers, D., Stauder, R., & Herrstedt, J. (2018). Management of anaemia and iron deficiency in patients with cancer : ESMO Clinical Practice Guidelines. Annals of Oncology, 29, 96-110. doi:10.1093/annonc/mdx758 Peer Reviewed verified by ORBi |
 | DETRY, O., VANDERMEULEN, M., DELBOUILLE, M.-H., SOMJA, J., BLETARD, N., Briquet, A., LECHANTEUR, C., GIET, O., BAUDOUX, E., Hannon, M., Baron, F., & Beguin, Y. (July 2017). Infusion of mesenchymal stromal cells after deceased liver transplantation: A phase I-II, open-label, clinical study. Journal of Hepatology, 67 (1), 47-55. doi:10.1016/j.jhep.2017.03.001 Peer Reviewed verified by ORBi |
 | Van Obbergh, F., Knoops, L., Devos, T., BEGUIN, Y., Graux, C., Benghiat, S., Kargar-Samani, K., Bauwens, D., Efira, A., Dubois, C., Springael, C., Montfort, L., Connerotte, T., Delannoy, A., & Wallemacq, P. (2017). The clinical relevance of imatinib plasma trough concentrations in chronic myeloid leukemia. A Belgian study. Clinical Biochemistry, 50, 452-454. doi:10.1016/j.clinbiochem.2016.12.006 Peer Reviewed verified by ORBi |
 | Heusschen, R., Muller, J., WITHOFS, N., BARON, F., BEGUIN, Y., & CAERS, J. (2017). Multiple myeloma bone disease: from mechanisms to next generation therapy. Belgian Journal of Hematology, 8, 66-74. Peer Reviewed verified by ORBi |
 | Heidenreich, S., Ziagkos, D., De Wreede, L., Van Biezen, A., Finke, J., Platzbecker, U., Niederwieser, D., Einsele, H., Bethge, W., Schleuning, M., Beelen, D., Tischer, J., Nagler, A., Glass, B., Maertens, J., Yanez, L., BEGUIN, Y., Sill, H., Scheid, C., ... Kröger, N. (2017). Allogeneic stem cell transplantation for patients with myelodysplastic syndrome 70 years of age or older: A retrospective study of the MDS subcommittee of the Chronic Malignancies Working Party (CMWP) of the EBMT. Biology of Blood and Marrow Transplantation, 23, 44-52. doi:10.1016/j.bbmt.2016.09.027 Peer Reviewed verified by ORBi |
 | Roth-Guepin, G., Canaani, J., Ruggeri, A., Labopin, M., Finke, J., Cornelissen, J. J., Delage, J., Stuhler, G., Rovira, M., Potter, M., Stadler, M., Veelken, H., Cahn, J. Y., Collin, M., Beguin, Y., Giebel, S., Nagler, A., & Mohty, M. (2017). Allogeneic stem cell transplantation in acute lymphoblastic leukemia patients older than 60 years: A survey from the acute leukemia working party of EBMT. Oncotarget, 8 (68), 112972-112979. doi:10.18632/oncotarget.22934 Peer Reviewed verified by ORBi |
 | SERVAIS, S., Hannon, M., Peffault de Latour, R., Socie, G., & BEGUIN, Y. (2017). Reconstitution of adaptive immunity after umbilical cord blood transplantation and clinical implication regarding risk of infections. Stem Cell Investigation, 4, 40. Peer Reviewed verified by ORBi |
 | Gauthier, J., Castagna, L., Garnier, F., Guillaume, T., Socié, G., Maury, S., Maillard, N., Tabrizi, R., Marchand, T., Malfuson, J.-V., Gac, A.-C., Gyan, E., Mercier, M., BEGUIN, Y., Delage, J., Turlure, P., Marcais, A., Nguyen, S., Dulery, R., ... Blaise, D. (2017). Reduced intensity and non-myeloablative allogenic stem cell transplantation from alternative HLA-mismatched donors for Hodgkin's lymphoma: a study by the French Society of Bone Marrow Transplantation and Cellular Therapy. Bone Marrow Transplantation, 52, 689-696. doi:10.1038/bmt.2016.34 Peer Reviewed verified by ORBi |
 | GREGOIRE, C., LECHANTEUR, C., BRIQUET, A., BAUDOUX, E., BARON, F., LOUIS, E., & BEGUIN, Y. (2017). Review article: mesenchymal stromal cell therapy for inflammatory bowel diseases. Alimentary Pharmacology and Therapeutics, 45, 205-221. doi:10.1111/apt.13864 Peer Reviewed verified by ORBi |
 | Roux, C., Tifratene, K., Socié, G., Galambrun, C., Bertrand, Y., Rialland, F., Jubert, C., Pochon, C., Paillard, C., Sirvent, A., Nelken, B., Vannier, J.-P., Freycon, C., BEGUIN, Y., Raus, N., Yakoub-Agha, I., Mohty, M., Dalle, J.-H., Michel, G., ... Rohrlich, P.-S. (2017). Outcome after failure of allogeneic hematopoietic stem cell transplantation in children with acute leukemia: a study by the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC). Bone Marrow Transplantation, 52, 678-682. doi:10.1038/bmt.2016.360 Peer Reviewed verified by ORBi |
 | Libert, Y., Borghgraef, C., BEGUIN, Y., Delvaux, N., DEVOS, M., Doyen, C., Dubruille, S., Etienne, A.-M., Lienard, A., Merckaert, I., Slachmuylder, J., Straetmans, N., Van Den Neste, E., Bron, D., & Razavi, D. (2017). Factors associated with self-perceived burden to the primary caregiver in older patients with hematologic malignancies: an exploratory study. Psycho-oncology, 26, 118-124. doi:10.1002/pon.4108 Peer Reviewed verified by ORBi |
 | Libert, Y., Borghgraef, C., Beguin, Y., Delvaux, N., DEVOS, M., Doyen, C., Dubruille, S., Etienne, A.-M., Liénard, A., Merckaert, I., Reynaert, C., Slachmuylder, J.-L., Straetmans, N., Van Den Neste, E., Bron, D., & Razavi, D. (2017). Cognitive compensatory processes of older, clinically fit patients with hematologic malignancies undergoing chemotherapy: A longitudinal cohort study. Psycho-oncology, 26 (12), 2086-2093. doi:10.1002/pon.4424 Peer Reviewed verified by ORBi |
 | Ehx, G., Fransolet, G., De Leval, L., D'Hondt, S., Lucas, S., Hannon, M., Delens, L., DUBOIS, S., Drion, P., Beguin, Y., Humblet-Baron, S., & Baron, F. (2017). Azacytidine prevents experimental xenogeneic graft-versus-host disease without abrogating graft-versus-leukemia effects. Oncoimmunology, 6:e1314425. doi:10.1080/2162402X.2017.1314425 Peer Reviewed verified by ORBi |
 | WITHOFS, N., COUSIN, F., DE PRIJCK, B., Bonnet, C., Hustinx, R., Gambhir, S. S., Beguin, Y., & Caers, J. (2017). A First Report on [(18)F]FPRGD2 PET/CT Imaging in Multiple Myeloma. Contrast Media and Molecular Imaging, 2017, 6162845. doi:10.1155/2017/6162845 Peer Reviewed verified by ORBi |
 | Averbuch, D., Tridello, G., Hoek, J., Mikulska, M., Akan, H., Yaňez San Segundo, L., Pabst, T., Özçelik, T., Klyasova, G., Donnini, I., Wu, D., Gülbas, Z., Zuckerman, T., Botelho De Sousa, A., Beguin, Y., Xhaard, A., Bachy, E., Ljungman, P., De La Camara, R., ... Cesaro, S. (2017). Antimicrobial Resistance in Gram-Negative Rods Causing Bacteremia in Hematopoietic Stem Cell Transplant Recipients: Intercontinental Prospective Study of the Infectious Diseases Working Party of the European Bone Marrow Transplantation Group. Clinical Infectious Diseases, 65 (11), 1819-1828. doi:10.1093/cid/cix646 Peer Reviewed verified by ORBi |
 | Magro, L., Forcade, E., Giraud, C., Granata, A., Parquet, N., Rohrlich, P.-S., Terriou, L., Yakoub-Agha, I., & Beguin, Y. (2017). Prise en charge de la maladie du greffon contre l'hôte chronique : Recommandations de la Société francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC). Bulletin du Cancer, 104S, 145-S168. doi:10.1016/j.bulcan.2017.10.023 Peer Reviewed verified by ORBi |
 | Vrancken, L., Delens, L., BEGUIN, Y., BARON, F., & SERVAIS, S. (2017). Focus sur les lymphocytes T dans la maladie du greffon contre l'hôte après allogreffe de cellules soucges hématopoïétiques: implications pour de nouvelles stratégies de prévention. OncoHemato : Revue Multidisciplinaire d'Oncologie et Hématologie, 11, 23-31. Peer reviewed |
 | Sticca, T., CABERG, J.-H., Wenric, S., Poulet, C., HERENS, C., JAMAR, M., Josse, C., El Guendi, S., MAX, S., BEGUIN, Y., GOTHOT, A., CAERS, J., & Bours, V. (2017). Genomic Studies of Multiple Myeloma Reveal an Association between X Chromosome Alterations and Genomic Profile Complexity. Genes, Chromosomes and Cancer, 56, 18-27. doi:10.1002/gcc.22397 Peer Reviewed verified by ORBi |
 | Belle, L.* , Fransolet, G.* , Somja, J., BINSFELD, M., Delvenne, P., Drion, P., Hannon, M., BEGUIN, Y., Ehx, G.* , & Baron, F.*. (12 December 2016). Limited Impact of Imatinib in a Murine Model of Sclerodermatous Chronic Graft-versus-Host Disease. PLoS ONE, 11, 0167997. doi:10.1371/journal.pone.0167997 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Fransolet, G.* , Ehx, G.* , SOMJA, J., Delens, L., Hannon, M., Muller, J., DUBOIS, S., Drion, P., CAERS, J., Humblet-Baron, S., DELVENNE, P., BEGUIN, Y., Conteduca, G.* , & BARON, F.*. (04 July 2016). Azacytidine mitigates experimental sclerodermic chronic graft-versus-host disease. Journal of Hematology and Oncology, 9, 53. doi:10.1186/s13045-016-0281-2 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | SERVAIS, S., BEGUIN, Y., Delens, L., Ehx, G., Fransolet, G., Hannon, M., WILLEMS, E., Humblet-Baron, S., Belle, L., & Baron, F. (11 May 2016). Novel approaches for preventing acute graftversus- host disease after allogeneic hematopoietic stem cell transplantation. Expert Opinion on Investigational Drugs, 9, 957-972. doi:10.1080/13543784.2016.1182498 Peer Reviewed verified by ORBi |
 | Grégoire, C., GUIOT, J., Vertenoeil, G., WILLEMS, E., HAFRAOUI, K., CORHAY, J.-L., LOUIS, R., & BEGUIN, Y. (February 2016). Yellow nail syndrome after allogeneic haematopoietic stem cell transplantation in two patients with multiple myeloma. Acta Clinica Belgica, 71, 428-430. doi:10.1080/17843286.2015.1122872 Peer Reviewed verified by ORBi |
 | SERVAIS, S., GREGOIRE, C., BARON, F., WILLEMS, E., BRIQUET, A., BAUDOUX, E., DELLOYE, O., GIET, O., LECHANTEUR, C., & BEGUIN, Y. (2016). Multipotent mesenchymal stromal cell therapy for steroid-refractory acute graft-versus-host disease after allogeneic stem cell transplantation. Belgian Journal of Hematology, 7, 229-235. Peer Reviewed verified by ORBi |
 | El Cheikh, J., Sfumato, P., Sobh, M., Fegueux, N., Mohty, M., Vigouroux, S., BEGUIN, Y., Yakoub-Agha, I., Socié, G., Cornillon, J., Mercier, M., Bay, J., Blaise, D., Michallet, M., & Peffault de Latour, R. (2016). Allogenic hematopoietic stem cell transplantation after reduced intensity conditioning regimen for elderly patients (60 years and older) with hematologic malignancies using unrelated donors: a retrospective study for the French society for stem cell transplantation (SFGM-TC). Haematologica, 101, 262-265. Peer Reviewed verified by ORBi |
 | Guièze, R., Damaj, G., Pereira, B., Robin, M., Chevallier, P., Michallet, M., Vigouroux, S., BEGUIN, Y., Blaise, D., Roosweil, D., Thiebaut, A., Rohrlich, P.-S., Huynh, A., Cornillon, J., Contentin, N., Suarez, F., Lioure, B., Mohty, M., Maillard, N., ... yakoub-Agha, I. (2016). Management of Myelodysplastic Syndrome Relapsing after Allogeneic Hematopoietic Stem Cell Transplantation: A Study by the French Society of Bone Marrow Transplantation and Cell Therapies. Biology of Blood and Marrow Transplantation, 22, 240-247. doi:10.1016/j.bbmt.2015.07.037 Peer Reviewed verified by ORBi |
 | Mamez, Levy, V., Chevallier, P., Blaise, D., Vigouroux, S., Xhaard, A., Fegueux, N., Contentin, N., BEGUIN, Y., Ifrah, N., Bulabois, C., Suarez, F., Yakoub-Agha, I., Turlure, P., Deconink, E., Lamy, T., Cahn, J.-Y., Huynh, A., Maury, S., ... Nguyen, S. (2016). Effet of immune modulation in relapsed peripheral T-cell lymphomas after allogeneic stem cell transplantation: a study by the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC). Bone Marrow Transplantation, 51, 358-364. doi:10.1038/bmt.2015.280 Peer Reviewed verified by ORBi |
 | LECHANTEUR, C., BRIQUET, A., GIET, O., DELLOYE, O., BAUDOUX, E., & BEGUIN, Y. (2016). Clinical - scale expansion of mesenchymal stromal cells: a large banking experience. Journal of Translational Medicine, 14, 145-159. doi:10.1186/s12967-016-0892-y Peer Reviewed verified by ORBi |
 | Binsfeld, M., Muller, J., Lamour, V., De Veirman, K., De Raeve, H., Bellahcene, A., Van Valckenborgh, E., BARON, F., BEGUIN, Y., CAERS, J., & Heusschen, R. (2016). Granulocytic myeloid-derived suppressor cells promote angiogenesis in the context of multiple myeloma. Oncotarget, 7, 37931-37943. doi:10.18632/oncotarget.9270 Peer Reviewed verified by ORBi |
 | VALDES SOCIN, H. G., SID, S., LUTTERI, L., POLUS, M., Louis, E., Beguin, Y., & Beckers, A. (2016). Le syndrome thyro-gastrique auto-immun : actualités cliniques et thérapeutiques. Vaisseaux, Coeur, Poumons, 21 (4), 40-45. Peer reviewed |
 | Pirotte, M., GUIOT, J., BEGUIN, Y., & Louis, R. (2016). L'anémie dans la bronchopneumopathie chronique obstructive sévère: une comorbidité plus fréquente que l'on ne croit. Revue Médicale de Liège, 71 (11), 488-494. Peer reviewed |
 | CAERS, J., de Larrea, C., Leleu, X., Heusschen, R., Zojer, N., Decaux, O., Kastritis, E., Minnema, M., Jurczyszyn, A., Beguin, Y., Wäsch, R., Palumbo, A., Dimopoulos, M., Mateos, M. V., Ludwig, H., & Engelhardt, M. (2016). The Changing Landscape of Smoldering Multiple Myeloma: A European Perspective. Oncologist, 21, 333-342. doi:10.1634/theoncologist.2015-0303 Peer Reviewed verified by ORBi |
 | Heusschen, R.* , Muller, J.* , Binsfeld, M., Marty, C., Plougonven, E., DUBOIS, S., Mahli, N., Moermans, K., Carmeliet, G., Léonard, A., BARON, F., BEGUIN, Y., Menu, E., Cohen-Solal, M., & CAERS, J. (2016). SRC Kinase Inhibition with Saracatinib Limits the Development of Osteolytic Bone Disease in Multiple Myeloma. Oncotarget, 7, 30712-30729. doi:10.18632/oncotarget.8750 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | JASPERS, A., Bouhya, S., Belaiche, S., Chevallier, P., Hermet, E., Hospital-Gustems, C., Michallet, M., Rialland, F., Samsonova, O., Sirvent, A., Yakoub-Agha, I., Rohrlich, P.-S., & BEGUIN, Y. (2016). Evaluation et prise en charge de la surcharge en fer post-greffe recommandations de la SFGM-TC. Bulletin du Cancer, 103, 255-S266. doi:10.1016/j.bulcan.2016.09.003 Peer Reviewed verified by ORBi |
 | Baron, F., & Beguin, Y. (2016). Prophylactic donor lymphocyte infusion in patients with high-risk acute myeloid leukemia: ready for prime time? Bone Marrow Transplantation, 51, 640-42. doi:10.1038/bmt.2016.38 Peer Reviewed verified by ORBi |
 | JASPERS, A., Baron, F., SERVAIS, S., LEJEUNE, M., WILLEMS, E., SEIDEL, L., HAFRAOUI, K., Bonnet, C., & Beguin, Y. (September 2015). Erythropoietin therapy after allogeneic hematopoietic cell transplantation has no impact on long-term survival. American Journal of Hematology, 90 (9), 197-199. doi:10.1002/ajh.24100 Peer Reviewed verified by ORBi |
 | HANNON, M., BEGUIN, Y., Ehx, G., SERVAIS, S., SEIDEL, L., Graux, C., Maertens, J., Kerre, T., Daulne, C., de Bock, M., Fillet, M., ORY, A., WILLEMS, E., GOTHOT, A., Humblet-Baron, S., & BARON, F. (15 July 2015). Immune Recovery after Allogeneic Hematopoietic Stem Cell Transplantation following Flu-TBI versus TLI-ATG Conditioning. Clinical Cancer Research, 21 (14), 3131-9. doi:10.1158/1078-0432.CCR-14-3374 Peer Reviewed verified by ORBi |
 | WITHOFS, N., NANNI, C., SIMONI, P., FANTI, S., BEGUIN, Y., & CAERS, J. (20 March 2015). Imaging myeloma and related monoclonal plasma cell disorders using MRI, low dose whole-body CT and FDG PET/CT. Clinical and Translational Imaging, 3, 95-109. doi:10.1007/s40336-015-0119-x Peer reviewed |
 | Benghiat, F., Beguin, Y., Dessars, B., Devos, T., Lewalle, P., Mineur, P., Straetmans, N., Van Eygen, K., Verhoef, G., & Knoops, L. (2015). Practical management of Chronic Myeloid Leukemia in Belgium. Belgian Journal of Hematology, 6 (1), 16-32. Peer Reviewed verified by ORBi |
 | BONNET, C., Janssens, A., Wu, K., Schroyens, W., Van Hende, V., Heimann, P., Tousseyn, T., André, M., Bron, D., Van Hoof, A., Verhoef, G., DE PRIJCK, B., Beguin, Y., & Dierickx, D. (2015). BHS guidelines for the treatment of Burkitt lymphoma. Belgian Journal of Hematology, 6 (2), 61-69. Peer Reviewed verified by ORBi |
 | Ehx, G.* , Hannon, M.* , BEGUIN, Y., Humblet-Baron, S.* , & BARON, F.*. (2015). Validation of a multicolor staining to monitor phosphoSTAT5 levels in regulatory T-cell subsets. Oncotarget, 6, 43255-43266. doi:10.18632/oncotarget.6486 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Servais, S., BAUDOUX, E., Brichard, B., Bron, D., Debruyn, C., De Bruyère, M., De Hemptinne, D., Deneys, V., Paulus, J.-M., Raymakers, N., Schaaps, J.-P., Van Cauwenberge, J., Cornu, G., Delforge, A., & Beguin, Y. (January 2015). Circadian and circannual variations in cord blood hematopoietic cell composition. Haematologica, 100 (1), 32-34. doi:10.3324/haematol.2014.115394 Peer Reviewed verified by ORBi |
 | Rowart, P., ERPICUM, P., Detry, O., WEEKERS, L., Grégoire, C., LECHANTEUR, C., BRIQUET, A., Beguin, Y., Krzesinski, J.-M., & Jouret, F. (2015). Mesenchymal Stromal Cell Therapy in Ischemia/Reperfusion Injury. Journal of Immunology Research, 602597. doi:10.1155/2015/602597 Peer Reviewed verified by ORBi |
 | SID, S., Dugauquier, C., DE PRIJCK, B., BONNET, C., & Beguin, Y. (2015). Haemolytic crisis induced by rasburicase administration revealing G-6-PD deficiency. Belgian Journal of Hematology, 6 (2), 74-78. Peer Reviewed verified by ORBi |
 | Guillaume, T., Beguin, Y., Tabrizi, R., Nguyen, S., Blaise, D., Deconinck, E., Redjoul, R., Cornillon, J., Guillerm, G., Contentin, N., Sirvent, A., Turlure, P., Salmon, A., Huynh, A., Francois, S., Peffault de Latour, R., Yakoub-Agha, I., & Mohty, M. (2015). Allogeneic hematopoietic stem cell transplantation for T-prolymphocytic leukemia: a report from the French society for stem cell transplantation (SFGM-TC). European Journal of Haematology, 94, 265-269. doi:10.1111/ejh.12430 Peer Reviewed verified by ORBi |
 | Beguin, Y., Selleslag, D., Meers, S., Graux, C., Bries, G., Deeren, D., Vrelust, I., Ravoet, C., Theunissen, K., Voelter, V., Potier, H., Trullemans, F., Noens, L., & Mineur, P. (2015). Safety and efficacy of azacitidine in Belgian patients with high-risk myelodysplastic syndromes, acute myeloid leukaemia, or chronic myelomonocytic leukaemia: results of a real-life, non-interventional post-marketing survey. Acta Clinica Belgica, 70, 34-43. doi:10.1179/2295333714Y.0000000102 Peer Reviewed verified by ORBi |
 | Leclerc, M., Suarez, F., Noël, M.-P., Vekhoff, A., Troussard, X., Claisse, J.-F., Thieblemont, C., Maloisel, F., Beguin, Y., Tamburini, J., Barbe, C., & Delmer, A. (2015). Rituximab therapy for hairy cell leukemia : a retrospective study of 41 cases. Annals of Hematology, 94, 89-95. doi:10.1007/s00277-014-2175-0 Peer Reviewed verified by ORBi |
 | Devos, T., Zachée, P., Bron, D., Noens, L., Van Droogenbroeck, J., Mineur, P., Beguin, Y., Berneman, Z., Benghiat, F. S., Kentos, A., Chatelain, C., Demuynck, H., Lemmens, J., Van Eygen, K., Theunissen, K., Trullemans, F., Pierre, P., Pluymers, W., & Knoops, L. (2015). Myelofibrosis patients in Belgium: disease characteristics. Acta Clinica Belgica, 70 (2), 105-111. doi:10.1179/2295333714Y.0000000097 Peer Reviewed verified by ORBi |
 | Baron, F., Zachée, P., Maertens, J., Kerre, T., ORY, A., SEIDEL, L., Graux, C., Lewalle, P., Van Gelder, M., Theunissen, K., WILLEMS, E., Emonts, M.-P., De Becker, A., & Beguin, Y. (2015). Non-myeloablative allogeneic hematopoietic cell transplantation following fludarabine plus 2 Gy TBI or ATG plus 8 Gy TLI: a phase II randomized study from the Belgian Hematological Society. Journal of Hematology and Oncology, 8, 4. doi:10.1186/s13045-014-0098-9 Peer Reviewed verified by ORBi |
 | Gauthier, J., Damaj, G., Langlois, C., Robin, M., Michallet, M., Chevallier, P., Beguin, Y., N'guyen, S., Bories, P., Blaise, D., Cornillon, J., Clavert, A., Mohty, M., Huynh, A., Thiébaut-Bertrand, A., Vigouroux, S., Duhamel, A., & Yakoub-Agha, I. (2015). Contribution of Revised International Prognostic Scoring System Cytogenetics to Predict Outcome After Allogeneic Stem Cell Transplantation for Myelodysplastic Syndromes: A Study From the Société Française de Greffe de Moelle et Thérapies Cellulaires. Transplantation, 99 (8), 1672-1680. Peer Reviewed verified by ORBi |
 | Binsfeld, M., HANNON, M., Otjacques, E., Humblet-Baron, S., BAUDOUX, E., BEGUIN, Y., BARON, F., & CAERS, J. (2015). Impact of the immunomodulating peptide thymosin alpha 1 on multiple myeloma and immune recovery after hematopoietic stem cell transplantation. Cancer Immunology, Immunotherapy, 64, 989-998. doi:10.1007/s00262-015-1708-2 Peer Reviewed verified by ORBi |
 | SERVAIS, S., Baron, F., & BEGUIN, Y. (2015). Impact of graft source and composition on outcomes after allogeneic stem cell transplantation. Belgian Journal of Hematology, 6 (4), 162-168. Peer Reviewed verified by ORBi |
 | Basak, G., Wiktor-Jedrzejczak, W., Labopin, M., Schoemans, H., Ljungman, P., Kobbe, G., Beguin, Y., Lang, P., Koenecke, C., Sykora, K., te Boome, L., van Biezen, A., van der Werf, S., Mohty, M., de Witte, T., Marsh, J., Dreger, P., Kröger, N., Duarte, R., & Ruutu, T. (2015). Allogeneic hematopoietic stem cell transplantation in solid organ transplant recipients: a retrospective, multicenter study of the EBMT. American Journal of Transplantation, 15, 705-714. doi:10.1111/ajt.13017 Peer Reviewed verified by ORBi |
 | SERVAIS, S., Menten-Dedoyart, C., Beguin, Y., SEIDEL, L., Gothot, A., Daulne, C., WILLEMS, E., Delens, L., Humblet-Baron, S., Hannon, M., & Baron, F. (2015). Impact of Pre-Transplant Anti-T Cell Globulin (ATG) on Immune Recovery after Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation. PLoS ONE, 10 (6), 0130026. doi:10.1371/journal.pone.0130026 Peer Reviewed verified by ORBi |
 | Halter, J., Michael, W., Schüpbach, W., Mandel, H., Casali, C., Orchard, K., Collin, M., Valcarcel, D., Rovelli, A., Filosto, M., Dotti, M., Marotta, G., Pintos, G., Barba, P., Accarino, A., Ferra, C., Illa, I., Beguin, Y., Bakker, J., ... Hirano, M. (2015). Allogeneic haematopoietic stem cell transplantation for mitochondrial neurogastrointestinal encephalomyopathy. Brain: a Journal of Neurology, 138, 2847-2858. doi:10.1093/brain/awv226 Peer Reviewed verified by ORBi |
 | Bonnet, C., LEJEUNE, M., VAN KEMSEKE, C., Bron, D., & Beguin, Y. (2015). Prise en charge actuelle du lymphome de la zone marginale. Revue Médicale Suisse, 11, 1549-1556. Peer Reviewed verified by ORBi |
 | DETRY, O., JOURET, F., VANDERMEULEN, M., ERPICUM, P., Delens, L., GREGOIRE, C., BRIQUET, A., WEEKERS, L., BAUDOUX, E., LECHANTEUR, C., & BEGUIN, Y. (December 2014). Cellules stromales mésenchymateuses et transplantation d'organes. Revue Médicale de Liège, 69, 53-56. Peer reviewed |
 | MOERMANS, C., BONNET, C., WILLEMS, E., Baron, F., NGUYEN DANG, D., HENKET, M., Sele, J., CORHAY, J.-L., Beguin, Y., & Louis, R. (November 2014). Sputum cytokines levels in patients undergoing hematopoietic SCT (HSCT) and comparison with healthy subjects and COPD: a pilot study. Bone Marrow Transplantation, 49 (11), 1382-1388. doi:10.1038/bmt.2014.164 Peer Reviewed verified by ORBi |
 | Delens, L., Jouret, F., DETRY, O., Beguin, Y., & Krzesinski, J.-M. (27 August 2014). Intérêt des cellules stromales mésenchymateuses en transplantation d’organes solides. Revue Médicale Suisse, 10, 1538-1543. Peer Reviewed verified by ORBi |
 | De Bock, M., BEGUIN, Y., Leprince, P., WILLEMS, E., BARON, F., Deroyer, C., Seidel, L., CAVALIER, E., DE SENY, D., MALAISE, M., GOTHOT, A., MERVILLE, M.-P., & Fillet, M. (July 2014). Comprehensive plasma profiling for the characterization of graft-versus-host disease biomarkers. Talanta, 125, 265-275. doi:10.1016/j.talanta.2014.03.017 Peer Reviewed verified by ORBi |
 | Hannon, M., LECHANTEUR, C., Lucas, S., Somja, J., Seidel, L., Belle, L., Bruck, F., BAUDOUX, E., GIET, O., Chantillon, A.-M., Delvenne, P., Drion, P., Beguin, Y., Humblet-Baron, S., & Baron, F. (17 June 2014). Infusion of clinical-grade enriched regulatory T cells delays experimental xenogeneic graft-versus-host disease. Transfusion, 54 (February), 353-363. doi:10.1111/trf.12279 Peer Reviewed verified by ORBi |
 | CAERS, J., WITHOFS, N., Hillengass, J., SIMONI, P., Zamagni, E., HUSTINX, R., & BEGUIN, Y. (April 2014). The role of positron emission tomography-computed tomography and magnetic resonance imaging in diagnosis and follow-up of multiple myeloma. Haematologica, 99 (4), 629-37. doi:10.3324/haematol.2013.091918 Peer Reviewed verified by ORBi |
 | CAERS, J., HAFRAOUI, K., KEUTGENS, A., CABERG, J.-H., LAMBERT, F., TASSIN, F., & BEGUIN, Y. (02 February 2014). Haematological and molecular responses in refractory anaemia with ring sideroblasts and thrombocytosis treated with lenalidomide. European Journal of Haematology, 92 (2), 179-180. doi:10.1111/ejh.12233 Peer Reviewed verified by ORBi |
 | Duléry, R., Mohty, M., Duhamel, A., Robin, M., BEGUIN, Y., Michallet, M., Vigouroux, S., Lioure, B., Garnier, A., El Cheikh, J., Bulabois, C.-E., Huynh, A., Bay, J.-O., Daguindau, E., Ceballos, P., Clément, L., Dauriac, C., Maillard, N., Legrand, F., ... Yakoub-Agha, I. (2014). Antithymocyte globulin before allogeneic stem cell transplantation for progressive myelodysplastic syndrome : a study from the French Society of Bone Marrow Transplantation and Cellular Therapy. Biology of Blood and Marrow Transplantation, 20, 646-654. doi:10.1016/j.bbmt.2014.01.016 Peer Reviewed verified by ORBi |
 | Baron, F., Humblet-Baron, S., Ehx, G., SERVAIS, S., HANNON, M., Belle, L., LECHANTEUR, C., BRIQUET, A., GIET, O., BAUDOUX, E., WILLEMS, E., & Beguin, Y. (2014). Thinking out of the box - New approaches to controlling GVHD. Current Hematologic Malignancy Reports, 9, 73-84. doi:10.1007/s11899-013-0187-9 Peer Reviewed verified by ORBi |
 | BRIQUET, A., GREGOIRE, C., Comblain, F., Servais, L., Zeddou, M., LECHANTEUR, C., & Beguin, Y. (2014). Human bone marrow, umbilical cord or liver mesenchymal stromal cells fail to improve liver function in a model of CCl4-induced liver damage in NOD/SCID/IL-2Ry(null) mice. Cytotherapy, 16, 1511-1518. doi:10.1016/j.jcyt.2014.07.003 Peer Reviewed verified by ORBi |
 | Binsfeld, M., Fostier, K., Muller, J., Baron, F., Schots, R., Beguin, Y., Heusschen, R., & CAERS, J. (2014). Cellular immunotherapy in multiple myeloma : lessons from preclinical models. Biochimica et Biophysica Acta - Reviews on Cancer, 1846, 392-404. doi:10.1016/j.bbcan.2014.08.001 Peer Reviewed verified by ORBi |
 | Binsfeld, M., Beguin, Y., Belle, L., Otjacques, E., HANNON, M., BRIQUET, A., Heusschen, R., Drion, P., Zilberberg, J., Bogen, B., Baron, F., & CAERS, J. (2014). Establishment of a murine graft-versus-myeloma model using allogeneic stem cell transplantation. PLoS ONE, 113764. doi:10.1371/journal.pone.0113764 Peer Reviewed verified by ORBi |
 | Beguin, Y., & JASPERS, A. (2014). Iron sucrose - characteristics, efficacy and regulatory aspects of an established treatment of iron deficiency and iron-deficiency anemia in a broad range of therapeutic areas. Expert Opinion on Pharmacotherapy, 15, 2087-2103. doi:10.1517/14656566.2014.953928 Peer Reviewed verified by ORBi |
 | Erpicum, P., DETRY, O., WEEKERS, L., BONVOISIN, C., LECHANTEUR, C., BRIQUET, A., Beguin, Y., Krzesinski, J.-M., & Jouret, F. (2014). Mesenchymal stromal cell therapy in conditions of renal ischaemia/reperfusion. Nephrology Dialysis Transplantation, 29, 1487-1493. doi:10.1093/ndt/gft538 Peer Reviewed verified by ORBi |
 | MOERMANS, C., LECHANTEUR, C., BAUDOUX, E., GIET, O., HENKET, M., SEIDEL, L., LEJEUNE, M., WILLEMS, E., Baron, F., LOUIS, R., & BEGUIN, Y. (2014). Impact of cotransplantation of mesenchymal stem cells on lung function after unrelated allogeneic hematopoietic stem cell transplantation following non-myeloablative conditioning. Transplantation, 98 (3), 348-353. doi:10.1097/TP.0000000000000068 Peer Reviewed verified by ORBi |
 | Damaj, G., Mohty, M., Robin, M., Michallet, M., Chevallier, P., Beguin, Y., Nguyen, S., Bories, P., Blaise, D., Maillard, N., Rubio, M.-T., Fegueux, N., Cornillon, J., Clavert, A., Huynh, A., Adès, L., Thiébaut-Bertrand, A., Hermine, O., Vigouroux, S., ... Yakoub-Agha, I. (2014). Upfront allogeneic stem cell transplantation after reduced-intensity/nonmyeloablative conditioning for patients with myelodysplastic syndrome : a study by the Société Française de Greffe de Moelle et de Thérapie Cellulaire. Biology of Blood and Marrow Transplantation, 20, 1349-1355. doi:10.1016/j.bbmt.2014.05.010 Peer Reviewed verified by ORBi |
 | LECHANTEUR, C., Baila, S., Janssen, M. E., GIET, O., BRIQUET, A., BAUDOUX, E., & Beguin, Y. (2014). Large-Scale Clinical Expansion of Mesenchymal Stem Cells in the GMP-Compliant, Closed Automated Quantum® Cell Expansion System: Comparison with Expansion in Traditional T-Flasks. Journal of Stem Cell Research and Therapy, 4 (8), 1000222. doi:10.4172/2157- 7633.1000222 Peer Reviewed verified by ORBi |
 | CAERS, J., Binsfeld, M., Muller, J., Heusschen, R., & Beguin, Y. (2014). Gammapathie monoclonale de signification indéterminée : information destinée aux médecins référents. Revue Médicale de Liège, 69, 41-46. Peer reviewed |
 | VANDERMEULEN, M., GREGOIRE, C., BRIQUET, A., LECHANTEUR, C., BEGUIN, Y., & DETRY, O. (2014). Rationale for the potential use of mesenchymal stromal cells in liver transplantation. World Journal of Gastroenterology, 20 (44), 16418-32. doi:10.3748/wjg.v20.i44.16418 Peer Reviewed verified by ORBi |
 | CAERS, J., & BEGUIN, Y. (2014). Le myélome multiple asymptomatique : le paysage thérapeutique change. Oncol. Hematol, 8, 39-45. Peer reviewed |
 | Belaiche, S., Yafour, N., Balcaen, S., Beguin, Y., Borel, C., Bruno, B., Godin, S., Labussière-Wallet, H., Sanhamut, N., Charbonnier, A., de Berranger, E., Konopacki-Potet, J., Turlure, P., & Yakoub-Agha, I. (2014). Immunosuppresseurs dans la prévention de la réaction du greffon contre l'hôte : rapport de la SFGM-TC. Pathologie Biologie, 62, 197-203. doi:10.1016/j.patbio.2014.05.010 Peer Reviewed verified by ORBi |
 | JASPERS, A., Baron, F., WILLEMS, E., HAFRAOUI, K., Vanstraelen, G., Bonnet, C., & Beguin, Y. (2014). Erythropoietin therapy after allogeneic hematopoietic cell transplantation : a prospective randomized trial. Blood, 124, 33-41. doi:10.1182/blood-2014-01-546333 Peer Reviewed verified by ORBi |
 | Ludwig, H. P., Aapro, M. S., Bokemeyer, C., Glaspy, J. A., Hedenus, M., Littlewood, T. J., Osterborg, A. C., Rzychon, B., Mitchell, D., & BEGUIN, Y. (2014). A European patient record study on diagnosis and treatment of chemotherapy-induced anaemia. Supportive Care in Cancer, 22, 2197-2206. doi:10.1007/s00520-014-2189-0 Peer Reviewed verified by ORBi |
 | Chevallier, P., Labopin, M., Milpied, N., Bilger, K., Socié, G., Yakoub-Agha, I., Michallet, M., Bulabois, C.-E., Maury, S., Beguin, Y., Bay, J.-O., Blaise, D., Maillard, N., Guillerm, G., Daguindeau, E., Raus, N., & Mohty, M. (2014). Outcomes of adults with active or progressive hematological malignancies at time of allogeneic stem cell transplantation : a survey from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC). Bone Marrow Transplantation, 49, 361-365. Peer Reviewed verified by ORBi |
 | Delforge, M., Selleslag, D., BEGUIN, Y., Triffet, A., Mineur, P., Theunissen, K., Graux, C., Trullemans, F., Boulet, D., Van Eygen, K., Noens, L., Van Steenweghen, S., Lemmens, J., Pierre, P., D'Hondt, R., Ferrant, A., Deeren, D., Van de Velde, A., Wynendaeke, W., ... Ravoet, C. (2014). Adequate iron chelation therapy for at least six months improves survival in transfusion-dependent patients wih lower risk myelodysplastic syndromes. Leukemia Research, 38, 557-563. Peer Reviewed verified by ORBi |
 | Battisti, O., & Beguin, Y. (2014). A propos de l'encéphalopathie du nouveau-né. Percentile, 19, 8-9. Peer reviewed |
 | Moors, I., Schoemans, H., Callens, S., Beguin, Y., & Kerre, T. (2014). Vaccination guidelines in hematopoietic transplant patients : recommendations from the BHS Transplant Committee. Belgian Journal of Hematology, 6, 44-54. Peer Reviewed verified by ORBi |
 | Beguin, Y., Aapro, M. S., Ludwig, H. P., Mizzen, L., & Osterborg, A. C. (2014). Epidemiological and nonclinical studies investigating effects of iron in carcinogenesis-A critical review. Critical Reviews in Oncology/Hematology, 89, 1-15. doi:10.1016/j.critrevonc.2013.10.008 Peer Reviewed verified by ORBi |
 | Bruck, F.* , Belle, L.* , LECHANTEUR, C., de Leval, L., Hannon, M., DUBOIS, S., CASTERMANS, E., Humblet-Baron, S., Rahmouni, S., Beguin, Y., BRIQUET, A.* , & Baron, F.*. (March 2013). Impact of bone marrow-derived mesenchymal stromal cells on experimental xenogeneic graft-versus-host disease. Cytotherapy, 15 (3), 267-279. doi:10.1016/j.jcyt.2012.09.003 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | JASPERS, A., CAERS, J., LE GAC, G., FEREC, C., BEGUIN, Y., & FILLET, G. (February 2013). A novel mutation in the CUB sequence of matriptase-2 (TMPRSS6) is implicated in iron-resistant iron deficiency anaemia (IRIDA). British Journal of Haematology, 160 (4), 564-565. doi:10.1111/bjh.12147 Peer Reviewed verified by ORBi |
 | HAFRAOUI, K., DE PRIJCK, B., & Beguin, Y. (2013). Leucémie myélomonocytaire chronique : diagnostic et thérapeutique. Revue Médicale Suisse, 9, 1512-1517. Peer Reviewed verified by ORBi |
 | De Bock, M., Fillet, M., Hannon, M., Seidel, L., Merville, M.-P., Gothot, A., Beguin, Y., & Baron, F. (2013). Kinetics of IL-7 and IL-15 Levels after Allogeneic Peripheral Blood Stem Cell Transplantation following Nonmyeloablative Conditioning. PLoS ONE, 8 (2), 55876. doi:10.1371/journal.pone.0055876 Peer Reviewed verified by ORBi |
 | Park, S., Labopin, M., Yakoub-Agha, I., Delaunay, J., Dhedin, N., Deconinck, E., Michallet, M., Robin, M., De Revel, T., Bernard, M., Vey, N., Lioure, B., Lapusan, S., Tabrizi, R., Bourhis, J.-H., Huynh, A., Beguin, Y., Socié, G., Dreyfus, F., ... Mohty, M. (2013). Allogeneic stem cell transplantation for chronic myelomonocytic leukemia : a report from the Société Française de Greffe de Moelle et de Thérapie Cellulaire. European Journal of Haematology, 90, 355-364. doi:10.1111/ejh.12073 Peer Reviewed verified by ORBi |
 | Otjacques, E., Binsfeld, M., Beguin, Y., Noël, A., Cataldo, D., & CAERS, J. (2013). Aspects biologiques de l'angiogenèse dans le myélome multiple. Oncohématologie, 7 (2), 6-12. Peer reviewed |
 | COLLINS, P., Vijgen, S., DE PRIJCK, B., BLETARD, N., Beguin, Y., & Delvenne, P. (2013). Chimiothérapie, immunodépression et cancers secondaires : rapport d'un cas clinique. Revue Médicale de Liège, 67, 418-422. Peer reviewed |
 | Otjacques, E., Binsfeld, M., Rocks, N., Blacher, S., Vanderkerken, K., Noël, A., Beguin, Y., Cataldo, D., & CAERS, J. (2013). Mithramycin Exerts an Anti-Myeloma Effect and Displays Anti-Angiogenic Effects through Up-Regulation of Anti-Angiogenic Factors. PLoS ONE, 8 (5), 62818. doi:10.1371/journal.pone.0062818 Peer Reviewed verified by ORBi |
 | SERVAIS, S., WILLEMS, E., Beguin, Y., & Baron, F. (2013). Allogreffe de cellules souches hématopoïétiques chez le patient âgé : jusqu'à quel âge ? Revue Médicale de Liège, 68 (1), 38-43. Peer reviewed |
 | SERVAIS, S., Beguin, Y., & Baron, F. (2013). Emerging drugs for prevention of graft failure after allogeneic hematopoietic stem cell transplantation. Expert Opinion on Emerging Drugs, 18 (2), 173-192. doi:10.1517/14728214.2013.798642 Peer Reviewed verified by ORBi |
 | BEGUIN, Y., Maertens, J., DE PRIJCK, B., Schots, R., Seidel, L., BONNET, C., HAFRAOUI, K., WILLEMS, E., Vanstraelen, G., SERVAIS, S., JASPERS, A., FILLET, G., & BARON, F. (2013). Darbepoetin-alfa and intravenous iron administration after autologous hematopoietic stem cell transplantation : A prospective multicenter randomized trial. American Journal of Hematology, 88, 990-996. doi:10.1002/ajh.23552 Peer Reviewed verified by ORBi |
 | Moermans, C., Poulet, C., HENKET, M., Bonnet, C., WILLEMS, E., Baron, F., Beguin, Y., & Louis, R. (2013). Lung function and airway inflammation monitoring after hematopoietic stem cell transplantation. Respiratory Medicine, 107, 2071-2080. doi:10.1016/j.rmed.2013.10.013 Peer Reviewed verified by ORBi |
 | Janssens, A., Lambert, C., Bries, G., Bosly, A., Selleslag, D., & Beguin, Y. (2013). Primary immune thrombocytopenia in adults. Belgian Journal of Hematology, 4 (1), 2-11. Peer Reviewed verified by ORBi |
 | BRIQUET, A., HALLEUX, A., LECHANTEUR, C., & BEGUIN, Y. (2013). Neuropeptides to replace serum in cryopreservation of mesenchymal stromal cells ? Cytotherapy, 15, 1385-1394. doi:10.1016/j.jcyt.2013.06.012 Peer Reviewed verified by ORBi |
 | Hauzeur, J.-P., Bernard, C., Egrise, D., Kurth, W., Van Cauwenberge, H., LECHANTEUR, C., Gillet, P., Beguin, Y., MALAISE, M., & HUSTINX, R. (2013). (111)Indium-oxine labelling for evaluating the homing process of autologous osteoblasts implanted percutaneously in atrophic nonunion fractures. International Orthopaedics, 37 (1), 131-6. doi:10.1007/s00264-012-1719-y Peer Reviewed verified by ORBi |
 | FRUSCH, N., SERVAIS, S., DE PRIJCK, B., Corhay, J.-L., Beguin, Y., Louis, R., & DUYSINX, B. (2012). Spontaneous pneumomediastinum caused by bleomycin-induced pneumonitis. Acta Clinica Belgica, 67-68. doi:10.2143/ACB.67.5.2062693 Peer Reviewed verified by ORBi |
 | VERTENOEIL, G., SERVAIS, S., & Beguin, Y. (2012). Comment j'explore... une fièvre d'origine indéterminée chez le patient adulte ? Revue Médicale de Liège, 67 (7-8), 391-397. Peer reviewed |
 | Aapro, M. S., Osterborg, A. C., Gascon, P., Ludwig, H. P., & BEGUIN, Y. (2012). Prevalence and management of cancer-related anaemia, iron deficiency and the specific role of intravenous iron. Annals of Oncology, 23, 1954-62. Peer Reviewed verified by ORBi |
 | Aapro, M. S., Österborg, A., Gascon, P., Ludwig, H., & Beguin, Y. (2012). Anaemia and cancer : oral or intravenous iron ? Therapeutics, 46-48. Peer reviewed |
 | Damaj, G., Duhamel, A., Robin, M., Beguin, Y., Michallet, M., Mohty, M., Vigouroux, S., Bories, P., Garnier, A., El Cheikh, J., Bulabois, C.-E., Huynh, A., Bay, J.-O., Legrand, F., Deconinck, E., Fegueux, N., Clement, L., Dauriac, C., Maillard, N., ... Yakoub-Agha, I. (2012). Impact of Azacitidine before allogeneic stem-cell transplantation for myelodysplastic syndromes : a study b the Société Française de Greffe de Moelle et de Thérapie-Cellulaire and the Groupe Francophone des Myélodysplasies. Journal of Clinical Oncology, 30, 4533-4540. doi:10.1200/JCO.2012.44.3499 Peer Reviewed verified by ORBi |
 | Roelants, V., DELGAUDINE, M., Walrand, S., Lhommel, R., Beguin, Y., Jamar, F., & Vanoverschelde, J.-L. (2012). Myocardial infarct size quantification in mice by SPECT using a novel algorithm independent of a normal perfusion database. EJNMMI Research, 2, 64-75. doi:10.1186/2191-219X-2-64 Peer Reviewed verified by ORBi |
 | Kermani, H., Goffinet, L., Mottet, M., Bodart, G., Morrhaye, G., Dardenne, O., Overbergh, L., Baron, F., Beguin, Y., Geenen, V., & Martens, H. (2012). Expression of growth hormone (GH)/insulin-like growth factor (IGF) axis during Balb/c ontogeny and effects of GH upon ex-vivo T-cell differentiation. Neuroimmunomodulation, 19, 137-147. Peer Reviewed verified by ORBi |
 | Belle, L., Bruck, F., FOGUENNE, J., GOTHOT, A., BEGUIN, Y., Baron, F., & Briquet, A. (2012). Imatinib and Nilotinib Inhibit Hematopoietic Progenitor Cell Growth, but Do Not Prevent Adhesion, Migration and Engraftment of Human Cord Blood CD34+ Cells. PLoS ONE, 7 (12), 52564. doi:10.1371/journal.pone.0052564 Peer Reviewed verified by ORBi |
 | Verbeke, N., Beguin, Y., Wildiers, H., Canon, J.-L., Bries, G., Bosly, A., & Van Belle, S. (2012). High prevalence of anaemia and limited use of therapy in cancer patients : a Belgian survey (Anaemia Day 2008). Supportive Care in Cancer, 20, 23-28. doi:10.1007/s00520-010-1045-0 Peer Reviewed verified by ORBi |
 | Malaise, O., FRUSCH, N., BECK, E., Servais, S., BETEA, D., CAERS, J., DE PRIJCK, B., & BEGUIN, Y. (2012). Panhypopituitarism and diabetus insipidus in a patient with primary central nervous system lymphoma. Leukemia and Lymphoma, 53 (12), 2515-16. Peer Reviewed verified by ORBi |
 | VANDAMME, A., Schots, R., & BEGUIN, Y. (2012). Academic clinical trials run by the transplant committee of the Belgian Hematological Society. Belgian Journal of Hematology, 3 (2), 62-67. Peer Reviewed verified by ORBi |
 | Huybrechts, S., BEGUIN, Y., Bordon, V., DRESSE, M.-F., Dupont, S., Ferster, A., Laureys, G., Meyts, I., Renard, M., & Vermylen, C. (2012). Less veno-occlusive disease after intravenous versus oral busulfan for autologous haematopoietic stem cell transp.l antation: the Belgian paediatric experlence. Belgian Journal of Hematology, 3 (2), 34-40. Peer Reviewed verified by ORBi |
 | Zeddou, M., RELIC, B., MALAISE, O., CHARLIER, E., Desouroux, A., BEGUIN, Y., DE SENY, D., & Malaise, M. (2012). Differential signalling through ALK-1 and ALK-5 regulates leptin expression in Mesenchymal Stem Cells. Stem Cells and Development, 21 (11), 1948-54. doi:10.1089/scd.2011.0321 Peer Reviewed verified by ORBi |
 | Bonnet, C., DE PRIJCK, B., LEJEUNE, M., FASSOTTE, M.-F., Van Den Neste, E., & Beguin, Y. (2012). Prise en charge du lymphome B diffus à grandes cellules en 2012. Revue Médicale Suisse, 8, 1582-90. Peer Reviewed verified by ORBi |
 | Noterdaeme, T., Longree, L., Bataille, C., DE ROOVER, A., LAMPROYE, A., DELWAIDE, J., Beguin, Y., Honoré, P., & DETRY, O. (July 2011). Liver transplantation for acute hepatic failure due to chemotherapy-induced HBV reactivation in lymphoma patients. World Journal of Gastroenterology, 17 (25), 3069-72. doi:10.3748/wjg.v17.i25.3069 Peer Reviewed verified by ORBi |
 | CAERS, J., BONNET, C., GRAUX, C., DE PRIJCK, B., & BEGUIN, Y. (2011). Prise en charge actuelle des syndromes myélodysplasiques. Revue Médicale Suisse, 7, 1634-1643. Peer Reviewed verified by ORBi |
 | Otjacques, E., Binsfeld, M., Noël, A., Beguin, Y., Cataldo, D., & CAERS, J. (2011). Biological aspects of angiogenesis in multiple myeloma. International Journal of Hematology, 94 (6), 505-18. doi:10.1007/s12185-011-0963-z Peer Reviewed verified by ORBi |
 | SERVAIS, S., Baron, F., & Beguin, Y. (2011). Allogeneic hematopoietic stem cell transplantation (HSCT) after reduced intensity conditioning. Transfusion and Apheresis Science, 44, 205-210. doi:10.1016/j.transci.2011.01.019 Peer Reviewed verified by ORBi |
 | Bonnet, C., CAERS, J., DE PRIJCK, B., HAFRAOUI, K., & Beguin, Y. (2011). Lymphome du manteau : prise en charge 2011. Revue Médicale Suisse, 7, 1644-1649. Peer Reviewed verified by ORBi |
 | DELGAUDINE, M., Lambermont, B., Lancellotti, P., Roelants, V., Walrand, S., Vanoverschelde, J.-L., Pierard, L., Gothot, A., & Beguin, Y. (2011). Effects of granulocyte-colony-stimulating factor on progenitor cell mobilization and heart perfusion and function in normal mice. Cytotherapy, 13, 237-247. doi:10.3109/14653249.2010.491820 Peer Reviewed verified by ORBi |
 | Robin, M., Sanz, G. F., Ionescu, I., Rio, B., Sirvent, A., Renaud, M., Carreras, E., Milpied, N., Mohty, M., Beguin, Y., Bordigoni, P., De Witte, T., Picardi, A., Purtill, D., Gluckman, E., Kroger, N., & Rocha, V. (2011). Unrelated cord blood transplantation in adults with myelodysplasia or secondary acute myeloblastic leukemia : a survey on behalf of Eurocord and CLWP of EBMT. Leukemia, 25, 75-81. doi:10.1038/leu.2010.219 Peer Reviewed verified by ORBi |
 | CASTERMANS, E., Hannon, M., Dutrieux, J., Humblet, S., Seidel, L., Cheynier, R., Willems, E., Gothot, A., Vanbellinghen, J.-F., Geenen, V., Sandmaier, B. M., Storb, R., Beguin, Y., & Baron, F. (2011). Thymic recovery after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning is limited to patients younger than 60 years of age. Haematologica, 96(2), 298-306. doi:10.3324/haematol.2010.029702 Peer Reviewed verified by ORBi |
 | Servais, S., Beguin, Y., & Baron, F. (2011). Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation (HSCT). Belgian Journal of Hematology, 2, 3-9. Peer Reviewed verified by ORBi |
 | Aapro, M. S., Beguin, Y., Birgegard, G., Gascon, P., Hedenus, M., & Osterborg, A. (2011). Too low iron doses and too many dropouts in negative iron trial. Journal of Clinical Oncology, 525-e526. doi:10.1200/JCO.2011.35.3219 Peer Reviewed verified by ORBi |
 | Willems, E.* , Baron, F.* , Seidel, L., Frère, P., Fillet, G., & Beguin, Y. (2010). Comparison of thrombotic microangiopathy after allogeneic hematopoietic cell transplantation with high-dose or nonmyeloablative conditioning. Bone Marrow Transplantation, 45, 689-693. doi:10.1038/bmt.2009.230 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Roufosse, R., & Beguin, Y. (2010). Observance thérapeutique en hématologie : le cas particulier de la leucémie myéloïde chronique. Revue Médicale de Liège, 65, 409-412. Peer reviewed |
 | Dirix, L., Awada, A., Bron, D., Canon, J.-L., De Grève, J., Humblet, Y., Peeters, M., Van Belle, S., Vansteenkiste, J., Beguin, Y., & Vermorken, J. (2010). Practice guidelines on the use of erythropoiesis-stimulating agents in the treatment of chemotherapy-induced anemia. Belgian Journal of Medical Oncology, 4, 57-64. Peer Reviewed verified by ORBi |
 | Servais, S., Willems, E., Beguin, Y., & Baron, F. (2010). Maladie du greffon contre l'hôte chronique : une prise en charge multidisciplinaire. Revue Médicale de Liège, 65, 81-87. Peer reviewed |
 | Delgaudine, M., Gothot, A., & Beguin, Y. (2010). Spontaneous and granulocyte–colony-stimulating factor-enhanced marrow response and progenitor cell mobilization in mice after myocardial infarction. Cytotherapy, 12 (7), 909-18. doi:10.3109/14653240903580262 Peer Reviewed verified by ORBi |
 | Briquet, A., Dubois, S., Bekaert, S., Dolhet, M., Beguin, Y., & Gothot, A. (2010). Prolonged ex vivo culture of human bone marrow mesenchymal stem cells influences their supportive activity toward NOD/SCID -repopulating cells and committed progenitor cells of B lymphoid and myeloid lineages. Haematologica, 95 (1), 47-56. doi:10.3324/haematol.2009.008524 Peer Reviewed verified by ORBi |
 | Willems, E., Humblet-Baron, S., Dengis, O., Seidel, L., Beguin, Y., & Baron, F. (2010). Elevations of tumor necrosis factor-receptor-1 at day 7 and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Bone Marrow Transplantation, 45, 1442-1448. doi:10.1038/bmt.2009.360 Peer Reviewed verified by ORBi |
 | Baron, F., Lechanteur, C., Willems, E., Bruck, F., Baudoux, E., Seidel, L., Vanbellinghen, J.-F., Hafraoui, K., LEJEUNE, M., Gothot, A., Fillet, G., & Beguin, Y. (2010). Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning. Biology of Blood and Marrow Transplantation, 16 (6), 838-47. doi:10.1016/j.bbmt.2010.01.011 Peer Reviewed verified by ORBi |
 | Jaspers, A., Baron, F., Bonnet, C., De Prijck, B., Fassotte, M.-F., & Beguin, Y. (2010). Le lymphome du manteau. Revue Médicale de Liège, 65, 171-176. Peer reviewed |
 | Baron, F., & Beguin, Y. (2010). Hematopoietic stem cell transplantation in the treatment strategy of acute leukemia. Belgian Journal of Medical Oncology, 4, 118-123. Peer Reviewed verified by ORBi |
 | Zeddou, M., Briquet, A., Relic, B., Josse, C., Malaise, M., Gothot, A., Lechanteur, C., & Beguin, Y. (2010). The umbilical cord matrix is a better source of mesenchymal stem cells (MSC) than the umbilical cord blood. Cell Biology International, 34 (7), 693-701. doi:10.1042/CBI20090414 Peer Reviewed verified by ORBi |
 | Servais, S., Caers, J., Warling, O., Frusch, N., Baron, F., De Prijck, B., & Beguin, Y. (2010). Enteroviral meningoencephalitis as complication of Rituximab therapy in a patient treated for diffuse large B-cell lymphoma. British Journal of Haematology, 150 (3), 379-381. doi:10.1111/j.1365-2141.2010.08202.x Peer Reviewed verified by ORBi |
 | Avivi, I., Montoto, S., Canals, C., Maertens, J., Al-Ali, H., Mufti, G. J., Finke, J., Schattenberg, A., Fanin, R., Cornelissen, J. J., Vernant, J.-P., Russel, N., Beguin, Y., Thomason, K., Verdonck, L. F., Kobbe, G., Tilly, H., Socié, G., & Sureda, A. (2009). Matched unrelated donor stem cell transplant in 131 patients with follicular lymphoma : an analysis from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. British Journal of Haematology, 147, 719-728. doi:10.1111/j.1365-2141.2009.07905.x Peer Reviewed verified by ORBi |
 | Beguin, Y. (2009). Utilisation thérapeutique de l'érythropoïétine. Revue du Praticien, 59, 82-83. Peer reviewed |
 | Bonnet, C., Beguin, Y., De Prijck, B., de Leval, L., & Fillet, G. (2009). Traitements actuels du lymphome folliculaire. Revue Médicale Suisse, 5, 1663-7. Peer Reviewed verified by ORBi |
 | Castermans, E., Hannon, M., Drion, P., Geenen, V., Beguin, Y., & Baron, F. (2009). Reconstitution du système immunitaire après allogreffe de cellules souches hématopoïétiques. Revue Médicale de Liège, 64 (S1), 2-8. Peer reviewed |
 | Bonnet, C., Beguin, Y., De Prijck, B., Witvrouw, N., Hustinx, R., & Fillet, G. (2009). Les anticorps monoclonaux en hématologie en 2009. Revue Médicale de Liège, 64, 268-273. Peer reviewed |
 | Willems, E., Canivet, J.-L., Ghaye, B., de Leval, L., Radermecker, M., Preiser, J.-C., & Beguin, Y. (2009). Pulmonary veno-occlusive disease in myeloproliferative disorder. European Respiratory Journal, 33 (1), 213-216. doi:10.1183/09031936.00157707 Peer Reviewed verified by ORBi |
 | Hafraoui, K., Beguin, Y., & Baron, F. (2009). Cancers secondaires après allogreffe de cellules souches hématopoïétiques. Revue Médicale de Liège, 64 (10), 496-499. Peer reviewed |
 | Foguenne, J., Di Stefano, Giet, O., Beguin, Y., & Gothot, A. (2009). Ex vivo expansion of hematopoietic progenitor cells is associated with downregulation of alpha4 integrin- and CXCR4-mediated engraftment in NOD/SCID beta2-microglobulin-null mice. Haematologica, 94, 185-194. doi:10.3324/haematol.13206 Peer Reviewed verified by ORBi |
 | Dugauquier, C., Bataille, Y., Willems, E., Frere, P., De Prijck, B., Beguin, Y., & Baron, F. (2009). Toxoplasmore cérébrale compliquant une mini-allogreffe de cellules souches hématopoïétiques du sang périphérique. Revue Médicale de Liège, 64 (7-8), 366-369. Peer reviewed |
 | Relic, B., Zeddou, M., Desoroux, A., Beguin, Y., De Seny, D., & Malaise, M. (2009). Genistein induces adipogenesis but inhibits leptin induction in human synovial fibroblasts. Laboratory Investigation, 89 (7), 811-822. doi:10.1038/labinvest.2009.41 Peer Reviewed verified by ORBi |
 | Willemze, R., Rodrigues, C. A., Labopin, M., Sanz, G., Michel, G., Socié, G., Rio, B., Sirvent, A., Renaud, M., Madero, L., Mothy, M., Ribera, J. M., Garnier, F., Garcia, J., Lecchi, L., Kögler, G., Beguin, Y., Navarette, C., Boogaerts, M., ... Rocha, V. (2009). KIR-ligand incompatibility in the Graft-versus-host direction improves outcome after umbilical cord blood transplantation for acute leukemia. Leukemia, 23, 492-500. doi:10.1038/leu.2008.365 Peer Reviewed verified by ORBi |
 | Morrhaye, G., Kermani, H., Legros, J.-J., Baron, F., Beguin, Y., Moutschen, M., Cheynier, R., Martens, H., & Geenen, V. (2009). Impact of growth hormone (GH) deficiency and GH replacement upon thymus function in adult patients. PLoS ONE, 4 (5), 5668. doi:10.1371/journal.pone.0005668 Peer Reviewed verified by ORBi |
 | Willems, E.* , Baron, F.* , Baudoux, E., Wanten, N., Seidel, L., Vanbellinghen, J.-F., Herens, C., Gothot, A., Frere, P., Bonnet, C., Hafraoui, K., Vanstraelen, G., Fillet, G., & Beguin, Y. (2009). Non-myeloablative transplantation with CD8-depleted or unmanipulated peripheral blood stem cells: a phase II randomized trial. Leukemia, 23 (3), 608-10. doi:10.1038/leu.2008.248 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Lejeune, M., Beguin, Y., De Prijck, B., Fassotte, M.-F., Fillet, G., & Baron, F. (2008). Comment je traite...La leucémie myéloblastique aiguë (LMA) du sujet age en bon état général. Revue Médicale de Liège, 63 (2), 59-63. Peer reviewed |
 | Hoyoux, C., Dresse, M.-F., Robinet, S., Forget, P., Pieltain, C., Ketelslegers, O., & Beguin, Y. (2008). Cord blood transplantation in a child with Pearson's disease. Pediatric Blood and Cancer, 51 (4), 566. doi:10.1002/pbc.21615 Peer Reviewed verified by ORBi |
 | Brand, A., Rebulla, P., Engelfriet, C. P., Reesink, H. W., Beguin, Y., Baudoux, E., Kögler, G., Ebrahimi, M., Grazzini, G., Costa, A. N., Bosi, A., Sacchi, S., Lombardini, L., Pupella, S., Lecchi, L., Calderon Garciduenas, E. D., van Beckhoven, J. M., de Wit, H. J. C., Fibbe, W. E., ... Regan, F. (2008). Cord blood banking. Vox Sanguinis, 95, 335-348. doi:10.1111/j.1423-0410.2008.01106.x Peer Reviewed verified by ORBi |
 | Castermans, E.* , Baron, F.* , Willems, E., Schaaf-Lafontaine, N., Meuris, N., Gothot, A., Vanbellinghen, J.-F., Herens, C., Seidel, L., Geenen, V., Cheynier, R., & Beguin, Y. (2008). Evidence for neo-generation of T cells by the thymus after non-myeloablative conditioning. Haematologica, 93 (2), 240-7. doi:10.3324/haematol.11708 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Beguin, Y. (2008). Le sang de cordon ombilical. Revue du Praticien, 58, 2107-08. Peer reviewed |
 | Bovy, C., Gothot, A., Krzesinski, J.-M., Warling, X., & Beguin, Y. (20 January 2007). Mature erythrocyte parameters as new markers of functional iron deficiency in haemodialysis: sensitivity and specificity. Nephrology Dialysis Transplantation, 11, 1156-1162. doi:10.1093/ndt/gfl765 Peer Reviewed verified by ORBi |
 | De Prijck, B., Baron, F., Beguin, Y., Bonnet, C., Willems, E., & Fillet, G. (2007). Actualités thérapeutiques en hématologie. Revue Médicale de Liège, 62 (5-6), 384-90. Peer reviewed |
 | Castermans, E., Morrhaye, G., Marchand, S., Martens, H., Moutschen, M., Geenen, V., Beguin, Y., & Baron, F. (2007). Evaluation de la thymopoiese: applications cliniques. Revue Médicale de Liège, 62 (12), 725-9. Peer reviewed |
 | Castermans, E., Morrhaye, G., Marchand, S., Martens, H., Moutschen, M., Baron, F., Beguin, Y., & Geenen, V. (2007). Evaluation clinique de la fonction du thymus. Revue Médicale de Liège, 62 (11), 675-8. Peer reviewed |
 | Bonnet, C., Beguin, Y., Fassotte, M.-F., Seidel, L., Luyckx, F., & Fillet, G. (2007). Limited usefulness of CA125 measurement in the management of Hodgkin's and non-Hodgkin's lymphoma. European Journal of Haematology, 78 (5), 399-404. doi:10.1111/j.1600-0609.2007.00843.x Peer Reviewed verified by ORBi |
 | Pirson, L.* , Baron, F.* , Meuris, N., Giet, O., Castermans, E., Greimers, R., Di Stefano, I., Gothot, A., & Beguin, Y. (2006). Despite inhibition of hematopoietic progenitor cell growth in vitro, the tyrosine kinase inhibitor imatinib does not impair engraftment of human CD133+ cells into NOD/SCIDbeta2mNull mice. Stem Cells, 24 (7), 1814-21. doi:10.1634/stemcells.2005-0290 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Van Overstraeten-Schlogel, N., Beguin, Y., & Gothot, A. (2006). Role of stromal-derived factor-1 in the hematopoietic-supporting activity of human mesenchymal stem cells. European Journal of Haematology, 76 (6), 488-93. doi:10.1111/j.1600-0609.2006.00633.x Peer Reviewed verified by ORBi |
 | Van Overstraeten-Schlogel, N., Delgaudine, M., Beguin, Y., & Gothot, A. (2006). Limitations of the use of GFP transgenic mice in bone marrow transplantation studies. Leukemia and Lymphoma, 47 (7), 1392-3. doi:10.1080/10428190500513512 Peer Reviewed verified by ORBi |
 | Jerusalem, G., & Beguin, Y. (2006). The place of positron emission tomography imaging in the management of patients with malignant lymphoma. Haematologica, 91 (4), 442-4. Peer Reviewed verified by ORBi |
 | Cavill, I., Auerbach, M., Bailie, G. R., Barrett-Lee, P., Beguin, Y., Kaltwasser, P., Littlewood, T., Macdougall, I. C., & Wilson, K. (2006). Iron and the anaemia of chronic disease: a review and strategic recommendations. Current Medical Research and Opinion, 22 (4), 731-7. doi:10.1185/030079906X100096 Peer Reviewed verified by ORBi |
 | Bovy, C., Baudoux, E., Salmon, J., & Beguin, Y. (2006). Increased iron absorption during autologous blood donation supported by recombinant human erythropoietin therapy. Transfusion, 46 (9), 1616-23. doi:10.1111/j.1537-2995.2006.00945.x Peer Reviewed verified by ORBi |
 | Baron, F., Vanstraelen, G., & Beguin, Y. (2006). Transfusions after nonmyeloablative or reduced-intensity conditioning regimens. Leukemia, 20 (12), 2081-6. doi:10.1038/sj.leu.2404431 Peer Reviewed verified by ORBi |
 | Vanstraelen, G., Baron, F., Willems, E., Bonnet, C., Hafraoui, K., Frere, P., Fillet, G., & Beguin, Y. (2006). Recombinant human erythropoietin therapy after allogeneic hematopoietic cell transplantation with a nonmyeloablative conditioning regimen: low donor chimerism predicts for poor response. Experimental Hematology, 34 (7), 841-50. doi:10.1016/j.exphem.2006.04.012 Peer reviewed |
 | Frere, P., Baron, F., Bonnet, C., Hafraoui, K., Pereira-Martins, M., Willems, E., Fillet, G., & Beguin, Y. (2006). Infections after allogeneic hematopoietic stem cell transplantation with a nonmyeloablative conditioning regimen. Bone Marrow Transplantation, 37 (4), 411-8. doi:10.1038/sj.bmt.1705255 Peer Reviewed verified by ORBi |
 | Frere, P., Pereira-Martins, M., Fillet, G., & Beguin, Y. (2006). Infections after CD34-selected or unmanipulated autologous hematopoietic stem cell transplantation. European Journal of Haematology, 76 (2), 102-8. doi:10.1111/j.1600-0609.2005.00569.x Peer Reviewed verified by ORBi |
 | Vanstraelen, G., Frere, P., Ngirabacu, M.-C., Willems, E., Fillet, G., & Beguin, Y. (2006). Pegfilgrastim compared with Filgrastim after autologous hematopoietic peripheral blood stem cell transplantation. Experimental Hematology, 34 (3), 382-8. doi:10.1016/j.exphem.2005.11.013 Peer reviewed |
 | Piette, C., Dresse, M.-F., Forget, P., Schmitz, V., Demarche, M., Erpicum, P., Closon, M.-T., Rutten, I., Paulus, P., Vivegnis, D., Beguin, Y., Jamblin, P., & Hoyoux, C. (2005). Les neuroblastomes de l'enfant. A propos de 23 cas. Revue Médicale de Liège, 60 (3), 173-80. Peer reviewed |
 | Jerusalem, G., Hustinx, R., Beguin, Y., & Fillet, G. (2005). Evaluation of therapy for lymphoma. Seminars in Nuclear Medicine, 35 (3), 186-96. doi:10.1053/j.semnuclmed.2005.02.004 Peer Reviewed verified by ORBi |
 | Bataille, Y., Bovy, C., Lancellotti, P., Melchior, V., Delbecque, K., Beguin, Y., & Krzesinski, J.-M. (2005). Primary amyloidosis (AL) as a cause of nephrotic syndrome. Acta Clinica Belgica, 60 (2), 94-7. doi:10.1179/acb.2005.017 Peer Reviewed verified by ORBi |
 | Glaspy, J., & Beguin, Y. (2005). Anaemia management strategies: optimising treatment using epoetin beta (NeoRecormon). Oncology, 69 Suppl 2, 8-16. doi:10.1159/000088283 Peer Reviewed verified by ORBi |
 | Bovy, C., Gothot, A., Krzesinski, J.-M., & Beguin, Y. (2005). Mature erythrocyte indices: new markers of iron availability. Haematologica, 90 (4), 549-51. Peer Reviewed verified by ORBi |
 | Willems, E., Baron, F., Vanstraelen, G., Frere, P., Fillet, G., & Beguin, Y. (2005). Immunotherapie du cancer par minigreffe de cellules souches hematopoietiques. Revue Médicale Suisse, 1 (30), 1973-7. Peer Reviewed verified by ORBi |
 | Beguin, Y. (2005). Intravenous iron and recombinant human erythropoietin in cancer patients. Journal of Clinical Oncology, 23 (3), 651-2; author reply 652-3. doi:10.1200/JCO.2005.05.184 Peer Reviewed verified by ORBi |
 | Jerusalem, G., Hustinx, R., Beguin, Y., & Fillet, G. (2005). Positron emission tomography imaging for lymphoma. Current Opinion in Oncology, 17 (5), 441-5. doi:10.1097/01.cco.0000174041.29557.5c Peer Reviewed verified by ORBi |
 | Vanstraelen, G., Baron, F., Frere, P., Hafraoui, K., Fillet, G., & Beguin, Y. (2005). Efficacy of recombinant human erythropoietin therapy started one month after autologous peripheral blood stem cell transplantation. Haematologica, 90 (9), 1269-70. Peer Reviewed verified by ORBi |
 | T'Sjoen, G., Beguin, Y., Feyen, E., Rubens, R., Kaufman, J.-M., & Gooren, L. (2005). Influence of exogenous oestrogen or (anti-) androgen administration on soluble transferrin receptor in human plasma. Journal of Endocrinology, 186 (1), 61-7. doi:10.1677/joe.1.06112 Peer Reviewed verified by ORBi |
 | Foguenne, J., Huygen, S., Greimers, R., Beguin, Y., & Gothot, A. (2005). Modulation of homing properties of primitive progenitor cells generated by ex vivo expansion. Haematologica, 90 (4), 445-51. Peer Reviewed verified by ORBi |
 | Bovy, C., Krzesinski, J.-M., Gothot, A., & Beguin, Y. (2004). Impact of erythropoietic activity on red cell parameters in chronic renal failure patients. Haematologica, 89 (6), 748-9. Peer Reviewed verified by ORBi |
 | Beguin, Y., & Weber, G. (2004). Serum selenium in lymphoma. Journal of Clinical Oncology, 22 (16), 3429; author reply 3430. doi:10.1200/JCO.2004.99.240 Peer Reviewed verified by ORBi |
 | Frere, P., Hermanne, J.-P., Debouge, M.-H., De Mol, P., Fillet, G., & Beguin, Y. (2004). Bacteremia after hematopoietic stem cell transplantation: incidence and predictive value of surveillance cultures. Bone Marrow Transplantation, 33 (7), 745-9. doi:10.1038/sj.bmt.1704414 Peer Reviewed verified by ORBi |
 | Baron, F., Copizza, S., Baudoux, E., Jerusalem, G., Fillet, G., & Beguin, Y. (2004). CD34+ cell dose predicts costs after autologous peripheral blood stem cell transplantation for breast cancer. Haematologica, 89 (9), 1146-8. Peer Reviewed verified by ORBi |
 | Passweg, J. R., Rabusin, M., Musso, M., Beguin, Y., Cesaro, S., Ehninger, G., Espigado, I., Iriondo, A., Jost, L., Koza, V., Lenhoff, S., Lisukov, I., Locatelli, F., Marmont, A., Philippe, Pilatrino, C., Quartier, P., Stary, J., Veys, P., ... Gratwohl, A. (2004). Haematopoetic stem cell transplantation for refractory autoimmune cytopenia. British Journal of Haematology, 125 (6), 749-55. doi:10.1111/j.1365-2141.2004.04978.x Peer Reviewed verified by ORBi |
 | Willems, E., Valdes Socin, H. G., Betea, D., Beckers, A., & Beguin, Y. (September 2003). Association of acute leukemia and autoimmune polyendocrine syndrome in two kindreds. Leukemia, 17 (9), 1912-1914. doi:10.1038/sj.leu.2403064 Peer Reviewed verified by ORBi |
 | Baron, F., DRESSE, M.-F., & Beguin, Y. (2003). Transmission of chronic myeloid leukemia through peripheral-blood stem-cell transplantation. New England Journal of Medicine, 349 (9), 913-4. doi:10.1056/NEJM200308283490921 Peer Reviewed verified by ORBi |
 | Baron, F., Frere, P., Fillet, G., & Beguin, Y. (2003). Recombinant human erythropoietin therapy is very effective after an autologous peripheral blood stem cell transplant when started soon after engraftment. Clinical Cancer Research, 9 (15), 5566-72. Peer Reviewed verified by ORBi |
 | Baron, F., Frere, P., & Beguin, Y. (2003). Once weekly recombinant human erythropoietin therapy is very efficient after allogeneic peripheral blood stem cell transplantation when started soon after engraftment. Haematologica, 88 (6), 718-20. Peer Reviewed verified by ORBi |
Canivet, J.-L., Yans, T., Piret, S., Frere, P., & Beguin, Y. (2003). Barotrauma-induced tension pneumoperitoneum. Acta Anaesthesiologica Belgica, 54 (3), 233-6. Peer Reviewed verified by ORBi |
 | Schetelig, J., Fetscher, S., Reichle, A., Berdel, W. E., Beguin, Y., Brunet, S., Caballero, D., Majolino, I., Hagberg, H., Johnsen, H. E., Kimby, E., Montserrat, E., Stewart, D., Copplestone, A., Rosler, W., Pavel, J., Kingreen, D., & Siegert, W. (2003). Long-term disease-free survival in patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation. Haematologica, 88 (11), 1272-8. Peer Reviewed verified by ORBi |
 | Jerusalem, G., Beguin, Y., Fassotte, M.-F., Belhocine, T., Hustinx, R., Rigo, P., & Fillet, G. (2003). Early detection of relapse by whole-body positron emission tomography in the follow-up of patients with Hodgkin's disease. Annals of Oncology, 14 (1), 123-30. doi:10.1093/annonc/mdg011 Peer Reviewed verified by ORBi |
 | Cazzola, M., Beguin, Y., Kloczko, J., Spicka, I., & Coiffier, B. (2003). Once-weekly epoetin beta is highly effective in treating anaemic patients with lymphoproliferative malignancy and defective endogenous erythropoietin production. British Journal of Haematology, 122 (3), 386-93. doi:10.1046/j.1365-2141.2003.04439.x Peer Reviewed verified by ORBi |
 | Jerusalem, G., Hustinx, R., Beguin, Y., Depas, G., Fassotte, M.-F., De Barsy, C., Foidart, J., & Fillet, G. (2003). Les lymphomes. Médecine Nucléaire: Imagerie Fonctionnelle et Métabolique, 27 (8), 401-410. Peer reviewed |
 | Andre, M., Baudoux, E., Bron, D., Canon, J.-L., D'Hondt, V., Fassotte, M.-F., D'Hondt, L., Fillet, G., Humblet, Y., Jerusalem, G., Vermeulen, P., Symann, M., & Beguin, Y. (2003). Phase III randomized study comparing 5 or 10 microg per kg per day of filgrastim for mobilization of peripheral blood progenitor cells with chemotherapy, followed by intensification and autologous transplantation in patients with nonmyeloid malignancies. Transfusion, 43 (1), 50-7. doi:10.1046/j.1537-2995.2003.00273.x Peer Reviewed verified by ORBi |
 | Jerusalem, G., Hustinx, R., Beguin, Y., & Fillet, G. (2003). PET scan imaging in oncology. European Journal of Cancer, 39 (11), 1525-34. doi:10.1016/S0959-8049(03)00374-5 Peer Reviewed verified by ORBi |
 | Baron, F., Frere, P., Baudoux, E., Sautois, B., Fillet, G., & Beguin, Y. (2003). Non-myeloablative stem cell transplantation with low-dose total body irradiation and fludarabine for metastatic renal cell carcinoma. Haematologica, 88 (4), 478-80. Peer Reviewed verified by ORBi |
 | Hafraoui, K., Humblet-Baron, S., Baron, F., Beguin, Y., & Fillet, G. (2003). Comment je traite ... la leucemie myeloide chronique (LMC). Revue Médicale de Liège, 58 (1), 7-12. Peer reviewed |
 | Gothot, A., Giet, O., Huygen, S., & Beguin, Y. (2003). Binding and migration across fibronectin and VCAM-1 of cycling hematopoietic progenitor cells. Leukemia and Lymphoma, 44 (8), 1379-83. doi:10.1080/1042819031000083406 Peer Reviewed verified by ORBi |
 | Baron, F., Baudoux, E., Frere, P., Tourqui, S., Schaaf-Lafontaine, N., Herens, C., De Prijck, B., Fillet, G., & Beguin, Y. (2003). Low T-cell chimerism is not followed by graft rejection after nonmyeloablative stem cell transplantation (NMSCT) with CD34-selected PBSC. Bone Marrow Transplantation, 32 (8), 829-34. doi:10.1038/sj.bmt.1704220 Peer Reviewed verified by ORBi |
 | Baron, F., Frere, P., Fillet, G., & Beguin, Y. (2003). Tandem high-dose therapy (HDT) for multiple myeloma: recombinant human erythropoietin therapy given between first and second HDT allows second peripheral blood stem cell transplantation without red blood cell transfusion. British Journal of Haematology, 123 (1), 103-5. doi:10.1046/j.1365-2141.2003.04556.x Peer Reviewed verified by ORBi |
 | Humblet-Baron, S., Baron, F., Chachati, A., Bury, J., Morelon, E., Kreis, H., & BEGUIN, Y. (2003). Donor lymphocyte infusion for late relapse followed by kidney transplantation for end-stage renal failure after allogeneic bone marrow transplantation for chronic myeloid leukemia. Transplantation, 76 (10), 1531-2. doi:10.1097/01.TP.0000085285.59061.D7 Peer Reviewed verified by ORBi |
 | Baron, F., Schaaf-Lafontaine, N., Humblet-Baron, S., Meuris, N., Castermans, E., Baudoux, E., Frere, P., Bours, V., Fillet, G., & Beguin, Y. (2003). T-cell reconstitution after unmanipulated, CD8-depleted or CD34-selected nonmyeloablative peripheral blood stem-cell transplantation. Transplantation, 76 (12), 1705-13. doi:10.1097/01.TP.0000093987.11389.F7 Peer Reviewed verified by ORBi |
 | Beguin, Y. (2003). Soluble transferrin receptor for the evaluation of erythropoiesis and iron status. Clinica Chimica Acta, 329 (1-2), 9-22. doi:10.1016/S0009-8981(03)00005-6 Peer Reviewed verified by ORBi |
 | Beguin, Y., & Baron, F. (2003). Minitransplants: allogeneic stem cell transplantation with reduced toxicity. Acta Clinica Belgica, 58 (1), 37-45. doi:10.1179/acb.2003.58.1.005 Peer Reviewed verified by ORBi |
 | Baron, F., Frere, P., Baudoux, E., Schaaf-Lafontaine, N., Fillet, G., & Beguin, Y. (2003). Low incidence of acute graft-versus-host disease after non-myeloablative stem cell transplantation with CD8-depleted peripheral blood stem cells: an update. Haematologica, 88 (7), 835-7. Peer Reviewed verified by ORBi |
 | Humblet-Baron, S., Baron, F., Pirson, L., Beguin, Y., & Fillet, G. (28 August 2002). Traitement moléculaire du cancer: le STI571, un inhibiteur des tyrosines kinases. Revue Médicale Suisse, 60 (598), 1504-1508. Peer Reviewed verified by ORBi |
 | Baron, F., & Beguin, Y. (2002). Nonmyeloablative allogeneic hematopoietic stem cell transplantation. Journal of Hematotherapy and Stem Cell Research, 11 (2), 243-63. doi:10.1089/152581602753658448 Peer Reviewed verified by ORBi |
 | Baron, F., Frere, P., Herens, C., Fillet, G., & Beguin, Y. (2002). Combination of nonmyeloablative stem cell transplantation and Imatinib in accelerated phase CML. Haematologica, 87 (12), 43. Peer Reviewed verified by ORBi |
 | Jerusalem, G., & Beguin, Y. (2002). Does positron emission tomography have a role in routine clinical practice in patients with Hodgkin's disease? Clinical Lymphoma, 3 (2), 125-6. doi:10.1016/S1526-9655(11)70258-5 Peer Reviewed verified by ORBi |
 | Verhoef, H., West, C. E., Veenemans, J., Beguin, Y., & Kok, F. J. (2002). Stunting may determine the severity of malaria-associated anemia in African children. Pediatrics, 110 (4), 48. doi:10.1542/peds.110.4.e48 Peer Reviewed verified by ORBi |
 | Jerusalem, G., Hustinx, R., Beguin, Y., & Fillet, G. (2002). The value of positron emission tomography (PET) imaging in disease staging and therapy assessment. Annals of Oncology, 13 Suppl 4, 227-34. doi:10.1093/annonc/mdf664 Peer Reviewed verified by ORBi |
 | Jerusalem, G., & Beguin, Y. (2002). Commentary on "Noninvasive detection of multidrug resistance in patients with hematological malignancies: are we there yet?". Clinical Lymphoma, 2 (4), 249. doi:10.1016/S1526-9655(11)70232-9 Peer Reviewed verified by ORBi |
 | Baron, F., & Beguin, Y. (2002). Preemptive cellular immunotherapy after T-cell-depleted allogeneic hematopoietic stem cell transplantation. Biology of Blood and Marrow Transplantation, 8 (7), 351-9. doi:10.1053/bbmt.2002.v8.pm12171481 Peer Reviewed verified by ORBi |
 | Gothot, A., Giet, O., Huygen, S., & Beguin, Y. (2002). Modulation par le cycle cellulaire de l'implantation des cellules souches hématopoïétiques. Hématologie, 8, 397-404. Peer reviewed |
 | Frere, P., Hermanne, J.-P., Debouge, M.-H., Fillet, G., & Beguin, Y. (2002). Changing pattern of bacterial susceptibility to antibiotics in hematopoietic stem cell transplant recipients. Bone Marrow Transplantation, 29 (7), 589-94. doi:10.1038/sj/bmt/1703413 Peer Reviewed verified by ORBi |
 | Warland, V., Jerusalem, G., Hustinx, R., Beguin, Y., Silvestre, R. M., Fassotte, M.-F., Foidart, J., & Fillet, G. (2002). Comment etablir le bilan de fin de traitement des patients atteints de lymphomes non-hodgkiniens (LNH) de malignite intermediaire ou elevee? Revue Médicale de Liège, 57 (12), 779-84. Peer reviewed |
 | Jerusalem, G., & Beguin, Y. (2002). Positron emission tomography in non-Hodgkin's lymphoma (NHL): relationship between tracer uptake and pathological findings, including preliminary experience in the staging of low-grade NHL. Clinical Lymphoma, 3 (1), 56-61. doi:10.3816/CLM.2002.n.012 Peer Reviewed verified by ORBi |
 | Giet, O., Van Bockstaele, D. R., Di Stefano, I., Huygen, S., Greimers, R., Beguin, Y., & Gothot, A. (2002). Increased binding and defective migration across fibronectin of cycling hematopoietic progenitor cells. Blood, 99 (6), 2023-31. doi:10.1182/blood.V99.6.2023 Peer Reviewed verified by ORBi |
 | Baron, F., Sautois, B., Baudoux, E., Matus, G., Fillet, G., & Beguin, Y. (2002). Optimization of recombinant human erythropoietin therapy after allogeneic hematopoietic stem cell transplantation. Experimental Hematology, 30 (6), 546-54. doi:10.1016/S0301-472X(02)00795-6 Peer reviewed |
 | Beguin, Y. (2002). Le métabolisme du fer. Hématologie, 8, 7-S11. Peer reviewed |
 | Engelfriet, C. P., Reesink, H. W., Wagner, J. E., Kogler, G., Rocha, V., Wernet, P., Lecchi, L., Lazzari, L., Ratti, I., Giovanelli, S., Poli, F., Rebulla, P., Beguin, Y., Baudoux, E., Navarrete, C., Armitage, S., Laughlin, M. J., & McClelland, W. M. (2002). International forum. Use of umbilical cord blood progenitor cells as an alternative for bone marrow transplantation. Vox Sanguinis, 83 (2), 172-87. doi:10.1046/j.1423-0410.2002.00197.x Peer Reviewed verified by ORBi |
 | Beguin, Y. (2002). Prediction of response and other improvements on the limitations of recombinant human erythropoietin therapy in anemic cancer patients. Haematologica, 87 (11), 1209-21. Peer Reviewed verified by ORBi |
 | Beguin, Y., Benoit, Y., Crokaert, F., Selleslag, D., & Vandercam, B. (2002). Outpatient and home parenteral antibiotic therapy (OHPAT) in low-risk febrile neutropenia: consensus statement of a Belgian panel. Acta Clinica Belgica, 57 (6), 309-16. doi:10.1179/acb.2002.058 Peer Reviewed verified by ORBi |
 | Huygen, S., Giet, O., Artisien, V., Di Stefano, I., Beguin, Y., & Gothot, A. (2002). Adhesion of synchronized human hematopoietic progenitor cells to fibronectin and vascular cell adhesion molecule-1 fluctuates reversibly during cell cycle transit in ex vivo culture. Blood, 100 (8), 2744-52. doi:10.1182/blood.V100.8.2744 Peer Reviewed verified by ORBi |
 | Baron, F., Baudoux, E., Frere, P., Tourqui, S., Schaaf-Lafontaine, N., Greimers, R., Herens, C., Fillet, G., & Beguin, Y. (2002). Nonmyeloablative stem cell transplantation with CD8-depleted or CD34-selected peripheral blood stem cells. Journal of Hematotherapy and Stem Cell Research, 11 (2), 301-14. doi:10.1089/152581602753658484 Peer Reviewed verified by ORBi |
 | Baron, F., Siquet, J., Schaaf-Lafontaine, N., Baudoux, E., Hermanne, J.-P., Fillet, G., & Beguin, Y. (2002). Pre-emptive immunotherapy with CD8-depleted donor lymphocytes after CD34-selected allogeneic peripheral blood stem cell transplantation. Haematologica, 87 (1), 78-88. Peer Reviewed verified by ORBi |
 | Baron, F., Baudoux, E., Fillet, G., & Beguin, Y. (2002). Retrospective comparison of CD34-selected allogeneic peripheral blood stem cell transplantation followed by CD8-depleted donor lymphocyte infusions with unmanipulated bone marrow transplantation. Hematology, 7 (3), 137-43. doi:10.1080/1024533021000008173 Peer Reviewed verified by ORBi |
 | Baron, F., Fillet, G., & Beguin, Y. (2002). Erythropoiesis after nonmyeloablative stem-cell transplantation is not impaired by inadequate erythropoietin production as observed after conventional allogeneic transplantation. Transplantation, 74 (12), 1692-6. doi:10.1097/00007890-200212270-00008 Peer Reviewed verified by ORBi |
 | Sylvestre, R.-M., Jerusalem, G., Sautois, B., Beguin, Y., & Fillet, G. (2001). Nouvelles approches thérapeutiques puor l'hypernéphrome métastasique. Médecine et Hygiène, 59, 1607-1609. Peer Reviewed verified by ORBi |
 | Sautois, B., Baudoux, E., Salmon, J., Michaux, S., Schaaf-Lafontaine, N., Pereira-Martins, M., Paulus, J.-M., Fillet, G., & Beguin, Y. (2001). Administration of erythopoietin and granulocyte colony-stimulating factor in donor/recipient pairs to collect peripheral blood progenitor cells (PBPC) and red blood cell units for use in the recipient after allogeneic PBPC transplantation. Haematologica, 86 (11), 1209-18. Peer Reviewed verified by ORBi |
Paquet, P., Arrese Estrada, J., Beguin, Y., & Pierard, G. (2001). Clinicopathological differential diagnosis of drug-induced toxic epidermal necrolysis (Lyell's syndrome) and acute graft-versus-host reaction. Current Topics in Pathology. Ergebnisse der Pathologie, 94, 49-63. doi:10.1007/978-3-642-59552-3_3 Peer Reviewed verified by ORBi |
 | Jerusalem, G., Beguin, Y., Najjar, F., Hustinx, R., Fassotte, M.-F., Rigo, P., & Fillet, G. (2001). Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin's lymphoma (NHL). Annals of Oncology, 12 (6), 825-30. doi:10.1023/A:1011169332265 Peer Reviewed verified by ORBi |
 | Beguin, Y. (2001). Intérêt du dosage du récepteur soluble de la transferrine (sTfR) pour l'évaluation de l'érythropoïèse et de l'état du fer. Hématologie, 7, 161-169. Peer reviewed |
 | Piron, M., Loo, M., Gothot, A., Tassin, F., Fillet, G., & Beguin, Y. (2001). Cessation of intensive treatment with recombinant human erythropoietin is followed by secondary anemia. Blood, 97 (2), 442-8. doi:10.1182/blood.V97.2.442 Peer Reviewed verified by ORBi |
 | R'Zik, S., & Beguin, Y. (2001). Serum soluble transferrin receptor concentration is an accurate estimate of the mass of tissue receptors. Experimental Hematology, 29 (6), 677-85. doi:10.1016/S0301-472X(01)00641-5 Peer reviewed |
 | R'Zik, S., Loo, M., & Beguin, Y. (2001). Reticulocyte transferrin receptor (TfR) expression and contribution to soluble TfR levels. Haematologica, 86 (3), 244-51. Peer Reviewed verified by ORBi |
 | Giet, O., Huygen, S., Beguin, Y., & Gothot, A. (2001). Cell cycle activation of hematopoietic progenitor cells increases very late antigen-5-mediated adhesion to fibronectin. Experimental Hematology, 29 (4), 515-24. doi:10.1016/S0301-472X(00)00682-2 Peer reviewed |
 | Baron, F., Frere, P., Fillet, G., & Beguin, Y. (2001). Treatment of leukemia relapse after allogeneic hematopoietic stem cell transplantation by donor lymphocyte infusion and STI-571. Haematologica, 86 (9), 993-4. Peer Reviewed verified by ORBi |
 | Jerusalem, G., Belhocine, T., Silvestre, R.-M., Sautois, B., Hustinx, R., Beguin, Y., Fillet, G., & Rigo, P. (2001). Place de la tomographie d'émission de positons dans le suivi thérapeutique du cancer du sein. Médecine Nucléaire: Imagerie Fonctionnelle et Métabolique, 25 (6), 341-346. Peer reviewed |
Verhoef, H., West, C. E., Ndeto, P., Burema, J., Beguin, Y., & Kok, F. J. (2001). Serum transferrin receptor concentration indicates increased erythropoiesis in Kenyan children with asymptomatic malaria. American Journal of Clinical Nutrition, 74 (6), 767-75. doi:10.1093/ajcn/74.6.767 Peer Reviewed verified by ORBi |
 | Jerusalem, G., Beguin, Y., Fassotte, M.-F., Najjar, F., Paulus, P., Rigo, P., & Fillet, G. (2001). Whole-body positron emission tomography using 18F-fluorodeoxyglucose compared to standard procedures for staging patients with Hodgkin's disease. Haematologica, 86 (3), 266-73. Peer Reviewed verified by ORBi |
 | Fillet, G., & Beguin, Y. (2001). Monitoring of erythropoiesis by the serum transferrin receptor and erythropoietin. Acta Clinica Belgica, 56 (3), 146-54. doi:10.1179/acb.2001.024 Peer Reviewed verified by ORBi |
 | JERUSALEM, G., & BEGUIN, Y. (June 2000). Commentary on "Positron emission tomography in lymphoma : comparison with computed tomography and Gallium-67 single photon emission computed tomography imaging". Clinical Lymphoma, 1 (1), 75-76. Peer Reviewed verified by ORBi |
Tassin, F., Dewé, W., Schaaf-Lafontaine, N., Herens, C., Ravoet, C., Albert, A., Beguin, Y., & Paulus, J.-M. (2000). A four-parameter index of marrow dysplasia has predictive value for survival in myelodysplastic syndromes. Leukemia and Lymphoma, 36 (5-6), 485-96. doi:10.3109/10428190009148396 Peer Reviewed verified by ORBi |
 | Herens, C., Tassin, F., Lemaire, V., Beguin, Y., Collard, E., Lampertz, S., Croisiau, C., Desouter-Lecomte, M., DE PRIJCK, B., Longree, L., & Koulischer, L. (2000). Deletion of the 5'-ABL region: a recurrent anomaly detected by fluorescence in situ hybridization in about 10% of Philadelphia-positive chronic myeloid leukaemia patients. British Journal of Haematology, 110 (1), 214-6. doi:10.1046/j.1365-2141.2000.02142.x Peer Reviewed verified by ORBi |
 | Fraipont, V., Sautois, B., Baudoux, E., Pereira-Martins, M., Fassotte, M.-F., Hermanne, J. P., Jerusalem, G., Longree, L., Schaaf-Lafontaine, N., Fillet, G., & Beguin, Y. (2000). Successful mobilization of peripheral blood HPCs with G-CSF alone in patients failing to achieve sufficient numbers of CD34+ cells and/or CFU-GM with chemotherapy and G-CSF. Transfusion, 40 (3), 339-47. doi:10.1046/j.1537-2995.2000.40030339.x Peer Reviewed verified by ORBi |
 | Magee, L. A., von Dadelszen, P., Darley, J., & Beguin, Y. (2000). Erythropoiesis and renal transplant pregnancy. Clinical Transplantation, 14 (2), 127-35. doi:10.1034/j.1399-0012.2000.140205.x Peer Reviewed verified by ORBi |
 | Roodenburg, A. J., West, C. E., Beguin, Y., Van Dijk, J. E., Van Eijk, H. G., Marx, J. J., & Beynen, A. C. (2000). Indicators of erythrocyte formation and degradation in rats with either vitamin A or iron deficiency. Journal of Nutritional Biochemistry, 11 (4), 223-30. doi:10.1016/S0955-2863(00)00070-X Peer Reviewed verified by ORBi |
 | Frere, P., Canivet, J.-L., Gennigens, C., Rebeix, J. P., Fillet, G., & Beguin, Y. (2000). Hyperammonemia after high-dose chemotherapy and stem cell transplantation. Bone Marrow Transplantation, 26 (3), 343-5. doi:10.1038/sj.bmt.1702485 Peer Reviewed verified by ORBi |
 | Jerusalem, G., Beguin, Y., Fassotte, M.-F., Najjar, F., Paulus, P., Rigo, P., & Fillet, G. (2000). Persistent tumor 18F-FDG uptake after a few cycles of polychemotherapy is predictive of treatment failure in non-Hodgkin's lymphoma. Haematologica, 85 (6), 613-8. Peer Reviewed verified by ORBi |
 | Jerusalem, G., Beguin, Y., Fassotte, M.-F., Belhocine, T., Najjar, F., Hustinx, R., Rigo, P., & Fillet, G. (2000). Evaluation thérapeutique précoce par tomographie à émission de positons. Médecine et Hygiène, 58, 1629-1632. Peer Reviewed verified by ORBi |
 | Baron, F., Gothot, A., Salmon, J., Hermanne, J. P., Pierard, G., Fillet, G., & Beguin, Y. (2000). Clinical course and predictive factors for cyclosporin-induced autologous graft-versus-host disease after autologous haematopoietic stem cell transplantation. British Journal of Haematology, 111 (3), 745-53. doi:10.1046/j.1365-2141.2000.02470.x Peer Reviewed verified by ORBi |
Jerusalem, G., & Beguin, Y. (2000). Clinical impact and perspectives of 18F-FDG PET in lymphoma. Clinical Lymphoma, 1, 75-76. Peer Reviewed verified by ORBi |
 | Sautois, B., Scerbo, F., Beguin, Y., & Fillet, G. (2000). Traitement des myélomes réfractaires par la Thalidomide. Médecine et Hygiène, 58, 1633-1634. Peer Reviewed verified by ORBi |
 | Baron, F., & Beguin, Y. (2000). Adoptive immunotherapy with donor lymphocyte infusions after allogeneic HPC transplantation. Transfusion, 40 (4), 468-76. doi:10.1046/j.1537-2995.2000.40040468.x Peer Reviewed verified by ORBi |
 | Baron, F., Dresse, M.-F., & Beguin, Y. (2000). Donor lymphocyte infusion to eradicate recurrent host hematopoiesis after allogeneic BMT for sickle cell disease. Transfusion, 40 (9), 1071-3. doi:10.1046/j.1537-2995.2000.40091071.x Peer Reviewed verified by ORBi |
 | Ribbens, C., Bonnet, V., Kaiser, M.-J., Andre, B., Kaye, O., Franchimont, N., De Groote, D., Beguin, Y., & Malaise, M. (2000). Increased synovial fluid levels of soluble CD23 are associated with an erosive status in rheumatoid arthritis (RA). Clinical and Experimental Immunology, 120 (1), 194-199. doi:10.1046/j.1365-2249.2000.01198.x Peer Reviewed verified by ORBi |
 | Baron, F., Ribbens, C., Kaye, O., Fillet, G., Malaise, M., & Beguin, Y. (2000). Effective treatment of Jo-1-associated polymyositis with T-cell-depleted autologous peripheral blood stem cell transplantation. British Journal of Haematology, 110 (2), 339-342. doi:10.1046/j.1365-2141.2000.02191.x Peer Reviewed verified by ORBi |
 | Cazzola, M., Beguin, Y., Bergamaschi, G., Guarnone, R., Cerani, P., Barella, S., Cao, A., & Galanello, R. (1999). Soluble transferrin receptor as a potential determinant of iron loading in congenital anaemias due to ineffective erythropoiesis. British Journal of Haematology, 106 (3), 752-5. doi:10.1046/j.1365-2141.1999.01600.x Peer Reviewed verified by ORBi |
 | Loo, M., & Beguin, Y. (1999). The effect of recombinant human erythropoietin on platelet counts is strongly modulated by the adequacy of iron supply. Blood, 93 (10), 3286-93. doi:10.1182/blood.v93.10.3286.410k29_3286_3293 Peer Reviewed verified by ORBi |
Bovy, C., Tsobo, C., Crapanzano, L., Rorive, G., Beguin, Y., Albert, A., & Paulus, J.-M. (1999). Factors determining the percentage of hypochromic red blood cells in hemodialysis patients. Kidney International, 56 (3), 1113-9. doi:10.1046/j.1523-1755.1999.00627.x Peer Reviewed verified by ORBi |
 | Sautois, B., Fraipont, V., Baudoux, E., Fassotte, M.-F., Hermanne, J. P., Jerusalem, G., Bours, V., Bosquee, L., Schaaf-Lafontaine, N., Paulus, J.-M., Sondag, D., Fillet, G., & Beguin, Y. (1999). Peripheral blood progenitor cell collections in cancer patients: analysis of factors affecting the yields. Haematologica, 84 (4), 342-9. Peer Reviewed verified by ORBi |
 | Beguin, Y. (1999). Erythropoietin and platelet production. Haematologica, 84 (6), 541-7. Peer Reviewed verified by ORBi |
 | Jerusalem, G., Beguin, Y., Fassotte, M.-F., Najjar, F., Paulus, P., Rigo, P., & Fillet, G. (1999). Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging. Blood, 94 (2), 429-33. doi:10.1182/blood.v94.2.429.414k26_429_433 Peer Reviewed verified by ORBi |
 | Dresse, M.-F., Boogaerts, M., Vermylen, C., Noens, L., Ferrant, A., Schots, R., Doyen, C., Bron, D., Berneman, Z., Ferster, A., Benoit, Y., Demuynck, H., & Beguin, Y. (1999). The belgian experience in unrelated donor bone marrow transplantation: identification of center experience as an important prognostic factor. Haematologica, 84 (7), 637-42. Peer Reviewed verified by ORBi |
 | Salmon, J., Michaux, S., Hermanne, J. P., Baudoux, E., Gerard, C., Sondag, D., Fillet, G., & Beguin, Y. (1999). Delayed massive immune hemolysis mediated by minor ABO incompatibility after allogeneic peripheral blood progenitor cell transplantation. Transfusion, 39 (8), 824-7. doi:10.1046/j.1537-2995.1999.39080824.x Peer Reviewed verified by ORBi |
Cornu, G., Vermylen, C., Ferster, A., Brichard, B., Ninane, J., Ferrant, A., Zenebergh, A., Maes, P., Dhooge, C., Benoit, Y., Beguin, Y., Dresse, M.-F., & Sariban, E. (1999). La greffe de cellules souches hematopoietiques dans la drepanocytose. Archives de Pédiatrie, 6 Suppl 2, 345s-347. doi:10.1016/s0929-693x(99)80463-1 Peer Reviewed verified by ORBi |
Baudoux, E., Beguin, Y., Cornu, G., Brichard, B., Debruyn, C., De Bruyere, M., De Hemptinne, D., Delforge, A., Deneys, V., Fillet, G., Germeau, N., Joris, I., Lefevre, P., Massy, M., Paulus, J.-M., Raymakers, N., Schaaps, J.-P., Sondag, D., Van Cauwenberge, J.-R., ... Strijckmans, P. (1998). Circadian and seasonal variations of hematopoiesis in cord blood. Bone Marrow Transplantation, 22 Suppl 1, 12. Peer Reviewed verified by ORBi |
 | Baron, F., Hermanne, J.-P., Dowlati, A., Weber, T., Thiry, A., Fassotte, M.-F., Fillet, G., & Beguin, Y. (1998). Bronchiolitis obliterans organizing pneumonia and ulcerative colitis after allogeneic bone marrow transplantation. Bone Marrow Transplantation, 21 (9), 951-4. doi:10.1038/sj.bmt.1701198 Peer Reviewed verified by ORBi |
 | Baron, F., Sadzot, B., Wang, F.-C., & Beguin, Y. (1998). Myasthenia gravis without chronic GVHD after allogeneic bone marrow transplantation. Bone Marrow Transplantation, 22 (2), 197-200. doi:10.1038/sj.bmt.1701297 Peer Reviewed verified by ORBi |
 | Cazzola, M., Guarnone, R., Cerani, P., Centenara, E., Rovati, A., & Beguin, Y. (1998). Red blood cell precursor mass as an independent determinant of serum erythropoietin level. Blood, 91 (6), 2139-45. doi:10.1182/blood.v91.6.2139.2139_2139_2145 Peer Reviewed verified by ORBi |
Beguin, Y. (1998). Prediction of response to treatment with recombinant human erythropoietin in anaemia associated with cancer. Medical Oncology, 15 Suppl 1, 38-46. Peer Reviewed verified by ORBi |
Baron, F., Hermanne, J. P., Fassotte, M.-F., Beguin, Y., & Fillet, G. (1998). Le cas clinique du mois. Association d'une maladie de Hodgkin et d'un syndrome nephrotique. Revue Médicale de Liège, 53 (11), 651-3. Peer reviewed |
 | Beguin, Y. (1998). Prediction of response to optimize outcome of treatment with erythropoietin. Seminars in Oncology, 25 (3 Suppl 7), 27-34. Peer Reviewed verified by ORBi |
 | Pierard, G., Nikkels, N., Nikkels, A., Arrese Estrada, J., Pierard, C., Jerusalem, G., Beguin, Y., & Fillet, G. (1998). Epidermal Calprotectin Expression in Lymphocyte-Depleted Cutaneous Graft-versus-Host Reaction. Archivos Argentinos de Dermatologia, 48, 139-142. Peer Reviewed verified by ORBi |
Beguin, Y., Baudoux, E., Sautois, B., Fraipont, V., Schaaf-Lafontaine, N., Pereira-Martins, M., Paulus, J.-M., Sondag, D., & Fillet, G. (1998). Hematopoietic recovery in cancer patients after transplantation of autologous peripheral blood CD34+ cells or unmanipulated peripheral blood stem and progenitor cells. Transfusion, 38 (2), 199-208. doi:10.1046/j.1537-2995.1998.38298193106.x Peer Reviewed verified by ORBi |
 | Vermylen, C., Cornu, G., Ferster, A., Brichard, B., Ninane, J., Ferrant, A., Zenebergh, A., Maes, P., Dhooge, C., Benoit, Y., Beguin, Y., Dresse, M.-F., & Sariban, E. (1998). Haematopoietic stem cell transplantation for sickle cell anaemia: the first 50 patients transplanted in Belgium. Bone Marrow Transplantation, 22 (1), 1-6. doi:10.1038/sj.bmt.1701291 Peer Reviewed verified by ORBi |
 | Hellstrom-Lindberg, E., Ahlgren, T., Beguin, Y., Carlsson, M., Carneskog, J., Dahl, I. M., Dybedal, I., Grimfors, G., Kanter-Lewensohn, L., Linder, O., Luthman, M., Lofvenberg, E., Nilsson-Ehle, H., Samuelsson, J., Tangen, J. M., Winqvist, I., Oberg, G., Osterborg, A., & Ost, A. (1998). Treatment of anemia in myelodysplastic syndromes with granulocyte colony-stimulating factor plus erythropoietin: results from a randomized phase II study and long-term follow-up of 71 patients. Blood, 92 (1), 68-75. doi:10.1182/blood.v92.1.68.413k23_68_75 Peer Reviewed verified by ORBi |
 | van Iperen, C. E., Kraaijenhagen, R. J., Biesma, D. H., Beguin, Y., Marx, J. J., & van de Wiel, A. (1998). Iron metabolism and erythropoiesis after surgery. British Journal of Surgery, 85 (1), 41-5. doi:10.1046/j.1365-2168.1998.00571.x Peer Reviewed verified by ORBi |
Beguin, Y. (1998). A risk-benefit assessment of epoetin in the management of anaemia associated with cancer. Drug Safety: An International Journal of Medical Toxicology and Drug Experience, 19 (4), 269-82. doi:10.2165/00002018-199819040-00003 Peer Reviewed verified by ORBi |
 | Beguin, Y., Baron, F., & Fillet, G. (1998). Influence of marrow erythropoietic activity on serum erythropoietin levels after autologous hematopoietic stem cell transplantation. Haematologica, 83 (12), 1076-81. Peer Reviewed verified by ORBi |
 | Corazza, F., Beguin, Y., Bergmann, P., Andre, M.-E., Ferster, A., Devalck, C., Fondu, P., Buyse, M., & Sariban, E. (1998). Anemia in children with cancer is associated with decreased erythropoietic activity and not with inadequate erythropoietin production. Blood, 92 (5), 1793-8. doi:10.1182/blood.v92.5.1793.417k23_1793_1798 Peer Reviewed verified by ORBi |
Baron, F., & Beguin, Y. (1997). Complications hépatiques de la chimiothérapie : de la cytolyse banale à la maladie veino-occlusive du foie. Médecine and Chirurgie Digestives, 26, 269-272. Peer Reviewed verified by ORBi |
Beguin, Y. (1997). Mechanisms of cancer-related anemia and rationale for erythropoietin treatment. Cancer Biotherapy, 1, 88-96. Peer Reviewed verified by ORBi |
Baron, F., & Beguin, Y. (1997). Complications hepatiques de la chimiotherapie. De la cytolyse banale a la maladie veino-occlusive du foie. Revue Médicale de Liège, 52 (2), 93-7. Peer reviewed |
Dowlati, A., Loo, Bury, T., Fillet, G., & Beguin, Y. (1997). Soluble and cell-associated transferrin receptor in lung cancer. British Journal of Cancer, 75 (12), 1802-6. doi:10.1038/bjc.1997.307 Peer Reviewed verified by ORBi |
 | Sautois, B., Fillet, G., & Beguin, Y. (1997). Comparative cytokine production by in vitro stimulated mononucleated cells from cord blood and adult blood. Experimental Hematology, 25 (2), 103-8. Peer reviewed |
 | Baron, F., Deprez, M., & Beguin, Y. (1997). The veno-occlusive disease of the liver. Haematologica, 82 (6), 718-25. Peer Reviewed verified by ORBi |
 | Beguin, Y., Sautois, B., Forget, P., Bury, J., & Fillet, G. (1997). Long term follow-up of patients with acute myelogenous leukemia who received the daunorubicin, vincristine, and cytosine arabinoside regimen. Cancer, 79 (7), 1351-4. doi:10.1002/(SICI)1097-0142(19970401)79:7<1351::AID-CNCR12>3.0.CO;2-Z Peer Reviewed verified by ORBi |
 | Beguin, Y., Grek, V., Weber, G., Sautois, B., Paquot, N., Pereira-Martins, M., Scheen, A., Lefèbvre, P., & Fillet, G. (1997). Acute Functional Iron Deficiency in Obese Subjects During a Very-Low-Energy All-Protein Diet. American Journal of Clinical Nutrition, 66 (1), 75-9. doi:10.1093/ajcn/66.1.75 Peer Reviewed verified by ORBi |
Cazzola, M., Borgna-Pignatti, C., Locatelli, F., Ponchio, L., Beguin, Y., & De Stefano, P. (1997). A moderate transfusion regimen may reduce iron loading in beta-thalassemia major without producing excessive expansion of erythropoiesis. Transfusion, 37 (2), 135-40. doi:10.1046/j.1537-2995.1997.37297203514.x Peer Reviewed verified by ORBi |
Dowlati, A., R'Zik, S., Fillet, G., & Beguin, Y. (1997). Anaemia of lung cancer is due to impaired erythroid marrow response to erythropoietin stimulation as well as relative inadequacy of erythropoietin production. British Journal of Haematology, 97 (2), 297-9. doi:10.1046/j.1365-2141.1997.472694.x Peer Reviewed verified by ORBi |
 | Cavill, I., Macdougall, I. C., Gokal, R., Beguin, Y., Peters, T. J., Pippard, M., Schaefer, R. M., & Winearls, C. G. (1997). Iron management in patients on rHuEpo. British Journal of Renal Medicine, 2, 6-8. Peer reviewed |
Beguin, Y. (1996). La greffe de cellules souches hematopoietiques (greffe de moelle osseuse"): indications, modalites et risques.". Revue Médicale de Liège, 51 (4), 270-5. Peer reviewed |
Beguin, Y., Lampertz, S., Bron, D., & Fillet, G. (1996). Serum erythropoietin in chronic lymphocytic leukaemia. British Journal of Haematology, 93 (1), 154-6. doi:10.1046/j.1365-2141.1996.452992.x Peer Reviewed verified by ORBi |
 | Hermanne, J.-P., TASSIN, F., Beguin, Y., & Fillet, G. (1996). Actualités thérapeutiques dans la thrombocytémie essentielle. Médecine et Hygiène, 54, 1487-1489. Peer Reviewed verified by ORBi |
Beguin, Y. (1996). Erythropoietin and the anemia of cancer. Acta Clinica Belgica, 51 (1), 36-52. doi:10.1080/17843286.1996.11718483 Peer Reviewed verified by ORBi |
Pasquasy, V., Delvenne, P., Thiry, A., Beguin, Y., & Boniver, J. (1996). Confrontation anatomo-clinique. Purpura thrombocytopenique thrombotique dans le decours d'une greffe de moelle. Revue Médicale de Liège, 51 (11), 714-7. Peer reviewed |
 | Cazzola, M., Ponchio, L., de Benedetti, F., Ravelli, A., Rosti, V., Beguin, Y., Invernizzi, R., Barosi, G., & Martini, A. (1996). Defective iron supply for erythropoiesis and adequate endogenous erythropoietin production in the anemia associated with systemic-onset juvenile chronic arthritis. Blood, 87 (11), 4824-30. doi:10.1182/blood.v87.11.4824.bloodjournal87114824 Peer Reviewed verified by ORBi |
 | Cazzola, M., Ponchio, L., Pedrotti, C., Farina, G., Cerani, P., Lucotti, C., Novella, A., Rovati, A., Bergamaschi, G., & Beguin, Y. (1996). Prediction of response to recombinant human erythropoietin (rHuEpo) in anemia of malignancy. Haematologica, 81 (5), 434-41. Peer Reviewed verified by ORBi |
Beguin, Y., Collignon, J., Laurent, C., & Fillet, G. (1996). Spontaneous complete remission and recovery of donor haemopoiesis without GVHD after relapse and apparent marrow graft rejection in poor-prognosis myelodysplastic syndrome. British Journal of Haematology, 94 (3), 507-9. doi:10.1046/j.1365-2141.1996.d01-1824.x Peer Reviewed verified by ORBi |
Davies, S. V., Fegan, C. D., Kendall, R., Beguin, Y., & Cavill, I. (1995). Serum erythropoietin during autologous bone marrow transplantation: relationship to measures of erythroid activity. Clinical and Laboratory Haematology, 17 (2), 139-44. Peer Reviewed verified by ORBi |
Beguin, Y. (1995). Erythropoiesis and erythropoietin in multiple myeloma. Leukemia and Lymphoma, 18 (5-6), 413-21. doi:10.3109/10428199509059639 Peer Reviewed verified by ORBi |
Beguin, Y. (1995). Pharma clinics. Comment je traite ... une anemie (3e partie). Revue Médicale de Liège, 50 (12), 497-8. Peer reviewed |
Biesma, D. H., Van de Wiel, A., Beguin, Y., Kraaijenhagen, R. J., & Marx, J. J. (1995). Post-operative erythropoiesis is limited by the inflammatory effect of surgery on iron metabolism. European Journal of Clinical Investigation, 25 (6), 383-9. doi:10.1111/j.1365-2362.1995.tb01718.x Peer Reviewed verified by ORBi |
Beguin, Y., Loo, M., R'Zik, S., Sautois, B., Lejeune, F., Rorive, G., & Fillet, G. (1995). Quantitative assessment of erythropoiesis in haemodialysis patients demonstrates gradual expansion of erythroblasts during constant treatment with recombinant human erythropoietin. British Journal of Haematology, 89 (1), 17-23. doi:10.1111/j.1365-2141.1995.tb08916.x Peer Reviewed verified by ORBi |
Cazzola, M., De Stefano, P., Ponchio, L., Locatelli, F., Beguin, Y., Dessi, C., Barella, S., Cao, A., & Galanello, R. (1995). Relationship between transfusion regimen and suppression of erythropoiesis in beta-thalassaemia major. British Journal of Haematology, 89 (3), 473-8. doi:10.1111/j.1365-2141.1995.tb08351.x Peer Reviewed verified by ORBi |
Beguin, Y. (1995). Comment j'explore ... une anemie (2eme partie). Revue Médicale de Liège, 50 (11), 487-8. Peer reviewed |
Danielson, B., Beguin, Y., Bommer, J., Cannata, B., De Broe, M.-E., Drüeke, T. B., Ittel, T. H., Jolliffe, L. K., Krantz, S. B., Nielsen, O. J., Pippard, M. J., Rosenlöf, K., Stockenhuber, B., & Winearls, C. G. (1995). R-HuEPO hyporesponsiveness - who and why ? Nephrology Dialysis Transplantation, 10, 69-76. doi:10.1093/ndt/10.supp2.69 Peer Reviewed verified by ORBi |
 | Beguin, Y. (1995). Biology and clinical uses of erythropoietin in infants and children. International Journal of Pediatric Hematology/Oncology, 2, 457-470. Peer Reviewed verified by ORBi |
Beguin, Y. (1995). Comment j'explore... Une anemie (1e partie). Revue Médicale de Liège, 50 (10), 443-4. Peer reviewed |
Dowlati, A., Honore, P., Damas, P., Deprez, M., Delwaide, J., Fillet, G., & Beguin, Y. (1995). Hepatic rejection after orthotopic liver transplantation for hepatic veno-occlusive disease or graft-versus-host disease following bone marrow transplantation. Transplantation, 60 (1), 106-9. doi:10.1097/00007890-199507150-00020 Peer Reviewed verified by ORBi |
Fraipont, V., Beguin, Y., & Fillet, G. (1994). L'anemie ferriprive de la grossesse. Revue Médicale de Liège, 49 (8), 436-45. Peer reviewed |
Locatelli, F., Zecca, M., Ponchio, L., Beguin, Y., Giorgiani, G., Maccario, R., Bonetti, F., De Stefano, P., & Cazzola, M. (1994). Pilot trial of combined administration of erythropoietin and granulocyte colony-stimulating factor to children undergoing allogeneic bone marrow transplantation. Bone Marrow Transplantation, 14 (6), 929-35. Peer Reviewed verified by ORBi |
Locatelli, F., Zecca, M., Pedrazzoli, P., Prete, L., Quaglini, S., Comoli, P., De Stefano, P., Beguin, Y., Robustelli della Cuna, G., Severi, F., & Cazzola, M. (1994). Use of recombinant human erythropoietin after bone marrow transplantation in pediatric patients with acute leukemia: effect on erythroid repopulation in autologous versus allogeneic transplants. Bone Marrow Transplantation, 13 (4), 403-10. Peer Reviewed verified by ORBi |
Bowen, D. T., Culligan, D., Beguin, Y., Kendall, R., & Willis, N. (1994). Estimation of effective and total erythropoiesis in myelodysplasia using serum transferrin receptor and erythropoietin concentrations, with automated reticulocyte parameters. Leukemia, 8 (1), 151-5. Peer Reviewed verified by ORBi |
Beguin, Y., Loo, M., R'Zik, S., Sautois, B., Lejeune, F., Rorive, G., & Fillet, G. (1994). Effect of recombinant human erythropoietin on platelets in patients with anemia of renal failure: correlation of platelet count with erythropoietic activity and iron parameters. European Journal of Haematology, 53 (5), 265-70. doi:10.1111/j.1600-0609.1994.tb01318.x Peer Reviewed verified by ORBi |
Biesma, D. H., Van de Wiel, A., Beguin, Y., Kraaijenhagen, R. J., & Marx, J. J. (1994). Erythropoietic activity and iron metabolism in autologous blood donors during recombinant human erythropoietin therapy. European Journal of Clinical Investigation, 24 (6), 426-32. doi:10.1111/j.1365-2362.1994.tb02187.x Peer Reviewed verified by ORBi |
 | Martelli, M., Ponchio, L., Beguin, Y., Meloni, G., Mandelli, F., & Cazzola, M. (1994). Pure red cell aplasia following peripheral stem cell transplantation: complete response to a short course of high-dose recombinant human erythropoietin. Haematologica, 79 (5), 456-9. Peer Reviewed verified by ORBi |
Beguin, Y., Oris, R., & Fillet, G. (1993). Dynamics of erythropoietic recovery following bone marrow transplantation: role of marrow proliferative capacity and erythropoietin production in autologous versus allogeneic transplants. Bone Marrow Transplantation, 11 (4), 285-92. Peer Reviewed verified by ORBi |
Locatelli, F., Zecca, M., Beguin, Y., Giorgiani, G., Ponchio, L., De Stefano, P., & Cazzola, M. (1993). Accelerated erythroid repopulation with no stem-cell competition effect in children treated with recombinant human erythropoietin after allogeneic bone marrow transplantation. British Journal of Haematology, 84 (4), 752-4. doi:10.1111/j.1365-2141.1993.tb03158.x Peer Reviewed verified by ORBi |
 | Beguin, Y., Clemons, G. K., Pootrakul, P., & Fillet, G. (1993). Quantitative assessment of erythropoiesis and functional classification of anemia based on measurements of serum transferrin receptor and erythropoietin. Blood, 81 (4), 1067-76. doi:10.1182/blood.v81.4.1067.1067 Peer Reviewed verified by ORBi |
Beguin, Y. (1993). Mesures quantitatives de l'erythropoiese. Le recepteur soluble de la transferrine. Bulletin et Mémoires de l'Académie Royale de Médecine de Belgique, 148 (1-2), 100-4; discussion 105-7. Peer Reviewed verified by ORBi |
Beguin, Y., Loo, M., R'Zik, S., Sautois, B., Lejeune, F., Rorive, G., & Fillet, G. (1993). Early prediction of response to recombinant human erythropoietin in patients with the anemia of renal failure by serum transferrin receptor and fibrinogen. Blood, 82 (7), 2010-6. doi:10.1182/blood.v82.7.2010.bloodjournal8272010 Peer Reviewed verified by ORBi |
 | Feron, C., Gothot, A., Grosdent, J.-C., Van Cauwenberge, J.-R., Schaaps, J.-P., Beguin, Y., & Paulus, J.-M. (1993). Purification, expansion, and multiple fluorochrome labeling of cord blood hemopoietic precursors: preliminary results. Journal of Hematotherapy, 2 (2), 259-61. doi:10.1089/scd.1.1993.2.259 Peer Reviewed verified by ORBi |
 | Beguin, Y., Lampertz, S., De Groote, D., Igot, D., Malaise, M., & Fillet, G. (1993). Soluble CD23 and other receptors (CD4, CD8, CD25, CD71) in serum of patients with chronic lymphocytic leukemia. Leukemia, 7 (12), 2019-2025. Peer Reviewed verified by ORBi |
Ponchio, L., Beguin, Y., Farina, G., Pedrazzoli, P., Pedrotti, C., Poggi, G., Rosti, V., Bergamaschi, G., Battistel, V., & Cazzola, M. (1992). Evaluation of erythroid marrow response to recombinant human erythropoietin in patients with cancer anaemia. Haematologica, 77 (6), 494-501. Peer Reviewed verified by ORBi |
Elira-Dokekias, A., R'Zik, S., Beguin, Y., & Fillet, G. (1992). Monitoring of erythropoiesis by serum transferrin receptor levels in a case of chronic lymphocytic leukaemia and pure red cell aplasia treated with ciclosporin. Nouvelle Revue Française d'Hématologie, 34 (3), 257-8. Peer Reviewed verified by ORBi |
Cazzola, M., & Beguin, Y. (1992). Serum erythropoietin levels during haematinic treatment. British Journal of Haematology, 82, 631-632. Peer Reviewed verified by ORBi |
De Groote, D., Zangerlé, P.-F., Gevaert, Y., Fassotte, M.-F., Beguin, Y., Noizat-Pirenne, F., Pirenne, J., Gathy, R., Lopez Y Cadenas, M., & Dehart, I. (1992). Direct stimulation of cytokines (IL-1 beta, TNF-alpha, IL-6, IL-2, IFN-gamma and GM-CSF) in whole blood. I. Comparison with isolated PBMC stimulation. Cytokine, 4 (3), 239-48. doi:10.1016/1043-4666(92)90062-V Peer Reviewed verified by ORBi |
Antoine, N., Beckers, C., Marcoty, C., Bosseloir, A., Beguin, Y., Schaaf-Lafontaine, N., & Simar, L. J. (1992). Expression de l'antigene DRC1 par les cellules leucemiques. Revue Médicale de Liège, 47 (2), 95-9. Peer reviewed |
Beguin, Y., Yerna, M., Loo, M., Weber, M., & Fillet, G. (1992). Erythropoiesis in multiple myeloma: defective red cell production due to inappropriate erythropoietin production. British Journal of Haematology, 82 (4), 648-53. doi:10.1111/j.1365-2141.1992.tb06939.x Peer Reviewed verified by ORBi |
Beguin, Y. (1992). The soluble transferrin receptor: biological aspects and clinical usefulness as quantitative measure of erythropoiesis. Haematologica, 77 (1), 1-10. Peer Reviewed verified by ORBi |
 | Cazzola, M., Ponchio, L., Beguin, Y., Rosti, V., Bergamaschi, G., Liberato, N. L., Fregoni, V., Nalli, G., Barosi, G., & Ascari, E. (1992). Subcutaneous erythropoietin for treatment of refractory anemia in hematologic disorders. Results of a phase I/II clinical trial. Blood, 79 (1), 29-37. doi:10.1182/blood.v79.1.29.bloodjournal79129 Peer Reviewed verified by ORBi |
Cazzola, M., & Beguin, Y. (1992). New tools for clinical evaluation of erythron function in man. British Journal of Haematology, 80 (3), 278-84. doi:10.1111/j.1365-2141.1992.tb08133.x Peer Reviewed verified by ORBi |
 | Beguin, Y., Clemons, G. K., Oris, R., & Fillet, G. (1991). Circulating erythropoietin levels after bone marrow transplantation: inappropriate response to anemia in allogeneic transplants. Blood, 77 (4), 868-73. doi:10.1182/blood.v77.4.868.bloodjournal774868 Peer Reviewed verified by ORBi |
 | Beguin, Y., Sautois, B., & Fillet, G. (1991). Perspectives diagnostiques et thérapeutiques de l'érythropoïétine. Médecine et Hygiène, 49, 2034-2045. Peer Reviewed verified by ORBi |
 | Beguin, Y., Lipscei, G., Thoumsin, H., & Fillet, G. (1991). Blunted erythropoietin production and decreased erythropoiesis in early pregnancy. Blood, 78 (1), 89-93. doi:10.1182/blood.v78.1.89.89 Peer Reviewed verified by ORBi |
 | Beguin, Y., Loo, M., & Fillet, G. (1991). Le dosage du récepteur circulant de la transferringe : une nouveauté pour quantifier l'érythropoïèse. Médecine et Hygiène, 49, 2041-2045. Peer Reviewed verified by ORBi |
Beguin, Y., & Fillet, G. (1990). Erythropoietine: utilisation diagnostique et therapeutique. Revue Médicale de Liège, 45 (6), 261-7. Peer reviewed |
 | Andrien, F., Fassotte, M.-F., Beguin, Y., & Fillet, G. (1990). Traitement des lymphomes non hodgkiniens : de l'abstention thérapeutique à la greffe de moelle. Médecine et Hygiène, 48, 3672-3676. Peer Reviewed verified by ORBi |
Beguin, Y., Lipscei, G., Oris, R., Thoumsin, H., & Fillet, G. (1990). Serum immunoreactive erythropoietin during pregnancy and in the early postpartum. British Journal of Haematology, 76 (4), 545-9. doi:10.1111/j.1365-2141.1990.tb07914.x Peer Reviewed verified by ORBi |
 | Beguin, Y., Bours, V., Delbrouck, J.-M., Robaye, G., Roelandts, I., Fillet, G., & Weber, G. (1990). Use of PIXE to measure serum copper, zinc, selenium, and bromine in patients with hematologic malignancies. Nuclear Instruments and Methods in Physics Research. Section B, Beam Interactions with Materials and Atoms, B49, 202-204. doi:10.1016/0168-583X(90)90243-N Peer Reviewed verified by ORBi |
Beguin, Y., Fassotte, M.-F., Hay, F., Dokekias, A., Andrien, F., Bours, V., Moutschen, M., Runde, V., Bury, J., & Fillet, G. (1990). Greffes de moelle osseuse: bilan au CHU de Liege. Revue Médicale de Liège, 45 (6), 268-79. Peer reviewed |
 | Fassotte, M.-F., Beguin, Y., Andrien, F., & Fillet, G. (1990). Allogreffes et autogreffes de moelle osseuse. Indications, résultats, perspectives. Médecine et Hygiène, 48, 3666-3671. Peer Reviewed verified by ORBi |
Huebers, H. A., Beguin, Y., Pootrakul, P., Einspahr, D., & Finch, C. A. (1990). Intact transferrin receptors in human plasma and their relation to erythropoiesis. Blood, 75 (1), 102-7. doi:10.1182/blood.v75.1.102.102 Peer Reviewed verified by ORBi |
 | Beguin, Y., Bours, V., Delbrouck, J.-M., Robaye, G., Roelandts, I., & Fillet, G. (1990). Relationship of serum selenium to tumor activity in acute non lymphocytic leukemia (ANLL) and chronic lymohocytic leukemia (CLL). Metal ions in Biology and Medecine, 500-502. Peer reviewed |
Beguin, Y., Bours, V., Delbrouck, J. M., Robaye, G., Roelandts, I., Bury, J., Fillet, G., & Weber, G. (November 1989). Relationship of Serum Selenium Levels to Tumor Activity in Acute Non-Lymphocytic Leukemia. Carcinogenesis, 10 (11), 2089-91. doi:10.1093/carcin/10.11.2089 Peer Reviewed verified by ORBi |
 | Fillet, G., Baldelli, L., & BEGUIN, Y. (1989). Model of reticuloendothelial iron metabolism in humans: abnormal behavior in idiopathic hemochromatosis and in inflammation. Blood, 74 (2), 844-51. doi:10.1182/blood.v74.2.844.bloodjournal742844 Peer Reviewed verified by ORBi |
Beguin, Y., Fillet, G., Bury, J., & Fairon, Y. (1989). Ferrokinetic study of splenic erythropoiesis: relationships among clinical diagnosis, myelofibrosis, splenomegaly, and extramedullary erythropoiesis. American Journal of Hematology, 32 (2), 123-8. doi:10.1002/ajh.2830320209 Peer Reviewed verified by ORBi |
Beguin, Y., Huebers, H. A., Weber, G., Englebert, M., & Finch, C. A. (1989). Hepatocyte iron release in rats. Journal of Laboratory and Clinical Medicine, 113 (3), 346-54. Peer Reviewed verified by ORBi |
Defraigne, J.-O., Closon, M.-T., Bruyninx, L., Dewandre, J., Hourlay, P., Meurisse, M., Honore, P., Bury, J., & Beguin, Y. (1989). Experience with a totally implantable catheter in adult patients: a single institution retrospective study of 114 cases. European Journal of Surgical Oncology, 15 (1), 61-4. Peer Reviewed verified by ORBi |
Fillet, G., & Beguin, Y. (1989). Reutilisation du fer dans l'organisme et regulation du fer de reserve. Interet du dosage du recepteur de la transferrine dans le plasma. Bulletin et Mémoires de l'Académie Royale de Médecine de Belgique, 144 (1-2), 113-8; discussion 118-20. Peer Reviewed verified by ORBi |
Grek, V., Hay, F., Beguin, Y., Andrien, F., Dokekias, A., & Fillet, G. (1989). La leucémie a tricholeucocyte: 30 ans après. Revue Médicale de Liège, 44 (10), 358-64. Peer reviewed |
Beguin, Y., Bergamaschi, G., Huebers, H. A., & Finch, C. A. (1988). The behavior of asialotransferrin-iron in the rat. American Journal of Hematology, 29 (4), 204-10. doi:10.1002/ajh.2830290406 Peer Reviewed verified by ORBi |
Beguin, Y., Huebers, H., & Finch, C. A. (1988). Random distribution of iron among the two binding sites of transferrin in patients with various hematologic disorders. Clinica Chimica Acta, 173 (3), 299-304. doi:10.1016/0009-8981(88)90017-4 Peer Reviewed verified by ORBi |
Beguin, Y., & Fillet, G. (1988). Les états de surcharge en fer: hémosiderose et hémochromatose. Revue Médicale de Liège, 43 (8), 275-82. Peer reviewed |
Beguin, Y., Huebers, H. A., Josephson, B., & Finch, C. A. (1988). Transferrin receptors in rat plasma. Proceedings of the National Academy of Sciences of the United States of America, 85 (2), 637-40. doi:10.1073/pnas.85.2.637 Peer Reviewed verified by ORBi |
Beguin, Y., Stray, S. M., Cazzola, M., Huebers, H. A., & Finch, C. A. (1988). Ferrokinetic measurement of erythropoiesis. Acta Haematologica, 79 (3), 121-6. doi:10.1159/000205743 Peer Reviewed verified by ORBi |
Fillet, G., Bury, J., Beguin, Y., Duvivier, A., Hoyoux, C., & Bours, V. (1987). Les cancers hématologiques en 1987. Chimiothérapie et immunothérapie. Revue Médicale de Liège, 42 (10), 496-502. Peer reviewed |
Beguin, Y., Bury, J., Delbrouck, J. M., Fillet, G., Robaye, G., Roelandts, I., & Weber, G. (1987). Serum zinc and copper as prognostic factors in acute nonlymphocytic leukemia. Haematology and Blood Transfusion, 30, 380-4. doi:10.1007/978-3-642-71213-5_64 Peer Reviewed verified by ORBi |
 | Beguin, Y., Delbrouck, J.-M., Robaye, G., Roelandts, I., Bury, J., Fillet, G., & Weber, G. (1987). Correlation of serum trace elements with other biological parameters in hemoproliferative disorders. Trace element analytical chemistry in medicine and biology, 4, 537-545. Peer reviewed |
Bury, J., Andrien, F., Baudrihaye, M., Beguin, Y., Duvivier, A., Hoyoux, C., Runde, V., & Fillet, G. (1987). Greffe de moelle: résultats préliminaires au CHU. Revue Médicale de Liège, 42 (10), 510-5. Peer reviewed |
Beguin, Y., Brasseur, F., Weber, G., Bury, J., Delbrouck, J.-M., Roelandts, I., Robaye, G., & Fillet, G. (1987). Observations of serum trace elements in chronic lymphocytic leukemia. Cancer, 60 (8), 1842-6. doi:10.1002/1097-0142(19871015)60:8<1842::AID-CNCR2820600828>3.0.CO;2-W Peer Reviewed verified by ORBi |
Beguin, Y., Boniver, J., Bury, J., Defraigne, J.-O., Detroz, B., Fillet, G., & Lejeune, G. (1987). Plasmacytoma of the thyroid: a case report, a study with use of the immunoperoxidase technique, and a review of the literature. Surgery, 101 (4), 496-500. Peer Reviewed verified by ORBi |
 | Andrien, F., Lemaire, M., Beguin, Y., Bury, J., Closon, J., David, J.-L., Dejardin-Closon, M.-T., Duvivier, A., Fillet, G., & Tjean, M. (1986). Second tumors and myeloproliferative diseases after Hodgkin's disease treatment. Leukemia Research, 10, 887. Peer Reviewed verified by ORBi |
Beguin, Y., Weber, G., Delbrouck, J. M., Roelandts, I., Robaye, G., Bury, J., & Fillet, G. (1986). Serum trace elements during chemotherapy for acute myelogenous leukemia. Acta Pharmacologica et Toxicologica, 59 Suppl 7, 270-3. doi:10.1111/j.1600-0773.1986.tb02760.x Peer Reviewed verified by ORBi |
Beguin, Y., Bury, J., Fillet, G., & Lennes. (1985). Treatment of acute nonlymphocytic leukemia in young and elderly patients. Cancer, 56 (11), 2587-92. doi:10.1002/1097-0142(19851201)56:11<2587::AID-CNCR2820561109>3.0.CO;2-8 Peer Reviewed verified by ORBi |
Weber, G., Robaye, G., BARTSCH, P., Collignon, A., Beguin, Y., Roelandts, I., & Delbrouck, J.-M. (1984). Trace element analysis by PIXE in several biomedical fields. Nuclear Instruments and Methods in Physics Research. Section B, Beam Interactions with Materials and Atoms, B3, 326-331. doi:10.1016/0168-583X(84)90388-4 Peer Reviewed verified by ORBi |
 | Burniat, A., Noël, A., Colige, A., Vanderplasschen, A., de Kerchove d'Exaerde, A., Kupper Cardozo, A., Van Keymeulen, A., Moens, A., Bondue, A., Herpain, A., Marchant, A., Loumaye, A., Beck, B., Van den Heyden, B., Corvilain, B., Lakaye, B., Rogister, B., Malgrange, B., Michiels, C., ... Brunko, E. (2023). Cent scientifiques répliquent à SEA (Suppression des Expériences sur l’Animal vivant) et dénoncent sa désinformation. La Libre Belgique. |
 | Baron, F., & Beguin, Y. (2010). GVHD chronique et effet anti-tumoral. Correspondance en Onco-Hématologie, 5, 12-16. |
 | Dresse, M.-F., & Beguin, Y. (2007). Haematopoietic stem cell transplantation for children in Belgium. Tijdschrift van de Belgische Kinderarts, 1, 44-51. |
Hermanne, J.-P., & Beguin, Y. (1997). Use of recombinant human erythropoietin after allogeneic bone marrow transplantation. Erythropoiesis, 8, 80-83. |
 | Beguin, Y., Loo, M., R'Zik, S., Sautois, B., & Fillet, G. (1994). Significance of soluble transferrin receptor. Molecular Biology of Hematopoiesis, 451-464. |
Beguin, Y. (1994). Greffes de moelle dans les hémoglobinopathies. Mini Acta, 26, 249-250. |
Beguin, Y. (1993). Contribution of the soluble transferrin receptor to the quantitative evaluation of erythroid marrow function. Erythropoiesis, 4, 99-109. |
 | Beguin, Y., & Fillet, G. (1991). Erythropoïétine : utilisation diagnostique et thérapeutique. Revue de l'Association Belge des Technologues de Laboratoire, 18 (3), 161-168. |
 | VANDERMEULEN, M., Mohamed Wais, M., DELBOUILLE, M.-H., MAGGIPINTO, G., BEGUIN, Y., & DETRY, O. (August 2021). Long term follow-up of liver transplant recipients after allogeneic mesenchymal stromal cell infusion. Transplant International, 34 (S1 OP282), 45. Peer Reviewed verified by ORBi |
 | Ritacco, C., Ehx, G., Canti, L., DUBOIS, S., Vandenhove, B., SERVAIS, S., Beguin, Y., & Baron, F. (01 March 2020). Ptcy Prevents Xenogeneic Gvhd without Abrogating Gvl Effects. Biology of Blood and Marrow Transplantation, 26 (3), 168. doi:10.1016/j.bbmt.2019.12.028 Peer Reviewed verified by ORBi |
 | VANDERMEULEN, M., MAGGIPINTO, G., JOURET, F., BEGUIN, Y., & DETRY, O. (September 2017). DO MESENCHYMAL STROMAL CELLS PROMOTE HLA SPECIFIC ANTIBODIES FORMATION AFTER INFUSION IN LIVER TRANSPLANT RECIPIENTS? Transplant International, 30 (S2), 548 (PLB051. Peer Reviewed verified by ORBi |
 | Ehx, G., Hannon, M., DUBOIS, S., Daulne, C., Drion, P., BEGUIN, Y., Humblet-Baron, S., & BARON, F. (March 2017). Immunomodulatory effects of rapamycin in xenogeneic Graft versus Host Disease. Biology of Blood and Marrow Transplantation, 23 (3), 365–S366. doi:10.1016/j.bbmt.2016.12.314 Peer Reviewed verified by ORBi |
 | Ehx, G., HANNON, M., Dubois, S., Daulne, C., Drion, P., Beguin, Y., Humblet-Baron, S., & Baron, F. (10 February 2017). Immunomodulatory effects of rapamycin in xenogeneic Graft versus Host Disease. Journal of Clinical Immunology, 37 (2), 197-266. doi:10.1007/s10875-017-0372-z Peer Reviewed verified by ORBi |
 | DETRY, O., VANDERMEULEN, M., DELBOUILLE, M.-H., SOMJA, J., BLETARD, N., BRIQUET, A., LECHANTEUR, C., GIET, O., BAUDOUX, E., Hannon, M., Baron, F., & BEGUIN, Y. (January 2017). UNE INJECTION UNIQUE DE CELLULES STROMALES MESENCHYMATEUSES AU JOUR 3 APRES GREFFE HEPATIQUE EST INSUFFISANTE POUR INDUIRE UNE TOLERANCE OPERATIONNELLE. Transplant International, 30 (suppl 1), 8 (O12. Peer Reviewed verified by ORBi |
 | Farhat, K., Bodart, G., Martens, H., Baron, F., Beguin, Y., Moutschen, M., Salvatori, R., & Geenen, V. (2017). A surprising and dramatic neuroendocrine-immune phenotype of mice deficient in Growth Hormone-Releasing Hormone (GHRH). Neuroimmunomodulation. Peer Reviewed verified by ORBi |
 | HAUZEUR, J.-P., Tungouz, M., LECHANTEUR, C., Beguin, Y., BAUDOUX, E., de maertelaer, V., Pather, S., Katz, R., Ino, J., Egrise, D., Malaise, M., & Gangji, V. (October 2016). Ostéoblastes autologues (PREOB®) versus concentré de moelle autologue dans l’ostéonécrose de la tête fémorale : étude randomisée. Revue de Chirurgie Orthopédique et Traumatologie, 102, 73. doi:10.1016/j.rcot.2016.08.002 Peer reviewed |
 | Ehx, G., Fransolet, G., de Leval, L., D'Hondt, S., Lucas, S., Hannon, M., Delens, L., DUBOIS, S., Drion, P., Beguin, Y., Humblet-Baron, S., & Baron, F. (March 2016). Azacytidine Enhances Regulatory T-Cells In Vivo and Prevents Experimental Xenogeneic Graft-Versus-Host Disease. Biology of Blood and Marrow Transplantation, 22 (3), 393. doi:10.1016/j.bbmt.2015.11.917 Peer Reviewed verified by ORBi |
 | Heusschen, R., Muller, J., Binsfeld, M., Marty, C., Plougonven, E., DUBOIS, S., Mahli, N., Moermans, K., Carmeliet, G., Léonard, A., BARON, F., Cohen-Solal, M., Vanderkerken, K., BEGUIN, Y., Menu, E., & CAERS, J. (2016). SRC kinase inhibition with saracatinib limits the development of osteolytic bone disease in multiple myeloma. Belgian Journal of Hematology. Peer Reviewed verified by ORBi |
 | WEEKERS, L., Erpicum, P., DETRY, O., BONVOISIN, C., BRIQUET, A., LECHANTEUR, C., BAUDOUX, E., JOURET, F., & BEGUIN, Y. (2016). administration of Third-Party Mesenchymal Stromal Cells at the Time of Kidney Transplantation: Interim Safety Analysis at One-Year Follow-Up. Transplant International, 29 (Suppl 2), 13 -p6. Peer Reviewed verified by ORBi |
| Sid, S., LUTTERI, L., BEGUIN, Y., Louis, E., Beckers, A., & VALDES SOCIN, H. G. (2015). Familial thyrogastric autoimmune syndrome : a study of 22 kindreds. In Abstract book - 20th Annual Congress of the Belgian Society of Internal Medicine. |
 | WEEKERS, L., ERPICUM, P., DETRY, O., JOURET, F., LECHANTEUR, C., DELBOUILLE, M.-H., BRIQUET, A., BAUDOUX, E., & BEGUIN, Y. (November 2015). Third-party mesenchymal stem cell infusion in kidney transplant recipient: 6-month safety interim analysis. Transplant International, 28 (S4), 223-224/BO278. Peer Reviewed verified by ORBi |
 | DETRY, O., VANDERMEULEN, M., DELBOUILLE, M.-H., DE ROOVER, A., SOMJA, J., BLETARD, N., BRIQUET, A., LECHANTEUR, C., HONORE, P., & BEGUIN, Y. (November 2015). Infusion of third-party mesenchymal stem cells after liver transplantation: a phase-1, open-label, clinical study. Transplant International, 28 (S4), 10/O27. Peer Reviewed verified by ORBi |
 | WEEKERS, L., ERPICUM, P., DETRY, O., LECHANTEUR, C., BAUDOUX, E., JOURET, F., & BEGUIN, Y. (May 2015). Third-party mesenchymal stem cell infusion in kidney transplant recipient: 6-month safety interim analysis. American Journal of Transplantation, 15 (suppl 3). Peer Reviewed verified by ORBi |
 | DETRY, O., VANDERMEULEN, M., DELBOUILLE, M.-H., DE ROOVER, A., SOMJA, J., BLETARD, N., BRIQUET, A., LECHANTEUR, C., & BEGUIN, Y. (April 2015). Infusion of third-party mesenchymal stromal cells after liver transplantation: a phase 1, open-label, clinical study. Journal of Hepatology, 62 (S2), 311 (P0052. Peer Reviewed verified by ORBi |
 | DETRY, O., VANDERMEULEN, M., DELBOUILLE, M.-H., DE ROOVER, A., SOMJA, J., BLETARD, N., BRIQUET, A., LECHANTEUR, C., & BEGUIN, Y. (March 2015). Infusion of third-party mesenchymal stream cells after liver transplantation: a phase-1, open-label, clinical study. Acta Gastro-Enterologica Belgica, 78 (1), 29. Peer Reviewed verified by ORBi |
| Heusschen, R., Muller, J., Binsfeld, M., Plougonven, E., Mahli, N., Carmeliet, G., Léonard, A., Cohen-Solal, M., Vanderkerken, K., BEGUIN, Y., Menu, E., & CAERS, J. (2015). The SRC inhibitor AZD0530 prevents the development of osteolytic bone disease in multiple myeloma. Blood. Peer Reviewed verified by ORBi |
 | Heusschen, R., Muller, J., Binsfeld, M., Plougonven, E., Mahli, N., Carmeliet, G., Léonard, A., Cohen-Solal, M., Vanderkerken, K., BEGUIN, Y., Menu, E., & CAERS, J. (2015). The SRC inhibitor AZD0530 prevents the development of osteolytic bone disease in multiple myeloma. Blood, 126 (23), 3018. Peer Reviewed verified by ORBi |
| Muller, J., Binsfeld, M., DUBOIS, S., Carmeliet, G., Beguin, Y., Heusschen, R., & CAERS, J. (2015). The anti-angiogenic peptide Anginex blocks osteoclastogenesis. Belgian Journal of Hematology, Abstracts book. Peer Reviewed verified by ORBi |
 | FOGUENNE, J., SIMUL, M., KEUTGENS, A., TASSIN, F., Bonnet, C., BEGUIN, Y., JAMAR, M., LAMBERT, F., & GOTHOT, A. (2015). Multiparameter flow cytometric analysis of composite lymphoma: case report of a mantle cell lymphoma associated with a B-cell chronic lymphocytic leukemia and an aberrant T cell subset. Belgian Journal of Hematology. Peer Reviewed verified by ORBi |
 | BEGUIN, Y., ZACHEE, P., MAERTENS, J., KERRE, T., ORY, A., SEIDEL, L., GRAUX, C., LEWALLE, P., VAN GELDER, M., THEUNISSEN, K., WILLEMS, E., EMONDS, M.-P., DE BECKER, A., & BARON, F. (December 2014). Nonmyeloablative allogeneic hematopoietic cell transplantation following Fludarabine Plus 2 Gy TBI or ATG Plus 8 Gy TLI: a phase II randomized study from the Belgian Hematological Society. Blood, 124 (21), 542. Peer Reviewed verified by ORBi |
 | JASPERS, A., BARON, F., MAERTENS, J., DE PRIJCK, B., SCHOTS, H., BONNET, C., HAFRAOUI, K., WILLEMS, E., SERVAIS, S., FILLET, G., & BEGUIN, Y. (December 2014). Long-term safety follow-up of a rendomized trial of Darbepoetin Alpha and intravenous iron following autologous hematopoietic cell transplantation. Blood, 124 (21), 3948. Peer Reviewed verified by ORBi |
| VALDES SOCIN, H. G., Potorac, I., DE PASQUAL, A., BARON, F., DE PRIJCK, B., Beguin, Y., & Beckers, A. (2014). Leucémie myéloblastique aiguë : sécrétion paranéoplasique de GH et de PRL ? In Abstract book - Annales d'Endocrinologie : 31ème Congrès de la Société Françaose d'Endocrinologie, Lyon 5-8 novembre 2014. |
 | JASPERS, A., Baron, F., WILLEMS, E., HAFRAOUI, K., Bonnet, C., & Beguin, Y. (2014). Long-term survival in patients receiving rhEPO following allogeneic hematopoietic cell transplantation. Belgian Journal of Hematology, 14. Peer Reviewed verified by ORBi |
 | SID, S., Dugauquier, D., DE PRIJCK, B., Bonnet, C., & Beguin, Y. (2014). Hemolytic crisis induced by rasburicase administration revealing G-6-PD deficiency. Belgian Journal of Hematology, 17-18. Peer Reviewed verified by ORBi |
| Heusschen, R., Schulkens, I., Muller, J., Griffoen, A., Beguin, Y., Thijssen, V., & CAERS, J. (2014). Galectins in cancer: jacks of all trades. International Journal of Molecular Medicine. Peer Reviewed verified by ORBi |
 | Binsfeld, M., BEGUIN, Y., Belle, L., Otjacques, E., HANNON, M., BRIQUET, A., Drion, P., Bogen, B., Baron, F., & CAERS, J. (2014). Establishment of a murine graft-versus-myeloma model using allogeneic stem cell transplantation. Belgian Journal of Hematology. |
 | Binsfeld, M., Heusschen, R., Lamour, V., Van Valckenborgh, E., Bellahcene, A., Baron, F., BEGUIN, Y., & CAERS, J. (2014). Multiple myeloma cells instruct myeloid-derived suppressor cells to release pro-angiogenic cytokines. Belgian Journal of Hematology. |
 | Muller, J., CAERS, J., Binsfeld, M., Dubois, S., Carmeliet, G., BEGUIN, Y., & Heusschen, R. (2014). Galectin expression in the multiple myeloma microenvironment. Belgian Journal of Hematology. Peer Reviewed verified by ORBi |
 | Belle, L., Ehx, G., SOMJA, J., BINSFELD, M., Hannon, M., Caers, J., Fransolet, G., Beguin, Y., Humblet-Baron, S., & Baron, F. (December 2013). Combination Of Regulatory T Cells and Rapamycin As Treatment For Experimental Chronic Graft-Versus-Host Disease. Blood, 122 (21), 4474. Peer Reviewed verified by ORBi |
 | Belle, L., BINSFELD, M., DUBOIS, S., Hannon, M., Caers, J., BRIQUET, A., MENTEN, C., BEGUIN, Y., Humblet-Baron, S., & Baron, F. (February 2013). Prevention of murine sclerodermatous chronic graft-versus-host disease by Rapamycin. Biology of Blood and Marrow Transplantation, 19, 317. Peer Reviewed verified by ORBi |
 | Belle, L., Binsfeld, M., HANNON, M., CAERS, J., BRIQUET, A., MENTEN, C., BEGUIN, Y., Humblet-Baron, S., & Baron, F. (2013). Combination of Regulatory T Cells Injection with Rapamycin for Treatment of Chronic Graft-versus-Host Disease. Belgian Journal of Hematology. Peer Reviewed verified by ORBi |
 | Hannon, M., LECHANTEUR, C., Somja, J., Lucas, S., Belle, L., Bruck, F., Baudoux, E., Beguin, Y., Humblet-Baron, S., & Baron, F. (2013). Infusion of CliniMACS (Myltenyi Biotec) Enriched Regulatory T Cells Delays Experimental Xenogeneic Graft-versus-Host Disease. Belgian Journal of Hematology, Abstracts book (Supplement of 28th General Meeting of the Belgian Hematological Society), 15. |
 | JASPERS, A., Baron, F., WILLEMS, E., HAFRAOUI, K., Vanstraelen, G., Bonnet, C., & Beguin, Y. (2013). Erythropoietin therapy after allogeneic hematopoietic cell transplantation : a prospective randomised trial. Belgian Journal of Hematology, 16. Peer Reviewed verified by ORBi |
 | Binsfeld, M., Otjacques, E., Hannon, M., DUBOIS, S., Beguin, Y., Baron, F., & CAERS, J. (2013). The Immunomodulating Peptide Thymosin Alpha 1 Has no Effect on Multiple Myeloma Evolution and on Immune Reconstitution. Belgian Journal of Hematology, Abstracts book (Supplement of 28th General Meeting of the Belgian Hematological Society), 41. |
 | Hannon, M., Humblet-Baron, S., Graux, C., Maertens, J., Kerre, T., Theunissen, K., Daulne, C., Willems, E., Belle, L., Binsfeld, M., Gothot, A., Beguin, Y., & Baron, F. (2013). Comparison of Immune Reconstitution after Hematopoietic Stem Cell Transplantation with Flu-TBI versus TLI-ATG Conditioning. Belgian Journal of Hematology, Abstracts book (Supplement of 28th General Meeting of the Belgian Hematological Society), 38. |
 | Belle, L., BINSFELD, M., Dubois, S., Hannon, M., CAERS, J., BRIQUET, A., MENTEN, C., Beguin, Y., Humbelt-Baron, S., & BARON, F. (April 2012). Rapamycin prevents experimental sclerodermatous chronic graft-versus-host disease in mice. Bone Marrow Transplantation, 47 Suppl 1. Peer Reviewed verified by ORBi |
 | SERVAIS, S., Hannon, M., Daulne, C., Gothot, A., Beguin, Y., & Baron, F. (February 2012). Longitudinal Monitoring of Immune Reconstitution after Allogeneic Peripheral Blood Stem Cell Transplantation (PBSCT): Impact of T-Cell Depletion of the Graft. Biology of Blood and Marrow Transplantation, 18 (2), 274-S275. doi:10.1016/j.bbmt.2011.12.193 Peer Reviewed verified by ORBi |
 | MENTEN, C., Castermans, E., Hannon, M., Ormenese, S., Beguin, Y., & Baron, F. (2012). What is the Contribution of Host-Derived CMV Immunity after Allogeneic Transplantation following Non-Myeloablative Conditioning? Haematologica, 97 (Supplement 1), 720. Peer Reviewed verified by ORBi |
 | MENTEN, C., Castermans, E., Hannon, M., Ormenese, S., Beguin, Y., & Baron, F. (2012). Evidence for Expansion of Host-derived CMV-specific CD8+ T cells after Allogeneic Transplantation with Non-Myeloablative Conditioning. Belgian Journal of Hematology, Abstracts book (Supplement of 27th General Meeting of the Belgian Hematological Society), 16. |
 | Hannon, M., Humblet-Baron, S., Graux, C., Maertens, J., Kerre, T., Theunissen, K., Daulne, C., Willems, E., Belle, L., Binsfeld, M., Gothot, A., Beguin, Y., & Baron, F. (2012). Comparison of Immune Reconstitution after Hematopoietic Stem Cell Transplantation with Flu-TBI versus TLI-ATG Conditioning. Haematologica, 97 (Supplement 1), 180. Peer Reviewed verified by ORBi |
 | Binsfeld, M., Belle, L., Hannon, M., Hofgaard, Dubois, S., Otjacques, E., BEGUIN, Y., Bogen, BARON, F., & CAERS, J. (2012). Adaptation of a murine chronic GvH model to study graftversus- myeloma effect after allogeneic transplantation. Bone Marrow Transplantation, 47 (Suppl.1). Peer Reviewed verified by ORBi |
 | Belle, L., Bruck, F., FOGUENNE, J., Gothot, A., Beguin, Y., Baron, F., & BRIQUET, A. (2012). Imatinib and Nilotinib do not prevent adhesion and migration of human CD34+ in vitro and in immunodeficient mice. Belgian Journal of Hematology. Peer Reviewed verified by ORBi |
 | Binsfeld, M., Belle, L., Hannon, M., DUBOIS, S., Otjacques, E., Beguin, Y., Baron, F., & CAERS, J. (2012). Adaptation of a Murine Chronic GVH Model to Study Graft versus Myeloma Effect after Allogeneic Transplantation. Belgian Journal of Hematology, Abstracts book (Supplement of 27th General Meeting of the Belgian Hematological Society), 16. |
 | Noterdaeme, T., Longree, L., Bataille, C., DE ROOVER, A., LAMPROYE, A., DELWAIDE, J., Beguin, Y., Honoré, P., & DETRY, O. (February 2011). LIVER TRANSPLANTATION FOR ACUTE HEPATIC FAILURE DUE TO CHEMOTHERAPY-INDUCED HEPATITIS B VIRUS REACTIVATION IN LYMPHOMA PATIENTS. Transplant International, 24 (1), 10-10. Peer Reviewed verified by ORBi |
 | BERNARD, C., HAUZEUR, J.-P., LECHANTEUR, C., VAN CAUWENBERGE, H., BEGUIN, Y., MALAISE, M., KURTH, W., GILLET, P., & HUSTINX, R. (2011). Evaluation of the homing process in the treatment of atrophic nonunion fractures by percutaneous autologous osteoblast cell implantation. Journal of Nuclear Medicine, 52 (SUPPL), 510. Peer Reviewed verified by ORBi |
 | Belle, L., Baron, F., Bruck, F., Hannon, M., SERVAIS, S., Beguin, Y., & BRIQUET, A. (2011). Despite inhibitory effects on normal hematopoiesis in vitro, Imatinib and Nilotinib do not prevent engraftment of human CD34+ HSCs in immunodeficient NSG mice. Belgian Journal of Hematology. Peer Reviewed verified by ORBi |
 | SERVAIS, S., Hannon, M., Daulne, C., Gothot, A., Beguin, Y., & Baron, F. (2011). Longitudinal Monitoring of Immune Reconstitution After Allogeneic Peripheral Blood Stem Cell Transplantation (HSCT): Impact of T Cell Depletion of the Graft. Belgian Journal of Hematology, Abstracts book (Supplement of 26th General Meeting of the Belgian Hematological Society), 31. |
 | Hannon, M., Humblet-Baron, S., Graux, C., Maertens, J., Kerre, T., Daulne, C., Willems, E., Gothot, A., Beguin, Y., & Baron, F. (2011). Comparison of Immune Reconstitution after Non-myeloablative Hematopoietic Cell Transplantation (HCT) with Flu-TBI versus TLI-ATG Conditioning. Belgian Journal of Hematology, Abstracts book (Supplement of 26th General Meeting of the Belgian Hematological Society), 8. |
 | Humblet-Baron, S., CASTERMANS, E., Vanbellinghen, J.-F., Hannon, M., Jacobs, N., WILLEMS, E., Ormenese, S., Beguin, Y., & Baron, F. (February 2009). What Is The Role For Regulatory T-Cells After Nonmyeloablative Conditioning? Biology of Blood and Marrow Transplantation, 15 (2), 122-123. doi:10.1016/j.bbmt.2008.12.377 Peer Reviewed verified by ORBi |
 | Castermans, E., Hannon, M., Cheynier, R., Seidel, L., Humblet-Baron, S., WILLEMS, E., Corbier, S., Gothot, A., Geenen, V., Sandmaier, B. M., Storb, R. F., Beguin, Y., & Baron, F. (2009). Thymic Recovery After Allogeneic Hematopoietic Cell Transplantation with Nonmyeloablative Conditioning Might Be Limited to Patients Younger Than 60 Years of Age. Blood, 114 (22), 1149. Peer Reviewed verified by ORBi |
 | Briquet, A., Dolhet, M., Beguin, Y., & Gothot, A. (2009). Inhibition of the Jagged-1/Notch pathway increases the hematopoiesis-supportive activity of mesenchymal stem cells. Experimental Hematology, 37 (9), 77. Peer reviewed |
 | Humblet-Baron, S., CASTERMANS, E., Vanbellighen, J.-F., Hannon, M., Jacobs, N., Beguin, Y., & Baron, F. (February 2008). What is the Role for Regulatory T-Cells after Nonmyeloablative conditioning. Biology of Blood and Marrow Transplantation, 14 (2), 136-137. doi:10.1016/j.bbmt.2007.12.383 Peer Reviewed verified by ORBi |
 | Briquet, A., Beguin, Y., & Gothot, A. (September 2007). The hematopoiesis-supporting activity of mesenchymal stem cells increases with the number of passages. Experimental Hematology, 35 (9, Suppl. 2), 125-125. Peer reviewed |
 | Briquet, A., Dolhet, M., Demeuse, J., BEGUIN, Y., & GOTHOT, A. (August 2007). Study of contribution of signalling pathways Notch, Wnt, Shh and BMP in mesenchymal stem cell prohaematopoietic activity. Acta Clinica Belgica, 62 (4), 256. Peer Reviewed verified by ORBi |
 | Jerusalem, G., Silvestre, R., Beguin, Y., Hustinx, R., Fassotte, M.-F., & Fillet, G. (20 June 2006). FDG-PET for the routine follow-up in NHL: First prospective evaluation. Journal of Clinical Oncology, 24 (18, Part 1 Suppl. S), 439. Peer Reviewed verified by ORBi |
Castermans, E., Baron, F., Willems, E., Meuris, N., Schaaf-Lafontaine, N., Reynier, R., Geenen, V., & Beguin, Y. (2006). Immune reconstitution after CD8-depleted or unmanipulated peripheral blood stem cells transplantation with nonmyeloablative conditioning. Acta Clinica Belgica, 61 (2), 113. Peer Reviewed verified by ORBi |
 | WILLEMS, E., CASTERMANS, E., Baron, F., BAUDOUX, E., Wanten, N., Bonnet, C., HAFRAOUI, K., Frère, P., Fillet, G., & Beguin, Y. (2005). Nonmyeloablative stem cell transplantation with CD8-depleted or unmanipulated peripheral blood stem cells: a prospective randomized trial. Blood, 106 (1075). Peer Reviewed verified by ORBi |
 | Bovy, C., Beguin, Y., Gothot, A., Rorive, G., & Krzesinski, J.-M. (2003). Hypochromic mature erythrocytes: a specific marker of iron deficiency. Acta Clinica Belgica, 58-3 (4), 325. Peer Reviewed verified by ORBi |
 | Bovy, C., Beguin, Y., Gothot, A., Rorive, G., & Krzesinski, J.-M. (2003). Follow-up of iron microalbuminuria in hypertensive patients: a belgian promise survey. Acta Clinica Belgica, 58-3 (4), 328. Peer Reviewed verified by ORBi |
 | JERUSALEM, G., BEGUIN, Y., FASSOTTE, M.-F., BELHOCINE, T., HUSTINX, R., RIGO, P., & FILLET, G. (2000). Early detection of relapse by whole-body positron emission tomography (PET) using 18F-fluorodeoxyglucose (18F-FDG) in the follow-up of patients with Hodgkin’s disease (HD). PROCEEDINGS OF AMERICAN SOCIETY OF CLINICAL ONCOLOGY ANNUAL MEETING 2000, 19, 10. Peer reviewed |
 | Beguin, C., Kwan, O., Ritacco, C., Debray, J.-C., Dejardin, E., Dubois, S., Köse, M. C., Canti, L., Courtois, J., Seidel, L., Daulne, C., Caers, J., Beguin, Y., Ehx, G., & Baron, F. (17 November 2023). TNF-α priming of human regulatory T cells does not increase their ability to prevent xenogeneic graft-versus-host disease [Paper presentation]. Congrès annuel de la Société Francophone de Greffe de Moelle et Thérapie Cellulaire, Lille, France. Peer reviewed |
 | Kwan, O., Canti, L., Ehx, G., Beguin, Y., Humblet-Baron, S., & Baron, F. (16 November 2023). Utilisation de techniques de biologie des systèmes pour une analyse détaillée de la réponse immunitaire au vaccin à ARN messager BNT162b2 chez les patients ayant bénéficié d'une allogreffe [Paper presentation]. 26ème Congrès Annuel de l'Association Française de Cytométrie 2023, Toulouse, France. Peer reviewed |
 | Bodart, G., THYS, M., GANGOLF, M., CUNIN, M.-P., LAMBERT, F., POUSTOVOITOV, A., Beguin, Y., Kolh, P., & Jacques, J. (2022). Développement d’un outil de pilotage des patients oncologiques au CHU de Liège [Paper presentation]. Giseh 2022, Saint-Etienne, France. Peer reviewed |
 | Mina, M., Horrion Jil, SERVAIS, S., BEGUIN, Y., DRESSE, M.-F., MALAISE, M., & MALAISE, O. (September 2019). Multiple vertebral fractures after bone marrow transplantation in a young patient with sickle cell disease? [Paper presentation]. Belgian Congress of Rheumatology. Peer reviewed |
| Mina, M., Horrion, J., SERVAIS, S., BEGUIN, Y., DRESSE, M.-F., Malaise, M., & MALAISE, O. (March 2019). Multiple vertebral fractures after bone marrow transplantation in a young patient with sickle cell disease? [Paper presentation]. Bone Curriculum Symposium 2019. Peer reviewed |
